thiazoles has been researched along with Body Weight in 338 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 70 (20.71) | 18.7374 |
1990's | 62 (18.34) | 18.2507 |
2000's | 135 (39.94) | 29.6817 |
2010's | 64 (18.93) | 24.3611 |
2020's | 7 (2.07) | 2.80 |
Authors | Studies |
---|---|
Antman, EM; Berger, D; Braunwald, E; Chen, C; Eisen, A; Gencer, B; Giugliano, RP; Grip, LT; Lanz, H; Murphy, SA; Nordio, F; Ruff, CT | 1 |
Alarcan, J; Braeuning, A; Kumar, V; Lampen, A; Lichtenstein, D; Luckert, C; Marx-Stoelting, P; Peijnenburg, A; Sharma, RP; Solano, MLM; Stoopen, G; Waizenegger, J | 1 |
Abbasnezhad, A; Abd El-Ghafar, OA; Abhilash, L; Abouzid, KAM; Achberger, AM; Ackerman, S; Akhatayeva, Z; Akin, D; Al-Kaysi, RO; Alakhdar, AA; Alame, M; Aleksic Sabo, V; Alinezhadbalalami, N; Allen, JD; Alonso, JM; Alqatani, S; Alsayed, B; Álvarez Larraondo, M; Alvarez, M; Amini, SB; An, Z; Anasir, MI; Anderson, GH; Andremont, A; Andrés, S; Angel, S; Anigboro, AA; Anini, Y; Antonides, CFJ; Arafa, K; Arafa, RK; Aryal, UK; Asbaghi, O; Assefa, MK; Atyah, M; Avwioroko, OJ; Ayora-Talavera, G; Azpilikueta, A; Azyazov, VN; Ba, YF; Bachmann, KF; Badoual, J; Bae, SJ; Baek, SH; Bahrami, B; Bai, J; Baid-Agrawal, S; Bailey, MR; Baillie, JK; Balani, N; Balcar, VJ; Banica, T; Banks, L; Barb, J; Bardeen, CJ; Barrett, HE; Bartnikowski, N; Bashir, R; Battaglia, M; Bautista-Hernández, V; Becker, B; Beekman, FJ; Benidir, M; Benjelloun, M; Bentley, RF; Bergé, J; Berger, D; Bernsen, MR; Berraondo, P; Bhattacharya, R; Bhayani, SB; Bi, W; Bi, X; Bi, YL; Bi, Z; Bian, K; Biesecker, LG; Billadeau, DD; Blaszczyk, R; Blum, JL; Boachie, R; Boelte, K; Bogers, AJJC; Boileau, I; Bonduelle, C; Bonny, O; Bonsu, JM; Boos, LA; Borges-Argáez, R; Bouchard, PA; Boudot, C; Bourgeade-Delmas, S; Boutet-Robinet, E; Boyle, AJ; Branigan, D; Briones, S; Broniowska, KA; Brossas, JY; Brown, WA; Brzezinska, J; Buitron, G; Burnier, M; Bursulaya, B; Burton, PR; Bush, AA; Busuttil, RW; Cabello-Aguilar, S; Cáceres-Farfán, M; Cacheux, V; Caffrey, PJ; Cai, B; Cai, Q; Cai, S; Cai, Y; Calders, P; Cammarota, G; Campbell, DA; Cancelli, C; Cao, Q; Cao, WH; Cao, X; Capet, M; Capoluongo, E; Carey, ME; Carnero, M; Carrasco, LI; Carreno, J; Carrillo-Reyes, J; Casini, I; Cassar, M; Catalan, G; Cattamanchi, A; Cazares-Granillo, M; Celie, B; Cen, YK; Cena, H; Cerbo, RM; Ceron, E; Cetina-Montejo, L; Chaâbane-Banaoues, R; Chabanet, C; Chace-Donahue, F; Chalfun-Júnior, A; Chan-Balan, R; Chang, CS; Chen, CS; Chen, D; Chen, J; Chen, L; Chen, PN; Chen, Q; Chen, S; Chen, W; Chen, WP; Chen, X; Chen, Z; Cheng, H; Cheng, J; Cheng, Q; Cheng, T; Chi, T; Chianelli, D; Chieppa, M; Child, CJ; Cho, JH; Cho, JY; Chogtu, B; Choi, GH; Choi, J; Choi, M; Choi, NG; Cholu, CO; Chow, ES; Chowdhury, AH; Chu, PC; Chu, Q; Chu, S; Chua, H; Chung, T; Chunyan, L; Church, JS; Civardi, E; Cobiella, J; Colinge, J; Collado, CJ; Collins, TJ; Cong, LM; Conkrite, KL; Cope, SJ; Corbett, JA; Cornet, M; Cornillot, E; Corvaisier, S; Costes-Martineau, V; Courtioux, B; Coussens, M; Covino, M; Criado, A; Cui, J; Cui, Y; Cunitz, BW; Curry, AE; Cussó, L; D'Urzo, AD; D'Urzo, KA; Dabbous, S; Dahlgren, RA; Dai, H; Dai, T; Dai, W; Dalinghaus, M; Dang, S; Davalos, RV; Davidson, H; de Andrea, CE; De Angelis, M; de Blois, E; de Carvalho, PA; De Clercq, E; De Giuseppe, R; de Jong, M; De Langhe, S; De Oliveira, L; de Souza Pinto Lemgruber, R; de Souza, LB; de Swart, J; De Wandele, I; de Woestijne, PCV; Delaney, S; Delorme, M; Delvenne, P; Deng, L; Deng, Z; Denkinger, CM; der Meulen, MHV; Deraeve, C; Desco, M; DeSilva, S; Destere, A; Dhali, A; Di Ciano, P; Dias-Santagata, D; Diskin, SJ; Djè, MK; Doddipatla, S; Doerr, AJ; Dokla, EME; Domiciano, D; Domingo, N; Dong, C; Dong, J; Dong, Q; Dong, S; Dong, X; Dong, Z; Douair, I; Douglas, TA; Doyle, SM; Drain, PK; Du, K; Du, L; Du, Q; Du, S; Duan, C; Duan, H; Duan, J; Duan, S; Duan, W; Dueluzeau, R; Dukic, L; Dunmire, BL; Duvauchelle, T; Dymek, B; Dzwonek, K; Earnest, A; Eckardt, KU; El Ghadraoui, L; El Massoudi, S; Elloumi, F; Elnour, IE; Embarak, S; Ende, M; England, K; Enikeev, D; Enyedy, I; Epple, R; Erickson, GE; Eriksson, J; Erndt-Marino, J; Errachidi, F; Etxeberria, I; Evan, AP; Fairlamb, AH; Falahi, E; Fan, CC; Fan, H; Fan, M; Fan, MZ; Fan, S; Fan, Y; Fang, CS; Fang, J; Fang, X; Fang, Z; Farmany, A; Farooqi, A; Farouk, HO; Fazelipour, S; Feng, D; Feng, J; Feng, JX; Feng, YL; Ferraz, SL; Ferreira, CR; Figenshau, RS; Finn, AV; Fiseha, T; Fleischer, AS; Fogleman, AD; Fontaine, O; Ford, CR; Fouladvand, F; Four, M; Fousteri, G; Francis, JR; Fraser, JF; Frazier, RP; Fu, H; Fu, P; Fu, YJ; Fujishima, A; Fuster, V; Gabilan, JC; Gagliani, N; Gai, QY; Galán-Arriola, C; Gale, P; Galimova, GR; Galkin, A; Gallo, A; Gallo, AA; Gang, DD; Ganschow, S; Gao, C; Gao, F; Gao, GP; Gao, H; Gao, K; Gao, M; Gao, MY; Gao, P; Gao, R; Gao, S; Gao, WJ; Gao, Y; Garbacz, P; García Ruiz, L; Garcia, EM; Garofoli, F; Gasbarrini, A; Gattinoni, L; Gaudig, M; Gbureck, U; Ge, X; Genko, N; Gentile, GL; George, MW; Gerety, GF; Gestwicki, JE; Geusens, PP; Ghassemi, M; Giardina, JD; Giebultowicz, JM; Gifford, CA; Gijsen, FJH; Gilfillan, R; Gilson, E; Gingl, K; Giuliano, C; Glybochko, P; Goessler, W; Gofflot, S; Golab, J; Goldstein, A; Golebiowski, A; Gómez, L; Gómez-Carballo, J; Gonçalves, PEO; Gonzales, R; Gonzalez-Cotto, M; González-Fernández, D; Gonzalez-Lopez de Turiso, F; Goodman, JM; Govinda Raju, S; Grimm, J; Gross, AJ; Gruenheid, S; Gu, C; Gu, FF; Gu, S; Gu, Z; Guest, RL; Gui, C; Gui, J; Guillem, A; Guo, G; Guo, L; Guo, Q; Guo, S; Guo, SW; Guo, W; Guo, Y; Guo, YG; Guo, Z; Guretzky, JA; Haenggi, M; Hahn, MS; Hakkola, J; Halim, AA; Hampel, D; Han, B; Han, BH; Han, D; Han, G; Han, J; Han, LZ; Han, R; Han, S; Han, X; Han, Z; Handley, MA; Hanke, I; Hannongbua, S; Hao, P; Happ, JT; Hara, M; Haraux, F; Hare, JL; Harper, JD; Hartley, AM; Harvey, E; Hashimoto, K; Hassan, HM; Hautajärvi, H; Hayton, TW; He, C; He, H; He, HJ; He, WP; He, Y; He, Z; Hedrick, V; Heffernan, JK; Hegrová, J; Heidarimoghadam, R; Helms, K; Hengphasatporn, K; Henry, D; Herrmann, TRW; Hesson, T; Himmelbauer, MK; Hindle, A; Hoffmann, R; Hogg, N; Hong, KB; Hong, SK; Honjol, Y; Hood, C; Hsi, RS; Hsu, JL; Hu, B; Hu, BC; Hu, D; Hu, H; Hu, J; Hu, K; Hu, M; Hu, MK; Hu, T; Hu, W; Hu, Y; Hu, Z; Hua, S; Huang, H; Huang, J; Huang, L; Huang, M; Huang, P; Huang, X; Huang, Y; Huang, Z; Hukkanen, J; Hung, MC; Huo, X; Hyötyläinen, T; Ianiro, G; Ibanez, B; Imran, M; Ireland, S; Irwin, MS; Ishiguro, H; Jackowski, K; Jackson, C; Jacob, SI; Jahromy, MH; Jakob, SM; Jang, J; Javvaji, PK; Jefferson, KK; Jena, P; Ji, H; Jiang, F; Jiang, GH; Jiang, H; Jiang, J; Jiang, X; Jiang, Z; Jiao, J; Jiménez, A; Jin, X; Jincai, W; Jintao, X; Jo, K; Jofra, T; Johari, Y; Johnson, ACM; Jones, JH; Josephine Fauci, A; Juhl, AK; Jun, S; Kaiser, RI; Kajioka, J; Kajiyama, H; Kalliyil, A; Kalthur, SG; Kamalanathan, M; Kamaldinov, T; Kanaani, L; Kang, D; Kang, J; Kang, S; Känsäkoski, P; Kaplan, DL; Karwan, M; Kasibhatla, S; Kaur, A; Kawazoe, Y; Ke, C; Keyser, J; Khalique, A; Khan, IT; Kharshoum, RM; Kher, R; Kherani, J; Ki, KK; Kikkawa, F; Kikkawa, R; Kim, BT; Kim, EH; Kim, GA; Kim, GD; Kim, HB; Kim, HG; Kim, JS; Kim, MJ; Kim, SI; Kim, SJ; Kim, Y; King, K; Kinyamu-Akunda, J; Kirkkala, T; Kjaer-Sorensen, K; Kleppinger, EL; Kloner, RA; Klopfenstein, TJ; Knappe, D; Knezevic, P; Kobos, LM; Kohli, M; Kolano, L; Kolodgie, FD; Kolte, AP; Koneru, B; Kong, D; Kong, F; Kong, X; Konggidinata, MI; Köpke, M; Koski, KG; Kotsis, F; Köttgen, A; Kouakou-Kouamé, CA; Kraemer, US; Krane, V; Krehbiel, CR; Krenning, BJ; Kretzschmar, D; Ku, KB; Kubota, Y; Kulich, P; Kumar, NG; Kupiec-Weglinski, JW; Lalani, SS; Lan, X; Landfeldt, E; Langenberg, E; Lapauw, B; Larkin, J; Lassoued, MA; Laukhtina, E; Laura Martinez, J; Laveillé, A; Lavela, P; Law, AD; Lazraq, A; Le Foll, B; Lee, BK; Lee, C; Lee, CS; Lee, EJ; Lee, EY; Lee, G; Lee, HY; Lee, JH; Lee, JJ; Lee, JO; Lee, JS; Lee, R; Lei, H; Lei, P; Lellouche, F; Lennerz, JK; Leong, W; Leslie, I; Lessem, E; Levin, M; Levinger, I; Li, C; Li, CW; Li, CX; Li, CY; Li, D; Li, H; Li, HM; Li, J; Li, L; Li, LM; Li, N; Li, S; Li, W; Li, X; Li, XX; Li, Y; Li, Z; Li, ZL; Li, ZX; Lian, Q; Liang, C; Liang, GH; Liang, H; Liang, J; Liang, X; Liao, CX; Liao, R; Ličbinský, R; Lim, YS; Lima, HK; Lin, JG; Lin, L; Lin, S; Lin, WP; Lin, Z; Liso, M; Liu, BX; Liu, C; Liu, H; Liu, J; Liu, M; Liu, Q; Liu, S; Liu, SF; Liu, SL; Liu, T; Liu, W; Liu, X; Liu, XB; Liu, Y; Liu, YY; Liu, Z; Liu, ZQ; Lobo, M; Loitzenbauer, M; López, F; Lopez, G; López, GJ; Lou, Z; Lu, IC; Lu, J; Lu, M; Lu, W; Lu, X; Lu, Y; Luhovyy, BL; Luna-Abanto, J; Luo, J; Luo, K; Luo, L; Luo, M; Luo, W; Luo, X; Luo, XM; Lv, Y; Lv, YQ; Lyu, HD; Lyu, J; Ma, C; Ma, G; Ma, L; Ma, Q; Ma, X; Ma, Y; Macha, SJ; MacLean, E; Mahalapbutr, P; Maina, T; Malfait, F; Malfertheiner, MV; Malzert-Fréon, A; Mansouri, E; Mao, C; Marcellin, E; Marchiori, PER; Marcotte, DJ; Maréchal, A; Maric, N; Maris, JM; Maron, L; Marti, CN; Martínez-Milla, J; Mateo, J; Mather, K; Mathison, CJN; Matthay, MA; Maxwell, CL; Mazier, D; Mazumder, D; Mazurkiewicz, M; Mazzucchelli, TG; McAuley, DF; Mccoy, K; McVicar, DW; Mebel, AM; Mech, A; Meester, EJ; Meiselbach, H; Melero, I; Ménard, G; Meng, X; Mengya, Y; Merle, G; Meunier, B; Mfarrej, B; Mi, K; Migueliz, I; Mikuška, P; Miladi, K; Miletich, R; Millar, JE; Mills, MR; Milne, R; Minute, L; Misiak, M; Mo, F; Modi, A; Mok, F; Molina, C; Mollen, CJ; Molteni, V; Montalto, M; Montet, D; Monti, MC; Moor, MB; Moravec, P; Morsiani, C; Murillo, E; Murugan, P; Muslem, R; Myers, RK; N'guessan, FK; Nabil, H; Nadal, J; Nadeem, M; Nafady, MM; Nafie, MS; Nair, HP; Nakano, R; Nance, J; Naren, N; Neil, CJ; Nelson, J; Nery, FC; Netsch, C; Nguyen, TH; Ni, L; Ni, YX; Nie, W; Nielsen, LK; Nigam, K; Nikolayev, AA; Nishiyama, M; Niu, LL; Niu, PP; Nock, BA; Noer, PR; Noll, G; Noll, S; Norenberg, JP; Nowicka, J; Nutho, B; O'Connor, M; Obonyo, NG; Ochiai, T; Ochoa, MC; Oh, BL; Oh, S; Olczak, J; Olivares, X; Ommurugan, B; Oosthuizen, MC; Operario, D; Orešič, M; Oshima, K; Otano, I; Ou, Y; Owen, TW; Oxvig, C; Pacey, V; Pai, M; Paik, H; Paiva, R; Palmieri, EM; Palpant, N; Pan, L; Pan, Q; Panahi, S; Pang, B; Pang, ZC; Pannecouque, C; Paris, L; Park, D; Park, DJ; Park, E; Park, EC; Park, IH; Park, JH; Park, JI; Park, S; Passmore, MR; Pattaranggoon, NC; Paun, M; Pedersen, S; Pedron, J; Peng, M; Peng, X; Penzhorn, BL; Pérez-Camargo, D; Perez-Maldonado, R; Pérez-Vicente, C; Pham, TD; Pickering, L; Pickersgill, NA; Pinault, E; Pinotsis, N; Plan, M; Pocino, K; Poh, CL; Pons, EDC; Popoff, MR; Porri, D; Pourmand, A; Pratviel, G; Prudente, DO; Qi, H; Qi, N; Qian, LY; Qiao, L; Qiao, Q; Qin, QP; Qiu, N; Qiu, SW; Qu, F; Quan, M; Quigg, A; Raee, E; Raibaud, P; Ramanitrahasimbola, D; Rapoport, L; Rasby, RJ; Rasoanirina, BNV; Raspini, B; Ratner, JR; Razafindrakoto, Z; Redd, MA; Ren, H; Ren, N; Rey, J; Reynolds, CP; Rich, PR; Richards, CJ; Rigol, M; Rimoldi, S; Robert, P; Rodrigues, AE; Roe, JH; Rohde, S; Rokita, JL; Roland, J; Rombaut, L; Ronkainen, J; Rothenberg, SM; Roy, SC; Ruan, Z; Rucker, PV; Rueda, D; Ruhwald, M; Rungrotmongkol, T; Rupert, AS; Rusjan, P; Ryabov, AD; Rysä, J; Saad, NES; Sabioni, P; Sadow, PM; Sahai, N; Salem, HF; Salinas, B; Salonurmi, T; Samé Guerra, D; Sánchez, J; Sanchez-González, J; Sanmamed, MF; Sansores-Peraza, P; Santoro, JC; Santschi, PH; Saritas, T; Sarkisova, Y; Savolainen, MJ; Scherberich, JE; Schlom, DG; Schmelz, EM; Schmid, MC; Schneider, MP; Schumacher, S; Schwartz, JC; Schwartzer, JJ; Schwehr, K; Schweitzer, DH; Scott, ME; Sedky, NK; See Hoe, L; Sejian, V; Selvaraju, S; Sen, SK; Seo, G; Šerý, O; Settles, JA; Sfar, S; Shaffer, J; Shan, GL; Shang, Q; Shannahan, JH; Shao, B; Shao, H; Shao, J; Shao, ZH; Shasha, Y; Shaw, K; Sheeba, V; Shekar, K; Shen, G; Shen, H; Shen, XD; Shen, Y; Sherrell, PC; Shete, PB; Shi, AX; Shi, J; Shi, JH; Shi, S; Shi, X; Shigeta, Y; Shimbo, A; Shin, E; Sikka, N; Silhavy, TJ; Simanon, N; Simard, S; Simon, J; Simon, M; Simpson, SD; Simundic, AM; Since, M; Singh, B; Singhroy, DN; Sinisterra, OT; Smith, EH; Sobreira, TJP; Solanes, N; Somasundar, Y; Sommerer, C; Sonei, A; Song, B; Song, E; Song, J; Song, M; Song, Y; Soo Lee, M; Sorensen, MD; Sournia-Saquet, A; Spaepen, E; Spirk, D; Srivastava, S; Stancill, JS; Stanczak, PS; Starenki, D; Starr, F; Step, DL; Steubl, D; Stigliani, JL; Stráská, J; Sträter, N; Su, ZZ; Sudano, I; Suen, JY; Suh, HJ; Sui, ZY; Suico, JG; Suleiman, K; Sumon, K; Sun, HB; Sun, J; Sun, L; Sun, LL; Sun, M; Sun, Q; Sun, W; Sun, X; Sun, XF; Sun, Y; Sun, YB; Sun, YH; Sun, YN; Sun, Z; Sunada, K; Suzuki, S; Sylvan, JB; Takala, J; Talla, D; Tamir, Z; Tan, SJ; Tanda, S; Tang, H; Tang, J; Tang, LF; Tang, SJ; Tang, Y; Tao, FB; Tappel, R; Taratkin, M; Teijeira, Á; Tellew, JE; Thomas, AM; Thomas, SG; Thomson, SR; Tian, J; Tie, Y; Tirado, JL; Tolonen, A; Tosato, G; Tronnet, A; Tsai, S; Turtoi, A; Turtoi, E; Tvrdoňová, M; Tyagi, A; Tzou, DT; Uddin Ahmad, Z; Urias, E; Usawachintachit, M; Ustriyana, P; Utsumi, F; Vacca, M; Vaculovič, T; Vaidya, SS; Valentin, A; Valgepea, K; van den Berg, P; van den Bergh, JP; van der Heiden, K; van Gaalen, K; Van Gemert, W; van Haard, PMM; van Hest, JCM; Vecchiarelli, E; Večeřa, Z; Venkatesh, R; Verhaeghe, P; Verhagen, HJ; Vetter, JM; Vieira, D; Vilchez-Tschischke, JP; Villena-Gutierrez, R; Villoslada Terrones, V; Vital-Jacome, M; Voelkl, J; Vogel, K; Vogrin, S; Volke, D; von Bahr, V; Vysloužil, J; Wade, TL; Wagner-Gillespie, M; Walsh, SW; Wan, LJ; Wan, SP; Wang, AL; Wang, B; Wang, BY; Wang, C; Wang, D; Wang, F; Wang, H; Wang, HR; Wang, HY; Wang, J; Wang, JY; Wang, K; Wang, L; Wang, LF; Wang, P; Wang, Q; Wang, R; Wang, SF; Wang, SP; Wang, SR; Wang, T; Wang, W; Wang, WP; Wang, X; Wang, XJ; Wang, Y; Wang, YL; Wang, YN; Wáng, YXJ; Wang, Z; Wang, ZF; Wang, ZY; Waning, B; Warner, JM; Washington, SL; Watson, AK; Wei, B; Wei, C; Wei, F; Wei, X; Wei, Y; Wemhoff, AP; Wen, Z; Weng, TT; Wesdemiotis, C; Wheeler, DA; Wildner, M; Wilson, BK; Wirth, LJ; Wissler, M; Wu, F; Wu, G; Wu, J; Wu, KH; Wu, MC; Wu, P; Wu, PK; Wu, S; Wu, W; Wu, X; Wu, XP; Wu, Y; Wyatt, E; Wyllie, S; Xia, Y; Xiao, BH; Xiao, SZ; Xiao, W; Xiao, X; Xiao, Z; Xie, D; Xie, K; Xie, X; Xie, Y; Xie, YF; Xin, S; Xin, Z; Xing, Q; Xing, WQ; Xiong, D; Xiong, X; Xu, C; Xu, D; Xu, F; Xu, G; Xu, H; Xu, J; Xu, JY; Xu, L; Xu, N; Xu, W; Xu, X; Xu, Y; Xu, YM; Xue, H; Xue, J; Xue, Z; Yan, R; Yan, SQ; Yan, W; Yan, X; Yan, Z; Yang, C; Yang, D; Yang, F; Yang, FC; Yang, G; Yang, J; Yang, M; Yang, P; Yang, Q; Yang, R; Yang, S; Yang, SJ; Yang, TWW; Yang, X; Yang, Y; Yang, Z; Yao, C; Yao, L; Yao, LP; Yao, M; Yao, T; Yao, W; Yao, Y; Yaseen, T; Yazdani, V; Ye, J; Ye, S; Yerys, BE; Yi, HWL; Yi, JL; Yin, F; Yin, J; Yin, Y; Yin, Z; Yong, ZP; Yongli, S; Yoo, JS; Yoshikawa, N; You, Q; Yu, B; Yu, CQ; Yu, H; Yu, HG; Yu, J; Yu, L; Yu, Q; Yu, X; Yu, Y; Yu, YK; Yu, Z; Yuan, Q; Yuan, R; Yuan, W; Yuan, X; Yuan, Y; Zager, RA; Zagozdzon, A; Zaller, N; Zang, YP; Zappi, ME; Zelikoff, JT; Zeman, T; Zhai, X; Zhan, P; Zhang, B; Zhang, C; Zhang, G; Zhang, H; Zhang, HB; Zhang, J; Zhang, JS; Zhang, L; Zhang, M; Zhang, Q; Zhang, RX; Zhang, S; Zhang, T; Zhang, W; Zhang, WH; Zhang, X; Zhang, XX; Zhang, Y; Zhang, YQ; Zhang, YW; Zhang, Z; Zhang, ZH; Zhao, D; Zhao, FL; Zhao, K; Zhao, L; Zhao, M; Zhao, R; Zhao, S; Zhao, W; Zhao, WG; Zhao, X; Zhao, Y; Zheng, G; Zheng, J; Zheng, S; Zheng, W; Zheng, Y; Zheng, YG; Zhong, Z; Zhou, C; Zhou, D; Zhou, H; Zhou, HY; Zhou, L; Zhou, Q; Zhou, X; Zhou, Y; Zhou, YL; Zhou, Z; Zhu, J; Zhu, L; Zhu, N; Zhu, X; Zhu, XF; Zhu, Y; Zhu, Z | 1 |
DeBoer, MD; Donowitz, JR; Elwood, SE; Gratz, J; Houpt, ER; Jatosh, S; Katengu, S; Kivuyo, S; McDermid, JM; Mdoe, P; Mduma, E; Parpia, TC; Platts-Mills, JA; Rogawski McQuade, ET; Scharf, RJ; Svensen, E; Swann, JR; Wanjuhi, AW | 1 |
Antoine, B; Auclair, M; Capel, E; Fève, B; Roblot, N | 1 |
Jung, DW; Kim, HJ; Kim, JH; Kim, SW; Lee, JH; Um, J; Williams, DR | 1 |
Bang, E; Chun, P; Chung, HY; Kim, DH; Kim, MJ; Moon, HR; Noh, SG; Yokozawa, T | 1 |
Dai, YL; Li, KW; Li, Y; Liang, YY; Niu, FJ; Wan, XH; Wang, YY; Wei, HC; Zhou, CZ | 1 |
Adil, M; Ali, MR; Bawa, S; Paudel, YN; Sharma, M | 1 |
Crespo-Facorro, B; Díaz Martínez, Á; Ortiz-García de la Foz, V; Pérez-Iglesias, R; Suárez Pinilla, P; Vázquez-Bourgon, J | 1 |
de Oliveira, L; Graus-Nunes, F; Mandarim-de-Lacerda, CA; Rachid, TL; Silva-Veiga, FM; Souza-Mello, V | 1 |
Arco, R; Baixeras, E; Decara, J; Gavito, A; Lopez-Gambero, AJ; Martínez, A; Navarro, JA; Pavón, FJ; Rivera, P; Rodríguez de Fonseca, F; Serrano, A; Suárez, J; Tovar, R; Vargas, A | 1 |
Abbasi, M; Hao, L; Khan, MSH; Scott, S; Wang, S; Wu, D; Yang, Y; Zhao, L; Zu, Y | 1 |
Cucchiaro, J; Hsu, C; Kalali, AH; Loebel, A; Pikalov, A; Potkin, SG; Sarma, K; Xu, L | 1 |
Duffield, TF; Leblanc, SJ; Leslie, KE; Newby, NC; Pearl, DL; von Keyserlingk, MA | 1 |
Chen, H; Dong, Y; Huang, H; Zhang, J; Zhang, W; Zhao, T; Zhu, J | 1 |
Larson, JL; Potter, DA; Redmond, CT | 1 |
Hong, JP; Kim, MS; Park, S; Yi, KK | 1 |
Bobes García, J; de la Gándara Martín, JJ; Gutiérrez Fraile, M | 1 |
Baxter, MG; Gillespie, VL; Goldschlager, GB; Palme, R | 1 |
Boyd, S; deSchoolmeester, J; Dossetter, AG; Goldberg, FW; Groombridge, SD; Gutierrez, PM; Kemmitt, PD; Robb, GR; Scott, JS; Sjögren, T; Swales, JG; Turnbull, AV; Wild, MJ | 1 |
Busso, N; Ives, A; Kobayashi, T; Matsui, C; Nomura, J; Shirakura, T; So, A; Tamura, M; Tsujimoto, S; Yamanaka, Y | 1 |
Brossard, P; D'Ambrosio, D; Dingemanse, J; Krause, A | 1 |
Fukuda, S; Ito, M; Morinaga, H; Ohta, T; Sakata, S | 1 |
Bohnert, DW; Cappellozza, BI; Cooke, RF; Guarnieri Filho, TA; Marques, RS; Reis, MM | 1 |
Belson, S; Colditz, IG; Holm, M; Small, AH | 1 |
Gore, JC; Hiwatari, K; Ikejima, T; Kitamura, T; Koike, S; Kumagai, H; McClure, R; Mohri, K; Pham, W; Sakuma, S; Shimosato, M; Tobita, E | 1 |
Backes, EA; Brown, AC; Burdick Sanchez, NC; Carroll, JA; Gadberry, MS; Hughes, HD; Kegley, EB; Powell, JG; Reynolds, JL; Richeson, JT; Thaxton, YV | 1 |
Arava, S; Arya, DS; Bharti, S; Bhatia, J; Golechha, M; Krishnamurthy, B; Nag, TC; Rani, N; Ray, R | 1 |
Cai, ZX; Guo, HS; Li, P; Lin, XL; Sui, H; Tang, XD; Wang, FY | 1 |
El Ghormli, L; Hirst, K; Ievers-Landis, CE; Linder, B; Marcus, MD; van Buren, DJ; Walders-Abramson, N; Wilfley, DE; Zeitler, P | 1 |
Adams, SC; Felt, SA; Jampachaisri, K; Pacharinsak, C; Seymour, TL; Yeomans, DC | 1 |
Ishibashi, T; Kano, T; Katsube, T; Wajima, T | 1 |
Elmarakby, AA; Katary, MM; Pye, C | 1 |
Ianiski, FR; Luchese, C; Pinz, MP; Reis, AS; Soares, MP; Vaucher, RA; Villalba, BT; Vogt, AG; Wilhelm, EA | 1 |
Alexandre, EC; Antunes, E; Calmasini, FB; Candido, TZ; da Silva, CPV; da Silva, FH; de Oliveira, MG; Mónica, FZ | 1 |
Fernandez-Marcos, PJ; Lopez-Guadamillas, E; Martinez, S; Muñoz-Martin, M; Pastor, J; Serrano, M | 1 |
Duan, H; Huang, Z; Jiang, J; Xu, J; Yan, Z; Yu, Z; Zhou, H | 1 |
Besselink, H; Brouwer, A; De Boer, J; Klungsøyr, J; Leonards, P; McHugh, B; Nixon, E; Rimkus, G | 1 |
Choung, SY; Du, XF; Jiang, CZ; Won, EK; Wu, CF | 1 |
Shinomol, GK | 1 |
Flecknell, PA; Roughan, JV; Wright-Williams, SL | 1 |
Barrett, DA; Bradshaw, TD; Bruce, M; Farmer, PB; Gaskell, M; Henderson, CJ; Leong, CO; Stevens, MF; Wolf, R; Wren, JE; Wright, EK | 1 |
Brennan, MP; Collins, JG; Harding, MJ; Horvath, TL; Sinusas, AJ | 1 |
Castillero, E; Granado, M; López-Calderón, A; Martín, AI; Villanúa, MA | 1 |
Blasey, C; Davis, JM; Kraemer, H; Lieberman, JA; Reaven, GM; Schatzberg, AF; Sethuraman, G; Tsuang, MT | 1 |
Galluzzo, A; Gorini, B; Romeo, F; Sacchetti, E; Valsecchi, P; Warrington, L | 2 |
Borba, CP; Boxill, R; Cather, C; Copeland, PM; Evins, AE; Fan, X; Forstbauer, SI; Freudenreich, O; Goff, DC; Henderson, DC; Miley, K; Sharma, B | 1 |
Barat, CE; Cook, JA; Cooper, CS; Metcalf-Pate, KA; Scorpio, DG | 1 |
Egashira, S; Fukami, T; Gomori, A; Haga, Y; Ishihara, A; Iwaasa, H; Kanatani, A; Mashiko, S; Matsushita, H; Moriya, R; Takahashi, T | 1 |
Buitelaar, JK; Grootens, KP; Kahn, RS; Peuskens, J; Sabbe, BG; Thys, E; van Veelen, NM; Verkes, RJ | 1 |
Eder, K; Gutgesell, A; Koch, A; König, B; Ringseis, R; Spielmann, J; Stangl, GI; Wen, G | 1 |
Ha, JR; Kim, DH; Kim, DY; Oh, SW | 1 |
Abu-Elheiga, L; Asakura, K; Choo, HY; Gu, Z; Kamisuki, S; Kawazoe, Y; Kugimiya, A; Kwon, Y; Mao, Q; Sakai, J; Sato, S; Shinohara, T; Uesugi, M; Wakil, SJ | 1 |
Chang, KM; Chen, YJ; Cheng, SP; Chi, CW; Lee, JJ | 1 |
Kalonia, H; Kumar, A; Kumar, P | 1 |
Baik, JH; Choi, SY; Noh, JS; Yoon, S | 1 |
Duffield, TF; Leslie, KE; McKnight, DR; Millman, ST; Todd, CG | 1 |
Arioz, DT; Dilek, H; Koken, T; Saylan, A; Saylan, F; Yilmazer, M | 1 |
Bae, KY; Kim, JM; Kim, SW; Shin, IS; Yang, SJ; Yoon, JS | 1 |
Kalonia, H; Kumar, A; Kumar, P; Nehru, B | 1 |
Akiyama, TE; Berger, JP; Bergeron, R; Castriota, GA; Chapman, KT; de Jesus, RK; Doebber, TW; Ellsworth, KP; Feng, Z; Lassman, ME; Levorse, DA; Li, C; Mills, SG; Owens, KA; Pasternak, A; Tang, H; Wu, MS; Yan, Y; Yang, L; Zhang, BB | 1 |
Adams, MA; Bourque, SL; Nakatsu, K; Winterborn, A | 1 |
Iwasaki, R; Satoh, E | 1 |
Barron, GH; Budsberg, SC; Divers, SJ; Hernandez, SM; Koch, TF; McBride, M; Papich, M; Perpinan, D; Pethel, M; Stedman, NL | 1 |
Celikyurt, IK; Erden, FB; Kayir, H; Ulak, G; Ulusoy, GK; Uzbay, TI | 1 |
Dänicke, S; Döll, S; Höltershinken, M; Renner, L; Schwabe, A | 1 |
Cheng, P; Di, W; Ding, G; Hu, M; Li, Y; Liu, J; Lv, S; Qi, H; Wang, L; Wu, L; Yu, J; Zha, J; Zhang, A; Zhang, X; Zhong, Y | 1 |
Bachinsky, M; Cavus, I; Chappell, P; Glue, P; Karayal, ON; Kolluri, S; Stewart, M | 1 |
Jiang, L; Qiao, K; Shi, X; Wang, D; Wang, H; Wang, K | 1 |
Calabrese, JR; Ice, KS; Karayal, ON; Kemp, DE; Pappadopulos, E; Sachs, GS; Siu, CO; Vieta, E | 1 |
Boykin, D; Debache, K; Guionaud, C; Hemphill, A; Kropf, C; Stephens, CE | 1 |
Cucchiaro, J; Loebel, A; Ogasa, M; Potkin, SG | 1 |
Kaushik, S; Khan, A; Lindenmayer, JP; Parakadavil, M; Smith, RC; Tedeschi, F; Yusim, A | 1 |
Hong, JP; Kim, MS; Namkoong, C; Park, MH; Park, S | 1 |
Kane, JM | 1 |
Alonso, M; Alonso-Gascón, M; Baixeras, E; Bermúdez-Silva, FJ; López-Ogalla, J; Martínez, A; Pavón, FJ; Pérez-Valero, V; Rivera, P; Rodríguez de Fonseca, F; Romero-Cuevas, M; Santamaría, G; Serrano, A; Suarez, J; Vida, M | 1 |
Tanaka, T | 1 |
Alves, CB; Alves, MP; Ianiski, FR; Luchese, C; Pinton, S; Rhoden, CR; Roman, SS; Souza, AC | 1 |
Chung, YC; Huang, GB; Kim, MG; Lee, KH; Park, TW; Yang, JC; Zhao, T | 1 |
Cao, D; Chen, J; Chen, L; Chen, T; Huang, L; Liang, X; Liu, J; Ma, L; Peng, A; Peng, F; Qiu, J; Qiu, N; Wang, G; Wei, Y; Xiang, M; Xu, Q; Yang, Z | 1 |
Cheng, P; Di, W; Ding, G; Kong, X; Liu, J; Lv, S; Qi, H; Wang, L; Wu, L; Yu, J; Zha, J; Zhang, A; Zhang, X; Zhong, Y | 1 |
Kolluri, S; Newcomer, JW; Pappadopulos, E | 1 |
Chen, HH; Fan, X; Gao, K; Guo, XF; Ou, JJ; Wang, J; Wu, RR; Xu, Y; Zhao, JP | 1 |
Drogendijk, T; Eltink, C; Grunenberg, N; Iitsuka, H; Kerbusch, V; Kowalski, D; Lee, J; Matsushima, H; Meijer, J; Moy, S; Sawamoto, T; Schaddelee, M; van Gelderen, M; van Marle, S; Zhang, W | 1 |
Kong, Q; Lin, B; Liu, H; Sun, R; Xi, Z; Yang, H; Zhang, H; Zhang, W | 1 |
Choe, W; Ha, J; Jeong, JH; Kang, I; Kim, SS; Lee, S; Ra, YM; Song, JH; Yang, WK | 1 |
Li, M; Lin, Y; Ma, Y; Zheng, Z | 1 |
Gao, X; Gao, Y; Jia, P; Li, G; Lin, H; Luo, B; Pan, C; Shi, H; Tian, H; Xing, X; Zhao, Y; Zhou, L | 1 |
Fujii, M; Igarashi, N; Kameyama, K; Kimata, M; Kitajima, M; Kubota, T; Kumai, K; Okada, Y; Otani, Y; Wada, N; Yokoyama, T; Yoshimizu, N | 1 |
Kamide, K; Kawano, Y; Minami, J; Tsunoda, S | 1 |
Chen, H; Freed, MI; Greenberg, AS; Haffner, SM; Weston, WM; Williams, K | 1 |
Hevener, AL; Javorschi, S; Kruszynska, YT; Norman, RA; Olefsky, JM; Sinha, M; Yu, JG | 1 |
Aleksunes, LM; Reagan, LA; Vergara, CM; Wang, F | 1 |
Hällsten, K; Knuuti, J; Lönnqvist, F; Nuutila, P; Oksanen, A; Rönnemaa, T; Sipilä, H; Viikari, J; Viljanen, T; Virtanen, KA | 1 |
Andersen, B; Brand, CL; Fleckner, J; Fledelius, C; Gotfredsen, CF; Hansen, BF; Sauerberg, P; Sturis, J; Wassermann, K; Ye, JM | 1 |
Chehade, J; Haas, MJ; Mooradian, AD; Wong, NC | 1 |
Quattrone, A; Zappia, M | 1 |
Amiri, F; Diep, QN; Iglarz, M; Lavoie, MF; Schiffrin, EL; Touyz, RM | 1 |
Cleasby, ME; Livingstone, DE; Nyirenda, MJ; Seckl, JR; Walker, BR | 1 |
Hällsten, K; Huupponen, R; Janatuinen, T; Knuuti, J; Lönnqvist, F; Lönnroth, P; Nuutila, P; Parkkola, R; Rönnemaa, T; Viljanen, T; Virtanen, KA | 1 |
Cohen, S; Fitzgerald, B; Khan, A; Khan, S; Okos, A | 1 |
Burns, WC; Burrell, LM; Candido, R; Cooper, ME; Dean, RG; Forbes, JM; Ritchie, RH; Thallas, V; Thomas, MC; Tikellis, C; Twigg, SM | 1 |
Kohno, M; Miyatake, A; Mizushige, K; Murakami, K; Noma, T; Tsuji, T | 1 |
Fujita, H; Hirose, H; Kawai, T; Miyashita, K; Ogawa, T; Saruta, T; Seto, Y; Ukeda, K; Yajima, K; Yamada, T; Yamamoto, Y | 1 |
Handa, O; Ichikawa, H; Naito, Y; Takagi, T; Tomatsuri, N; Yoshida, N; Yoshikawa, T | 1 |
Evans, RM; Ham, J; Kang, H; Lee, CH; Tiep, S; Wang, YX; Yu, RT | 1 |
Osawa, K; Ota, T | 1 |
Harding, CO; Held, P | 1 |
Chao, L; Chen, Y; Choi, H; Fillmore, JJ; Gavrilova, O; Haluzik, M; Higashimori, T; Kim, HJ; Kim, JK; Qu, X; Reitman, ML; Shulman, GI; Yu, C | 1 |
Amiri, F; Diep, QN; Iglarz, M; Paradis, P; Schiffrin, EL; Touyz, RM; Viel, EC | 1 |
Bachelard, H; Nadeau, A; Pitre, M; Santuré, M | 1 |
Havekes, LM; Mensink, RP; Muurling, M; Pijl, H; Romijn, JA; Voshol, PJ | 1 |
Flecknell, PA; Roughan, JV | 1 |
SCHWINGHAMER, LA; SNAIR, DW | 1 |
Narce, M; Poisson, JP | 1 |
Daniel, DG; Romano, SJ; Simpson, G; Weiden, PJ | 1 |
Akaike, T; Fang, J; Greish, K; Maeda, H; Sawa, T | 1 |
Barbuto, JA; Bergami-Santos, PC; Mariano, M | 1 |
Allen, TJ; Burns, WC; Calkin, AC; Candido, R; Cooper, ME; Forbes, JM; Jandeleit-Dahm, KA; Lassila, M; Seah, KK; Thallas, V; Thomas, MC | 1 |
Arnold, G; Meisel, A; Winter, C; Zschenderlein, R | 1 |
Arch, JR; Augstein, P; Cawthorne, MA; Demuth, HU; Heinke, P; Hoffmann, T; Meyer, A; Sennitt, MV; Stocker, C; Subramanian, A; Wargent, E | 1 |
Green, T; Lee, R; Noakes, J; Toghill, A; Waechter, F; Weber, E | 1 |
Brown, RR; Estoup, MW | 1 |
Allison, DB; Casey, DE; Cope, MB; Fernández, JR; Geary, N; Nagy, TR | 1 |
Fell, MJ; Gibson, R; Marshall, KM; McDermott, E; Neill, JC; Sisodia, G | 1 |
Fu, J; Gaetani, S; Lin, E; Oveisi, F; Piomelli, D | 1 |
Graham, TL; Mookherjee, C; Palmer, CN; Patel, L; Suckling, KE | 1 |
Champy, P; Duyckaerts, C; Féger, J; Hirsch, EC; Höglinger, GU; Khondiker, ME; Lannuzel, A; Lombes, A; Medja, F; Michel, PP; Oertel, WH; Prigent, A; Ruberg, M | 1 |
Berthelot, P; Chavatte, P; Lebegue, N; Poupaert, JH; Yous, S | 1 |
Kostulski, A; Rabe-Jabłońska, J; Wyszogrodzka-Kucharska, A | 1 |
Heinig, R; Higuchi, S; Kuroki, Y; Tanigawa, T | 1 |
Jones, DN; Kalinichev, M; Rourke, C | 1 |
Davis, CE; Davis, SM; Hsiao, JK; Keefe, RS; Lieberman, JA; McEvoy, JP; Perkins, DO; Rosenheck, RA; Severe, J; Stroup, TS; Swartz, MS | 1 |
Arch, JR; Birtles, S; de Schoolmeester, J; Hislop, D; Moody, G; O'Dowd, J; Smith, DM; Swales, J; Turnbull, AV; Wang, SJ | 1 |
de Beaurepaire, R; Even, PC; Lacroix, M; Minet-Ringuet, J; Tomé, D | 1 |
Baumgartner, S; Ebenbichler, C; Edlinger, M; Fleischhacker, WW; Hofer, A; Hummer, M; Kemmler, G; Lechleitner, M; Rettenbacher, MA | 1 |
Balbo, E; Delgado, JF; Diez, T; Martin, E; Montes, JM; Rodriguez, JL; Sopelana, P; Soto, JA; Villardaga, I | 1 |
Domin, S; Kasper, S; Kudla, D; Lambert, M; Naber, D | 1 |
Kanayama, T; Sakuta, T; Uchiyama, T | 1 |
Courade, JP; Flecknell, PA; Richardson, CA; Roughan, JV; Wright-Williams, SL | 1 |
Colasanti, A; Dragogna, F; Fiorentini, A; Mauri, MC; Papa, P; Rossattini, M; Valli, A; Volonteri, LS | 1 |
Anjum, N; Cheetham, S; Dickinson, K; Fell, MJ; Marshall, KM; Neill, JC; Peltola, LM; Vickers, S | 1 |
Lebovitz, HE; Loebel, AD; Newcomer, JW; Weiden, PJ; Yang, R | 1 |
Gibel, A; Ratner, Y; Ritsner, MS; Yorkov, V | 1 |
Altmann, S; Augstein, P; Berg, S; Demuth, HU; Freyse, EJ; Heinke, P; Salzsieder, E | 1 |
Gangula, PR; Jeyabal, PV; Kumar, R; Micci, MA; Pasricha, PJ | 1 |
Aleardi, M; Biederman, J; Dougherty, M; Mick, E; Spencer, T; Wozniak, J | 1 |
Ishii, K; Kametaka, S; Kasahara, T; Nakahara, T; Saito, M; Sakamoto, K; Takenaka, M; Ueo, M | 1 |
Hamlin, RL; Kijtawornrat, A; Lolly, JL; Roche, BM; Shemanski, D; Wessale, JL; Zhao, L | 1 |
Avila-Casado, C; Bautista-García, P; Franco, M; Johnson, RJ; Nakagawa, T; Sánchez-Lozada, LG; Soto, V; Tapia, E; Vega-Campos, IP; Zhao, L | 1 |
Soto-Peña, GA; Vega, L | 1 |
Bönner, G; Ganten, D; Rascher, W; Rockhold, RW; Schaz, K; Schömig, A; Speck, G; Unger, T | 1 |
Croft, WA; Kamiryo, Y; Wang, CY | 1 |
Iwasaki, M; Kobayashi, M; Maegawa, H; Ohgaku, S; Shigeta, Y; Watanabe, N | 1 |
Fiddler, W; Nishie, K; Pensabene, JW | 1 |
Cromwell, GL; O'Kelly, R; Speer, VC; Stahly, TS | 1 |
Fujita, T; Sugiyama, Y; Tanayama, S; Torii, H; Yoshida, K | 1 |
Arai, M; Cohen, SM; Friedell, GH; Fukushima, S; St John, M | 1 |
Hirakawa, K; Iino, T; Nose, T; Ogino, F; Takebe, H; Unno, T | 2 |
Antov, G; Ivanova-Chemishanska, L | 1 |
Hinderer, RK; Knickerbocker, M; Koschier, FJ | 1 |
Grossman, HB; Lesser, ML; Sonda, LP | 1 |
Rowland, RG; Wearly, DW | 1 |
Croft, MA; Croft, WA; Lower, GM; Paulus, KP; Wang, CY; Williams, JH | 1 |
Hayashi, M; Hirose, M; Imaida, K; Ishihara, Y; Ito, H; Ito, N | 1 |
McCallum, LW; Nissenkorn, I; Soloway, MS | 1 |
Gao, KM; Khoursheed, M; Lee, MK; Miles, PD; Moossa, AR; Olefsky, JM | 1 |
Chang, K; Corbett, JA; Currie, MG; Hasan, KS; McDaniel, ML; Misko, TP; Moore, WM; Petrash, JM; Smith, SR; Tilton, RG | 1 |
Fagnant, PM; Hirshman, MF; Horton, ED; Horton, ES; King, PA | 1 |
Hendriks, MG; Kam, KL; Paffendorf, M; Pijl, AJ; van Zwieten, PA | 1 |
Baum, ST; Bergman, RN; Elson, DF; Kemnitz, JW; Meglasson, MD; Roecker, EB | 1 |
Glosson, JA; Goldberg, DI; Madsen, DC; Rowe, WB; White, RD; Wilson, DM | 1 |
Elhilali, MM; Gagnon, C; Hassan, AA; Hassouna, MM; Taketo, T | 1 |
Fujiwara, T; Horikoshi, H; Ikeda, K; Koike, H; Nishino, H; Okuno, A; Shiraki, T; Wada, M; Yoshioka, S | 1 |
Chen, LB; Koya, K; Li, Y; Modica-Napolitano, J; Weisberg, EL | 1 |
Higa, S; Ishikawa, K; Mimura, G; Murakami, K; Takasu, N; Yagi, N | 1 |
Amano, N; Ebara, T; Hirano, T; Hozumi, T; Ishida, Y; Kazumi, T; Odaka, H; Yoshino, G | 1 |
Hayakawa, T; Ikeda, H; Morimoto, T; Shii, K; Shiraki, T | 1 |
Akanuma, Y; Iwamoto, Y; Kaneko, T; Kosaka, K; Kuzuya, T; Shigeta, Y | 1 |
Imai, S; Kanda, T; Kobayashi, I; Murata, K; Suzuki, T; Takahashi, T | 1 |
Higa, S; Komiya, I; Nagamine, F; Shimabukuro, M; Shinzato, T; Takasu, N | 1 |
Harada, Y; Inoue, I; Ishii, J; Itabashi, A; Katayama, S; Negishi, K; Takahashi, K | 1 |
Barański, B; Berlińska, B; Sitarek, K | 1 |
Burant, CF; Polonsky, KS; Pugh, W; Sreenan, S; Sturis, J | 1 |
Blair, SL; Burt, ME; Rose, DM; Sachar, S | 1 |
Cavalletti, E; Ceserani, R; Montaguti, P; Sala, F | 1 |
Abe, N; Akaike, N; Aotsuka, T; Ashizawa, N; Fukushima, K; Matsuura, A; Ohbayashi, S; Sugiyama, Y; Yoshida, M | 1 |
Grau, MT; Ortiz, JA; Romero, A; Sacristán, A; Villamayor, F | 2 |
Grau, MT; Ortiz, JA; Rives, A; Romero, A; Sacristán, A; Villamayor, F | 2 |
Diani, A; Messina, JL; Murray, FT; Sangani, GA; Wachowski, MB; Weinstock, RS | 1 |
Morimoto, Y; Nishikawa, K; Ohashi, M | 1 |
Auwerx, J; Berthault, MF; Doaré, L; Dugail, I; Ferré, P; Foufelle, F; Guerre-Millo, M; Hallakou, S; Kergoat, M; Morin, J | 1 |
Burant, CF; Davidson, NO; Graves, RA; Hirano, K; Lohmiller, J; Lukens, J; Ross, S; Sreenan, S; Tai, TA | 1 |
Mitsuo, M; Nakai, I; Oka, T; Shimizu, Y; Uchiyama, K; Yasunami, Y | 1 |
Bing, C; Buckingham, R; Dryden, S; Frankish, HM; Hopkins, D; Pickavance, L; Wang, Q; Williams, G | 1 |
Afify, M; Goldmann, C; Khorram-Sefat, R; Klosterhalfen, B; Küpper, W; Lennartz, A; Mottaghy, K; Radke, A | 1 |
Akanuma, Y; Fujiwara, T; Horikoshi, H; Iwamoto, K; Kadowaki, T; Mori, Y; Okuno, A; Tamemoto, H; Tobe, K; Ueki, K; Umesono, K; Yazaki, Y | 1 |
Abel, R; Alvey, CW; Koup, JR; Loi, CM; Randinitis, EJ; Young, MA | 1 |
Demacker, PN; Smits, P; Stalenhoef, AF; Tack, CJ | 1 |
Hashimoto, Y; Ito, F; Nakazawa, H; Onitsuka, S; Toma, H; Yamaguchi, Y | 1 |
Akaike, N; Aotsuka, T; Ashizawa, N; Matsuura, A; Ohbayashi, S; Sugiyama, Y; Yoshida, M | 1 |
Al-Barazanji, KA; Bond, B; Buckingham, RE; Clapham, JC; Connor, SC; Slaughter, M; Toseland, CD; Turner, NC; West, A | 1 |
Ghazzi, MN; Horton, ES; Venable, TC; Whitcomb, RW; Whitehouse, F | 1 |
Ishii, S; King, P; Pickavance, L; Tanaka, H; Widdowson, PS; Williams, G | 1 |
Fukuzawa, M; Masuda, T; Muto, G; Muto, Y; Qiang, X; Sagara, M; Sakata, Y; Satoh, J; Takahashi, K; Toyota, T | 1 |
Akanuma, Y; Ide, T; Kadowaki, T; Mochizuki, T; Murakami, K; Ohashi, M; Tobe, K; Yazaki, Y | 1 |
Ishii, S; Tanaka, H; Upton, R; Widdowson, PS; Williams, G | 1 |
Han, TS; Kelly, IE; Lean, ME; Walsh, K | 1 |
Burant, CF; Cockburn, B; Fuller, T; Keck, S; Sreenan, S | 1 |
Matsui, K; Shibata, T; Wakitani, K; Yonemori, F | 1 |
Aoki, T; Chimoto, T; Hosokawa, S; Sagami, F; Sato, G; Sumigama, S; Tsukidate, K | 1 |
Baetens, D; Higa, M; Orci, L; Ravazzola, M; Unger, RH; Zhou, YT | 1 |
Aizawa, S; Eto, K; Ezaki, O; Fujita, T; Hasegawa, G; Ishii, C; Kadowaki, T; Kitamura, T; Komeda, K; Kubota, N; Miki, H; Murakami, K; Naito, M; Nakano, R; Okuno, A; Satoh, S; Sekihara, H; Shiota, K; Sugiyama, T; Tamemoto, H; Tanaka, S; Terauchi, Y; Toyoshima, Y; Tsubamoto, Y; Yamauchi, T | 1 |
Brunmair, B; Fürnsinn, C; Furtmüller, R; Kühnle, HF; Meyer, M; Neschen, S; Nowotny, P; Roden, M; Schneider, B; Waldhäusl, W | 1 |
Kruszynska, YT; Mulford, MI; Olefsky, JM; Yu, JG | 1 |
Clausson, P; Heinemann, L; Heise, T; Hirschberger, S; Rave, K | 1 |
Buckingham, RE; Pickavance, LC; Tadayyon, M; Widdowson, PS; Wilding, JP | 1 |
Abe, Y; Fukui, T; Hosomi, N; Kimura, S; Kiyomoto, H; Matsuo, H; Mizushige, K; Noma, T; Yao, L; Yu, Y | 1 |
Kako, M; Li, L; Nakai, N; Ohsawa, I; Oshida, Y; Sato, J; Sato, Y; Shimomura, Y | 1 |
Baetens, D; Grayburn, P; Higa, M; Karim, A; Orci, L; Shimabukuro, M; Unger, RH; Zhou, YT | 1 |
Chaput, E; Edgar, AD; Saladin, R; Silvestre, M | 1 |
Brinkmann, L; Goebel, FD; Michl, GM; Mühlbayer, D; Walli, R | 1 |
Gonzalez, R; Grinsell, JW; Lardinois, CK; Michaels, JR; Sare, JS; Starich, GH; Swislocki, A | 1 |
Kakimoto, K; Shibata, T; Takeuchi, S; Wakitani, K; Yokota, S; Yonemori, F | 1 |
King, AB | 1 |
Hussey, HJ; Tisdale, MJ | 1 |
Fukui, Y; Masui, S; Motojima, K; Osada, S; Umesono, K | 1 |
Alencar, VB; Bezerra, MM; Brito, GA; de Lima, V; Ribeiro, RA; Rocha, FA; Vieira, IB | 1 |
Ikeda, Y; Imaida, K; Kimoto, N; Orita, S; Sakakibara, M; Shirai, T; Suzuki, S; Takahashi, S | 1 |
Cawthorne, MA; Crombie, DL; Heyman, RA; Hislop, DC; Liu, YL; Sennitt, MV | 1 |
Akiyama, T; Fukumitsu, KI; Jia, DM; Nakamura, H; Otsuki, M; Tabaru, A | 1 |
Brindley, DN; Davidge, ST; Delrat, P; Jochemsen, R; Kelly, SE; O'Brien, SF; Pégorier, JP; Ravel, D; Russell, JC | 1 |
Basabe, JC; Chicco, A; Ferraris, N; Fortino, A; Karabatas, L; Lombardo, YB | 1 |
Fujiwara, K; Hayashi, K; Nakamura, A; Ozawa, Y; Saruta, T; Tokuyama, H | 1 |
Gruenewald, DA; Marck, BT; Matsumoto, AM; Naai, MA; Wolden-Hanson, T | 1 |
Johnson, JH; McCarthy, KJ; Routh, RE; Shaw, W; Walsh, K; Welbourne, TC | 1 |
Esterbauer, H; Fürnsinn, C; Neschen, S; Oberkofler, H; Patsch, W; Waldhäusl, W | 1 |
Hirosumi, J; Kojo, H; Mutoh, S; Notsu, Y; Suzuki, A; Yasuno, T | 1 |
Hotta, N; Iguchi, A; Miura, H; Nakamura, J; Tamagawa, T; Tamaya, N; Uemura, K; Yoshioka, S | 1 |
Cawthorne, MA; Emilsson, V; Heyman, R; Liu, YL; O'Dowd, J; Sennitt, M; Wang, S | 1 |
Felder, MR; Hardwick, JP; Jeng, J; Jeong, KS; Soh, Y; Song, BJ | 1 |
Goodwin, GW; Guthrie, P; Laws, FA; Taegtmeyer, H; Wilson, CR; Ying, J; Young, ME | 1 |
Fonseca, VA; Granda-Ayala, R; Lee, TR; Parulkar, AA; Pendergrass, ML | 1 |
Haas, MJ; Mooradian, AD; Thampy, GK | 1 |
Anderson, RJ; Patel, J; Rappaport, EB | 1 |
Aoki, K; Ito, S; Kikuchi, T; Mukasa, K; Nakajima, A; Okamura, A; Satoh, S; Sekihara, H | 1 |
Collins, AR; Hsueh, WA; Jackson, S; Kintscher, U; Law, RE; Meehan, WP; Noh, G; Palinski, W; Wakino, S | 1 |
Chen, Z; Gotoda, T; Harada, K; Iizuka, Y; Ishibashi, S; Kitamine, T; Nagai, R; Ohashi, K; Okazaki, H; Perrey, S; Shimano, H; Shionoiri, F; Tamura, Y; Yahagi, N; Yamada, N | 1 |
Doyle, PJ; Naderali, EK; Pickavance, LC; Wilding, JP; Williams, G | 1 |
Asayama, K; Dobashi, K; Hayashibe, H; Kodera, K; Nakane, T; Nakazawa, S; Uchida, N | 1 |
Buckingham, RE; Finegood, DT; Kojwang, D; Leonard, T; McArthur, MD; Thomas, MJ; Topp, BG | 1 |
Jacinto, SM; Ljung, B; Oakes, ND; Thalén, PG | 1 |
Fayek, M; Kingsbury, SJ; Simpson, GM; Trufasiu, D; Zada, J | 1 |
Buckingham, RE; Pickavance, LC; Wilding, JP | 1 |
Han, YQ; Kitakoshi, K; Nakai, N; Oshida, Y; Sato, Y | 1 |
Bodkin, NL; Haney, J; Hansen, BC; Horikoshi, H; Ortmeyer, HK; Yoshioka, S | 1 |
Daimon, M; Hirata, A; Igarashi, M; Kato, T; Ohnuma, H; Tominaga, M; Tsuchiya, H; Yamaguchi, H | 1 |
Auwerx, J; Bac, P; Blanchard, SG; Champy, MF; Desreumaux, P; Dubuquoy, L; Gelman, L; Leesnitzer, LM; Moras, D; Picard, F; Plunket, KD; Potier, N; Renaud, JP; Rocchi, S; Vamecq, J; Zeyer, D | 1 |
Adler, A; Bush, E; Kramer, D; Rondinone, CM; Shapiro, R | 1 |
Funakoshi, A; Hayashi, H; Ichikawa, M; Kanai, S; Miyasaka, K; Sato, Y | 1 |
Brunmair, B; Fürnsinn, C; Gras, F; Nowotny, P; Roden, M; Vierhapper, H; Waldhäusl, W | 1 |
Asakawa, M; Hasegawa, H; Kadowaki, T; Komuro, I; Kubota, N; Masuda, Y; Nagai, T; Saito, T; Takano, H; Uozumi, H | 1 |
Jia, DM; Otsuki, M | 1 |
Kobayashi, K; Nagai, Y; Nohara, E; Takamura, T; Yamashita, H | 1 |
Brownsey, R; Demuth, HU; Finegood, DT; McIntosh, CH; Parkhouse, W; Pederson, RA; Pospisilik, JA; Stafford, SG | 1 |
Buckingham, RE; Clarke, K; Cole, MA; Desrois, M; Draper, NJ; Sidell, RJ | 1 |
Funakoshi, A; Ichikawa, M; Ichimaru, Y; Kanai, S; Kobayash, M; Miyasak, K; Ohta, M; Shimazoe, T; Watanabe, S; Yoshida, Y | 1 |
Caley, CF; Cooper, CK | 1 |
Ikeda, H; Odaka, H; Sugiyama, Y; Suzuki, M; Suzuki, N | 1 |
Amiri, F; Cohn, JS; Diep, QN; El Mabrouk, M; Endemann, D; Neves, MF; Schiffrin, EL; Virdis, A | 1 |
Cusi, K; DeFronzo, RA; Hardies, J; Mahankali, A; Mahankali, S; Mandarino, LJ; Matsuda, M; Miyazaki, Y | 1 |
Armstrong, DU; King, AB | 1 |
Akarca, C; Barton, DM; Baskar, V; Buch, HN; Kamalakannan, D; Singh, BM | 1 |
Economos, AC; Miquel, J | 1 |
Biamino, G; Kopp, H; Rudroff, W; Schneider, B | 1 |
Oguchi, E; Okazaki, M; Sakamoto, K; Yasuhara, H | 1 |
Herrmann, M; Leuschner, F; Wiegleb, J | 1 |
Koeppe, RE; Meghal, SK; O'Neal, RM | 1 |
Greven, J; Heidenreich, O; Klein, H | 1 |
Dove, PA; Rosenthale, ME; Sandor, A; Shriver, DA; White, CB | 1 |
Inoue, M; Morikawa, M; Tsuboi, M; Yoshida, S | 1 |
Bryan, GT; Cohen, SM; Wittenberg, JF | 1 |
Gill, AM; Powell, JG; Sampson, BM; Yen, TT | 1 |
Bauman, PF; Bray, TM; Sikorski, B; Taylor, CG | 1 |
Howard, MO; Newton, JF; Qualls, CW; Schwartz, LW; Ventre, JR; Yodis, LA | 1 |
Astre, C; Joyeux, H; Possompes, B; Recasens, MA; Saint Aubert, B | 1 |
Ikeda, H; Shimura, Y; Sugiyama, Y | 1 |
Esumi, H; Ito, Y; Kosaka, H; Kurashima, Y; Terada, N; Tsuda, M; Uozumi, M | 1 |
Deguchi, T; Mataki, Y; Naya, M; Noguchi, M; Yasuda, M | 1 |
Kamata, E; Kaneko, T; Kobayashi, K; Kurokawa, Y; Naito, K; Ogawa, Y; Suzuki, S; Tobe, M | 1 |
Bokelman, DL; Burek, JD; Majka, JA | 1 |
Carone, FA; Hjelle, JJ; Hjelle, JT; Maziasz, TJ | 1 |
Harada, T; Hotta, N; Kakuta, H; Kojima, K; Matsubara, H; Mizuno, K; Sakamoto, N; Suzuki, M | 1 |
Ballantyne, B; Myers, RC; Slesinski, RS | 1 |
Bauman, PF; Bray, TM; Smith, TK | 1 |
Rothwell, NJ; Stock, MJ; Tedstone, AE | 1 |
Cohen, SM; Hasegawa, R; Johansson, SL; Sakata, T; Zenser, TV | 1 |
Anderson, RC; Arroyave, JL; Gonzalez-Crussi, F; Houlihan, WJ; Hsueh, W; Lee, ML | 1 |
Crichton, RR; Longueville, A | 1 |
Bonnet, P; De Ceaurriz, J; Gagnaire, F; Simon, P | 1 |
Croft, WA; Hayashida, S; Kamiryo, Y; Wang, CY | 1 |
Friedmann, JC; Murphy, JR | 1 |
Fujii, T; Ito, N; Miyazaki, K; Takashima, T; Watanabe, N | 1 |
Gubler, CJ; Jaussi, AW; Sutherland, DJ | 1 |
Bryan, GT; Cohen, SM; Ertürk, E | 1 |
Fearn, HJ; Fennessy, MR | 1 |
Aures, D; Clark, WG; Menon, MK | 1 |
Renoux, G; Renoux, M | 1 |
Bohnenstengel, C; Jülich, WD; Wagner, R; Weber, P; Weuffen, W | 1 |
Bennion, M; Crane, LW; Gubler, CJ; Peterson, JW; Turner, LG; Turpin, KK | 1 |
Ashford, A; Brown, GR; Evans, DE; King, G; Palmer, PJ; Ross, JW; Shadbolt, RS; Sharpe, CJ; Trigg, RB; Ward, RJ | 1 |
Best, JM | 1 |
Keith, RK | 1 |
Ambrus, CM; Ambrus, JL | 1 |
De Chaneet, G; Lewis, R | 1 |
Boag, B; Thomas, RJ | 1 |
Caster, WO; Holbrook, CM; Wade, AE; Wu, BC | 1 |
Jezková, D; Smrcková, M | 1 |
Kawada, K; Matsuzawa, T; Sasaki, M; Yamazaki, M; Yusa, T | 1 |
Leland, SE; Lindquist, WD; Ridley, RK | 1 |
Cornwell, RL; Jones, RM; Pott, JM | 2 |
Konishi, G | 1 |
Blair, DM; Clarke, Vde V | 1 |
Ferrarese, G; Rindi, G; Sciorelli, G | 1 |
Cooper, KJ | 1 |
Bai, P; Bennion, M; Gubler, CJ | 1 |
Baker, NF; Douglas, JR; Fisk, BA | 1 |
Echenique, JA; Lukovich, R; Nesbitt, GH; Niec, R; Rosa, WA; San Martin, LA | 1 |
Bryan, GT; Cohen, SM; Ertürk, E; Price, JM | 1 |
Bell, RR; Smith, JP | 1 |
Dieckhoff, J; Koch, R; Wiegand, U | 1 |
Hanna, C; Thomason, HJ | 1 |
9 review(s) available for thiazoles and Body Weight
Article | Year |
---|---|
Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor Proteins, Signal Transducing; Adenine; Adenocarcinoma; Adipogenesis; Administration, Cutaneous; Administration, Ophthalmic; Adolescent; Adsorption; Adult; Aeromonas hydrophila; Aerosols; Aged; Aged, 80 and over; Aging; Agriculture; Air Pollutants; Air Pollution; Airway Remodeling; Alanine Transaminase; Albuminuria; Aldehyde Dehydrogenase 1 Family; Algorithms; AlkB Homolog 2, Alpha-Ketoglutarate-Dependent Dioxygenase; Alzheimer Disease; Amino Acid Sequence; Ammonia; Ammonium Compounds; Anaerobiosis; Anesthetics, Dissociative; Anesthetics, Inhalation; Animals; Anti-Bacterial Agents; Anti-HIV Agents; Anti-Infective Agents; Anti-Inflammatory Agents; Antibiotics, Antineoplastic; Antibodies, Antineutrophil Cytoplasmic; Antibodies, Monoclonal, Humanized; Antifungal Agents; Antigens, Bacterial; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antitubercular Agents; Antiviral Agents; Apolipoproteins E; Apoptosis; Arabidopsis; Arabidopsis Proteins; Arsenic; Arthritis, Rheumatoid; Asthma; Atherosclerosis; ATP-Dependent Proteases; Attitude of Health Personnel; Australia; Austria; Autophagy; Axitinib; Bacteria; Bacterial Outer Membrane Proteins; Bacterial Proteins; Bacterial Toxins; Bacterial Typing Techniques; Bariatric Surgery; Base Composition; Bayes Theorem; Benzoxazoles; Benzylamines; beta Catenin; Betacoronavirus; Betula; Binding Sites; Biological Availability; Biological Oxygen Demand Analysis; Biomarkers; Biomarkers, Tumor; Biopsy; Bioreactors; Biosensing Techniques; Birth Weight; Blindness; Blood Chemical Analysis; Blood Gas Analysis; Blood Glucose; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Blood-Brain Barrier; Blotting, Western; Body Mass Index; Body Weight; Bone and Bones; Bone Density; Bone Resorption; Borates; Brain; Brain Infarction; Brain Injuries, Traumatic; Brain Neoplasms; Breakfast; Breast Milk Expression; Breast Neoplasms; Bronchi; Bronchoalveolar Lavage Fluid; Buffaloes; Cadherins; Calcification, Physiologic; Calcium Compounds; Calcium, Dietary; Cannula; Caprolactam; Carbon; Carbon Dioxide; Carboplatin; Carcinogenesis; Carcinoma, Ductal; Carcinoma, Ehrlich Tumor; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Pancreatic Ductal; Carcinoma, Renal Cell; Cardiovascular Diseases; Carps; Carrageenan; Case-Control Studies; Catalysis; Catalytic Domain; Cattle; CD8-Positive T-Lymphocytes; Cell Adhesion; Cell Cycle Proteins; Cell Death; Cell Differentiation; Cell Line; Cell Line, Tumor; Cell Movement; Cell Nucleus; Cell Phone Use; Cell Proliferation; Cell Survival; Cell Transformation, Neoplastic; Cell Transformation, Viral; Cells, Cultured; Cellulose; Chemical Phenomena; Chemoradiotherapy; Child; Child Development; Child, Preschool; China; Chitosan; Chlorocebus aethiops; Cholecalciferol; Chromatography, Liquid; Circadian Clocks; Circadian Rhythm; Circular Dichroism; Cisplatin; Citric Acid; Clinical Competence; Clinical Laboratory Techniques; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Clostridioides difficile; Clostridium Infections; Coculture Techniques; Cohort Studies; Cold Temperature; Colitis; Collagen Type I; Collagen Type I, alpha 1 Chain; Collagen Type XI; Color; Connective Tissue Diseases; Copper; Coronary Angiography; Coronavirus 3C Proteases; Coronavirus Infections; Cost of Illness; Counselors; COVID-19; COVID-19 Testing; Creatine Kinase; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Cryoelectron Microscopy; Cryosurgery; Crystallography, X-Ray; Cues; Cultural Competency; Cultural Diversity; Curriculum; Cyclic AMP Response Element-Binding Protein; Cyclin-Dependent Kinase Inhibitor p21; Cycloparaffins; Cysteine Endopeptidases; Cytokines; Cytoplasm; Cytoprotection; Databases, Factual; Denitrification; Deoxycytidine; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diagnosis, Differential; Diatoms; Diet; Diet, High-Fat; Dietary Exposure; Diffusion Magnetic Resonance Imaging; Diketopiperazines; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Disease Models, Animal; Disease Progression; Disease-Free Survival; DNA; DNA Damage; DNA Glycosylases; DNA Repair; DNA-Binding Proteins; DNA, Bacterial; DNA, Viral; Docetaxel; Dose Fractionation, Radiation; Dose-Response Relationship, Drug; Down-Regulation; Doxorubicin; Drosophila; Drosophila melanogaster; Drug Carriers; Drug Delivery Systems; Drug Liberation; Drug Repositioning; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Drug Synergism; Drug Therapy, Combination; Edema; Edible Grain; Education, Graduate; Education, Medical, Graduate; Education, Pharmacy; Ehlers-Danlos Syndrome; Electron Transport Complex III; Electron Transport Complex IV; Electronic Nicotine Delivery Systems; Emergency Service, Hospital; Empathy; Emulsions; Endothelial Cells; Endurance Training; Energy Intake; Enterovirus A, Human; Environment; Environmental Monitoring; Enzyme Assays; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Epoxide Hydrolases; Epoxy Compounds; Erythrocyte Count; Erythrocytes; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Esophagectomy; Estrogens; Etanercept; Ethiopia; Ethnicity; Ethylenes; Exanthema; Exercise; Exercise Test; Exercise Tolerance; Extracellular Matrix; Extracorporeal Membrane Oxygenation; Eye Infections, Fungal; False Negative Reactions; Fatty Acids; Fecal Microbiota Transplantation; Feces; Female; Femur Neck; Fermentation; Ferritins; Fetal Development; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Fibroblasts; Fibroins; Fish Proteins; Flavanones; Flavonoids; Focus Groups; Follow-Up Studies; Food Handling; Food Supply; Food, Formulated; Forced Expiratory Volume; Forests; Fractures, Bone; Fruit and Vegetable Juices; Fusobacteria; G1 Phase Cell Cycle Checkpoints; G2 Phase Cell Cycle Checkpoints; Gamma Rays; Gastrectomy; Gastrointestinal Microbiome; Gastrointestinal Stromal Tumors; Gefitinib; Gels; Gemcitabine; Gene Amplification; Gene Expression; Gene Expression Regulation; Gene Expression Regulation, Bacterial; Gene Expression Regulation, Neoplastic; Gene Expression Regulation, Plant; Gene Knockdown Techniques; Gene-Environment Interaction; Genotype; Germany; Glioma; Glomerular Filtration Rate; Glucagon; Glucocorticoids; Glycemic Control; Glycerol; Glycogen Synthase Kinase 3 beta; Glycolipids; Glycolysis; Goblet Cells; Gram-Negative Bacterial Infections; Granulocyte Colony-Stimulating Factor; Graphite; Greenhouse Effect; Guanidines; Haemophilus influenzae; HCT116 Cells; Health Knowledge, Attitudes, Practice; Health Personnel; Health Services Accessibility; Health Services Needs and Demand; Health Status Disparities; Healthy Volunteers; Heart Failure; Heart Rate; Heart Transplantation; Heart-Assist Devices; HEK293 Cells; Heme; Heme Oxygenase-1; Hemolysis; Hemorrhage; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Hepatocytes; Hexoses; High-Throughput Nucleotide Sequencing; Hippo Signaling Pathway; Histamine; Histamine Agonists; Histidine; Histone Deacetylase 2; HIV Infections; HIV Reverse Transcriptase; HIV-1; Homebound Persons; Homeodomain Proteins; Homosexuality, Male; Hospice and Palliative Care Nursing; HSP70 Heat-Shock Proteins; Humans; Hyaluronan Receptors; Hydrogen; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrolysis; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypoglycemia; Hypoglycemic Agents; Hypoxia; Idiopathic Interstitial Pneumonias; Imaging, Three-Dimensional; Imatinib Mesylate; Immunotherapy; Implementation Science; Incidence; INDEL Mutation; Induced Pluripotent Stem Cells; Industrial Waste; Infant; Infant, Newborn; Inflammation; Inflammation Mediators; Infliximab; Infusions, Intravenous; Inhibitory Concentration 50; Injections; Insecticides; Insulin-Like Growth Factor Binding Protein 5; Insulin-Secreting Cells; Interleukin-1; Interleukin-17; Interleukin-8; Internship and Residency; Intestines; Intracellular Signaling Peptides and Proteins; Ion Transport; Iridaceae; Iridoid Glucosides; Islets of Langerhans Transplantation; Isodon; Isoflurane; Isotopes; Italy; Joint Instability; Ketamine; Kidney; Kidney Failure, Chronic; Kidney Function Tests; Kidney Neoplasms; Kinetics; Klebsiella pneumoniae; Knee Joint; Kruppel-Like Factor 4; Kruppel-Like Transcription Factors; Lactate Dehydrogenase 5; Laparoscopy; Laser Therapy; Lasers, Semiconductor; Lasers, Solid-State; Laurates; Lead; Leukocyte L1 Antigen Complex; Leukocytes, Mononuclear; Light; Lipid Peroxidation; Lipopolysaccharides; Liposomes; Liver; Liver Cirrhosis; Liver Neoplasms; Liver Transplantation; Locomotion; Longitudinal Studies; Lopinavir; Lower Urinary Tract Symptoms; Lubricants; Lung; Lung Diseases, Interstitial; Lung Neoplasms; Lymphocyte Activation; Lymphocytes, Tumor-Infiltrating; Lymphoma, Mantle-Cell; Lysosomes; Macrophages; Male; Manganese Compounds; MAP Kinase Kinase 4; Mass Screening; Maternal Health; Medicine, Chinese Traditional; Melanoma, Experimental; Memantine; Membrane Glycoproteins; Membrane Proteins; Mesenchymal Stem Cell Transplantation; Metal Nanoparticles; Metalloendopeptidases; Metalloporphyrins; Methadone; Methane; Methicillin-Resistant Staphylococcus aureus; Mexico; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Inbred ICR; Mice, Knockout; Mice, Nude; Mice, SCID; Mice, Transgenic; Microarray Analysis; Microbial Sensitivity Tests; Microbiota; Micronutrients; MicroRNAs; Microscopy, Confocal; Microsomes, Liver; Middle Aged; Milk; Milk, Human; Minority Groups; Mitochondria; Mitochondrial Membranes; Mitochondrial Proteins; Models, Animal; Models, Molecular; Molecular Conformation; Molecular Docking Simulation; Molecular Dynamics Simulation; Molecular Epidemiology; Molecular Structure; Molecular Weight; Multilocus Sequence Typing; Multimodal Imaging; Muscle Strength; Muscle, Skeletal; Muscular Diseases; Mutation; Mycobacterium tuberculosis; Myocardial Stunning; Myristates; NAD(P)H Dehydrogenase (Quinone); Nanocomposites; Nanogels; Nanoparticles; Nanotechnology; Naphthalenes; Nasal Cavity; National Health Programs; Necrosis; Needs Assessment; Neoadjuvant Therapy; Neonicotinoids; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasm Proteins; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasm Transplantation; Neoplasms; Neoplastic Stem Cells; Netherlands; Neuroblastoma; Neuroprotective Agents; Neutrophils; NF-kappa B; NFATC Transcription Factors; Nicotiana; Nicotine; Nitrates; Nitrification; Nitrites; Nitro Compounds; Nitrogen; Nitrogen Dioxide; North Carolina; Nuclear Magnetic Resonance, Biomolecular; Nuclear Proteins; Nucleic Acid Hybridization; Nucleosomes; Nutrients; Obesity; Obesity, Morbid; Oceans and Seas; Oncogene Protein v-akt; Oncogenes; Oocytes; Open Reading Frames; Osteoclasts; Osteogenesis; Osteoporosis; Osteoporosis, Postmenopausal; Outpatients; Ovarian Neoplasms; Ovariectomy; Overweight; Oxazines; Oxidants; Oxidation-Reduction; Oxidative Stress; Oxides; Oxidoreductases; Oxygen; Oxygen Inhalation Therapy; Oxygenators, Membrane; Ozone; Paclitaxel; Paenibacillus; Pain Measurement; Palliative Care; Pancreatic Neoplasms; Pandemics; Parasympathetic Nervous System; Particulate Matter; Pasteurization; Patient Preference; Patient Satisfaction; Pediatric Obesity; Permeability; Peroxiredoxins; Peroxynitrous Acid; Pharmaceutical Services; Pharmacists; Pharmacy; Phaseolus; Phenotype; Phoeniceae; Phosphates; Phosphatidylinositol 3-Kinases; Phospholipid Transfer Proteins; Phospholipids; Phosphorus; Phosphorylation; Photoperiod; Photosynthesis; Phylogeny; Physical Endurance; Physicians; Pilot Projects; Piperidines; Pituitary Adenylate Cyclase-Activating Polypeptide; Plant Extracts; Plant Leaves; Plant Proteins; Plant Roots; Plaque, Atherosclerotic; Pneumonia; Pneumonia, Viral; Point-of-Care Testing; Polyethylene Glycols; Polymers; Polysorbates; Pore Forming Cytotoxic Proteins; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Postprandial Period; Poverty; Pre-Exposure Prophylaxis; Prediabetic State; Predictive Value of Tests; Pregnancy; Pregnancy Trimester, First; Pregnancy, High-Risk; Prenatal Exposure Delayed Effects; Pressure; Prevalence; Primary Graft Dysfunction; Primary Health Care; Professional Role; Professionalism; Prognosis; Progression-Free Survival; Prolactin; Promoter Regions, Genetic; Proof of Concept Study; Proportional Hazards Models; Propylene Glycol; Prospective Studies; Prostate; Protein Binding; Protein Biosynthesis; Protein Isoforms; Protein Kinase Inhibitors; Protein Phosphatase 2; Protein Processing, Post-Translational; Protein Serine-Threonine Kinases; Protein Structure, Tertiary; Protein Transport; Proteoglycans; Proteome; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-myc; Proto-Oncogene Proteins c-ret; Proto-Oncogene Proteins p21(ras); Proton Pumps; Protons; Protoporphyrins; Pseudomonas aeruginosa; Pseudomonas fluorescens; Pulmonary Artery; Pulmonary Disease, Chronic Obstructive; Pulmonary Gas Exchange; Pulmonary Veins; Pyrazoles; Pyridines; Pyrimidines; Qualitative Research; Quinoxalines; Rabbits; Random Allocation; Rats; Rats, Sprague-Dawley; Rats, Wistar; Receptors, Histamine H3; Receptors, Immunologic; Receptors, Transferrin; Recombinant Proteins; Recurrence; Reference Values; Referral and Consultation; Regional Blood Flow; Registries; Regulon; Renal Insufficiency, Chronic; Reperfusion Injury; Repressor Proteins; Reproducibility of Results; Republic of Korea; Research Design; Resistance Training; Respiration, Artificial; Respiratory Distress Syndrome; Respiratory Insufficiency; Resuscitation; Retinal Dehydrogenase; Retreatment; Retrospective Studies; Reverse Transcriptase Inhibitors; Rhinitis, Allergic; Ribosomal Proteins; Ribosomes; Risk Assessment; Risk Factors; Ritonavir; Rivers; RNA Interference; RNA-Seq; RNA, Messenger; RNA, Ribosomal, 16S; RNA, Small Interfering; Rosuvastatin Calcium; Rural Population; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salivary Ducts; Salivary Gland Neoplasms; San Francisco; SARS-CoV-2; Satiation; Satiety Response; Schools; Schools, Pharmacy; Seasons; Seawater; Selection, Genetic; Sequence Analysis, DNA; Serine-Threonine Kinase 3; Sewage; Sheep; Sheep, Domestic; Shock, Hemorrhagic; Signal Transduction; Silver; Silymarin; Single Photon Emission Computed Tomography Computed Tomography; Sirolimus; Sirtuin 1; Skin; Skin Neoplasms; Skin Physiological Phenomena; Sleep Initiation and Maintenance Disorders; Social Class; Social Participation; Social Support; Soil; Soil Microbiology; Solutions; Somatomedins; Soot; Specimen Handling; Spectrophotometry, Ultraviolet; Spectroscopy, Fourier Transform Infrared; Spectrum Analysis; Spinal Fractures; Spirometry; Staphylococcus aureus; STAT1 Transcription Factor; STAT3 Transcription Factor; Streptomyces coelicolor; Stress, Psychological; Stroke; Stroke Volume; Structure-Activity Relationship; Students, Medical; Students, Pharmacy; Substance Abuse Treatment Centers; Sulfur Dioxide; Surface Properties; Surface-Active Agents; Surveys and Questionnaires; Survival Analysis; Survival Rate; Survivin; Sweden; Swine; Swine, Miniature; Sympathetic Nervous System; T-Lymphocytes, Regulatory; Talaromyces; Tandem Mass Spectrometry; tau Proteins; Telemedicine; Telomerase; Telomere; Telomere Homeostasis; Temperature; Terminally Ill; Th1 Cells; Thiamethoxam; Thiazoles; Thiophenes; Thioredoxin Reductase 1; Thrombosis; Thulium; Thyroid Cancer, Papillary; Thyroid Carcinoma, Anaplastic; Thyroid Neoplasms; Time Factors; Titanium; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Transcription Factor AP-1; Transcription Factors; Transcription, Genetic; Transcriptional Activation; Transcriptome; Transforming Growth Factor beta1; Transistors, Electronic; Translational Research, Biomedical; Transplantation Tolerance; Transplantation, Homologous; Transportation; Treatment Outcome; Tretinoin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Tubulin Modulators; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Twins; Ultrasonic Therapy; Ultrasonography; Ultraviolet Rays; United States; Up-Regulation; Uranium; Urethra; Urinary Bladder; Urodynamics; Uromodulin; Uveitis; Vasoconstrictor Agents; Ventricular Function, Left; Vero Cells; Vesicular Transport Proteins; Viral Nonstructural Proteins; Visual Acuity; Vital Capacity; Vitamin D; Vitamin D Deficiency; Vitamin K 2; Vitamins; Volatilization; Voriconazole; Waiting Lists; Waste Disposal, Fluid; Wastewater; Water Pollutants, Chemical; Whole Genome Sequencing; Wine; Wnt Signaling Pathway; Wound Healing; Wounds and Injuries; WW Domains; X-linked Nuclear Protein; X-Ray Diffraction; Xanthines; Xenograft Model Antitumor Assays; YAP-Signaling Proteins; Yogurt; Young Adult; Zebrafish; Zebrafish Proteins; Ziziphus | 2016 |
Meloxicam fails to augment the reno-protective effects of soluble epoxide hydrolase inhibition in streptozotocin-induced diabetic rats via increased 20-HETE levels.
Topics: Animals; Blood Glucose; Blood Pressure; Body Weight; Cytochrome P-450 Enzyme System; Cytoprotection; Diabetes Mellitus, Experimental; Drug Synergism; Enzyme Inhibitors; Epoxide Hydrolases; Gene Expression Regulation, Enzymologic; Hydroxyeicosatetraenoic Acids; Kidney; Male; Meloxicam; Rats; Rats, Sprague-Dawley; Solubility; Thiazines; Thiazoles | 2017 |
Lurasidone: a clinical overview.
Topics: Antipsychotic Agents; Blood Glucose; Body Weight; Humans; Hypotension, Orthostatic; Isoindoles; Long QT Syndrome; Lurasidone Hydrochloride; Schizophrenia; Thiazoles; Treatment Outcome | 2011 |
Changes in weight, plasma lipids, and glucose in adults treated with ziprasidone: a comprehensive analysis of pfizer-initiated clinical trials.
Topics: Antipsychotic Agents; Bipolar Disorder; Blood Glucose; Body Mass Index; Body Weight; Clinical Trials as Topic; Drug Industry; Fasting; Humans; Lipids; Piperazines; Psychotic Disorders; Randomized Controlled Trials as Topic; Schizophrenia; Thiazoles; Time Factors | 2012 |
Management of rosiglitazone-induced edema: two case reports and a review of the literature.
Topics: Body Weight; Clinical Trials as Topic; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diuresis; Edema; Female; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Middle Aged; Obesity; Rosiglitazone; Thiazoles; Thiazolidinediones | 2002 |
[Mechanisms of the body weight gain induced by novel antipsychotic drugs and concomitant lipid abnormalities].
Topics: Antipsychotic Agents; Body Weight; Clozapine; Dibenzothiazepines; Humans; Hyperlipidemias; Leptin; Piperazines; Psychotic Disorders; Quetiapine Fumarate; Risperidone; Thiazoles; Weight Gain | 2005 |
Meta-analysis of steady-state pharmacokinetics of troglitazone and its metabolites.
Topics: Age Factors; Area Under Curve; Body Weight; Chromans; Diabetes Mellitus, Type 2; Humans; Hypoglycemic Agents; Sex Factors; Smoking; Thiazoles; Thiazolidinediones; Troglitazone | 1997 |
Nonhypoglycemic effects of thiazolidinediones.
Topics: Body Weight; Cardiovascular Diseases; Cardiovascular System; Diabetes Mellitus, Type 2; Endothelium, Vascular; Female; Hemostasis; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Lipid Metabolism; Liver Failure; Oxidation-Reduction; Pancreas; Polycystic Ovary Syndrome; Risk Factors; Thiazoles | 2001 |
Ziprasidone: the fifth atypical antipsychotic.
Topics: Acute Disease; Antipsychotic Agents; Basal Ganglia Diseases; Body Weight; Headache; Humans; Injections, Intramuscular; Long QT Syndrome; Nausea; Piperazines; Randomized Controlled Trials as Topic; Schizophrenia; Thiazoles; Treatment Outcome; Weight Gain | 2002 |
51 trial(s) available for thiazoles and Body Weight
Article | Year |
---|---|
Edoxaban versus Warfarin in high-risk patients with atrial fibrillation: A comprehensive analysis of high-risk subgroups.
Topics: Aged; Anticoagulants; Atrial Fibrillation; Body Weight; Factor Xa Inhibitors; Humans; Pyridines; Stroke; Thiazoles; Treatment Outcome; Warfarin | 2022 |
Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor Proteins, Signal Transducing; Adenine; Adenocarcinoma; Adipogenesis; Administration, Cutaneous; Administration, Ophthalmic; Adolescent; Adsorption; Adult; Aeromonas hydrophila; Aerosols; Aged; Aged, 80 and over; Aging; Agriculture; Air Pollutants; Air Pollution; Airway Remodeling; Alanine Transaminase; Albuminuria; Aldehyde Dehydrogenase 1 Family; Algorithms; AlkB Homolog 2, Alpha-Ketoglutarate-Dependent Dioxygenase; Alzheimer Disease; Amino Acid Sequence; Ammonia; Ammonium Compounds; Anaerobiosis; Anesthetics, Dissociative; Anesthetics, Inhalation; Animals; Anti-Bacterial Agents; Anti-HIV Agents; Anti-Infective Agents; Anti-Inflammatory Agents; Antibiotics, Antineoplastic; Antibodies, Antineutrophil Cytoplasmic; Antibodies, Monoclonal, Humanized; Antifungal Agents; Antigens, Bacterial; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antitubercular Agents; Antiviral Agents; Apolipoproteins E; Apoptosis; Arabidopsis; Arabidopsis Proteins; Arsenic; Arthritis, Rheumatoid; Asthma; Atherosclerosis; ATP-Dependent Proteases; Attitude of Health Personnel; Australia; Austria; Autophagy; Axitinib; Bacteria; Bacterial Outer Membrane Proteins; Bacterial Proteins; Bacterial Toxins; Bacterial Typing Techniques; Bariatric Surgery; Base Composition; Bayes Theorem; Benzoxazoles; Benzylamines; beta Catenin; Betacoronavirus; Betula; Binding Sites; Biological Availability; Biological Oxygen Demand Analysis; Biomarkers; Biomarkers, Tumor; Biopsy; Bioreactors; Biosensing Techniques; Birth Weight; Blindness; Blood Chemical Analysis; Blood Gas Analysis; Blood Glucose; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Blood-Brain Barrier; Blotting, Western; Body Mass Index; Body Weight; Bone and Bones; Bone Density; Bone Resorption; Borates; Brain; Brain Infarction; Brain Injuries, Traumatic; Brain Neoplasms; Breakfast; Breast Milk Expression; Breast Neoplasms; Bronchi; Bronchoalveolar Lavage Fluid; Buffaloes; Cadherins; Calcification, Physiologic; Calcium Compounds; Calcium, Dietary; Cannula; Caprolactam; Carbon; Carbon Dioxide; Carboplatin; Carcinogenesis; Carcinoma, Ductal; Carcinoma, Ehrlich Tumor; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Pancreatic Ductal; Carcinoma, Renal Cell; Cardiovascular Diseases; Carps; Carrageenan; Case-Control Studies; Catalysis; Catalytic Domain; Cattle; CD8-Positive T-Lymphocytes; Cell Adhesion; Cell Cycle Proteins; Cell Death; Cell Differentiation; Cell Line; Cell Line, Tumor; Cell Movement; Cell Nucleus; Cell Phone Use; Cell Proliferation; Cell Survival; Cell Transformation, Neoplastic; Cell Transformation, Viral; Cells, Cultured; Cellulose; Chemical Phenomena; Chemoradiotherapy; Child; Child Development; Child, Preschool; China; Chitosan; Chlorocebus aethiops; Cholecalciferol; Chromatography, Liquid; Circadian Clocks; Circadian Rhythm; Circular Dichroism; Cisplatin; Citric Acid; Clinical Competence; Clinical Laboratory Techniques; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Clostridioides difficile; Clostridium Infections; Coculture Techniques; Cohort Studies; Cold Temperature; Colitis; Collagen Type I; Collagen Type I, alpha 1 Chain; Collagen Type XI; Color; Connective Tissue Diseases; Copper; Coronary Angiography; Coronavirus 3C Proteases; Coronavirus Infections; Cost of Illness; Counselors; COVID-19; COVID-19 Testing; Creatine Kinase; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Cryoelectron Microscopy; Cryosurgery; Crystallography, X-Ray; Cues; Cultural Competency; Cultural Diversity; Curriculum; Cyclic AMP Response Element-Binding Protein; Cyclin-Dependent Kinase Inhibitor p21; Cycloparaffins; Cysteine Endopeptidases; Cytokines; Cytoplasm; Cytoprotection; Databases, Factual; Denitrification; Deoxycytidine; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diagnosis, Differential; Diatoms; Diet; Diet, High-Fat; Dietary Exposure; Diffusion Magnetic Resonance Imaging; Diketopiperazines; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Disease Models, Animal; Disease Progression; Disease-Free Survival; DNA; DNA Damage; DNA Glycosylases; DNA Repair; DNA-Binding Proteins; DNA, Bacterial; DNA, Viral; Docetaxel; Dose Fractionation, Radiation; Dose-Response Relationship, Drug; Down-Regulation; Doxorubicin; Drosophila; Drosophila melanogaster; Drug Carriers; Drug Delivery Systems; Drug Liberation; Drug Repositioning; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Drug Synergism; Drug Therapy, Combination; Edema; Edible Grain; Education, Graduate; Education, Medical, Graduate; Education, Pharmacy; Ehlers-Danlos Syndrome; Electron Transport Complex III; Electron Transport Complex IV; Electronic Nicotine Delivery Systems; Emergency Service, Hospital; Empathy; Emulsions; Endothelial Cells; Endurance Training; Energy Intake; Enterovirus A, Human; Environment; Environmental Monitoring; Enzyme Assays; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Epoxide Hydrolases; Epoxy Compounds; Erythrocyte Count; Erythrocytes; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Esophagectomy; Estrogens; Etanercept; Ethiopia; Ethnicity; Ethylenes; Exanthema; Exercise; Exercise Test; Exercise Tolerance; Extracellular Matrix; Extracorporeal Membrane Oxygenation; Eye Infections, Fungal; False Negative Reactions; Fatty Acids; Fecal Microbiota Transplantation; Feces; Female; Femur Neck; Fermentation; Ferritins; Fetal Development; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Fibroblasts; Fibroins; Fish Proteins; Flavanones; Flavonoids; Focus Groups; Follow-Up Studies; Food Handling; Food Supply; Food, Formulated; Forced Expiratory Volume; Forests; Fractures, Bone; Fruit and Vegetable Juices; Fusobacteria; G1 Phase Cell Cycle Checkpoints; G2 Phase Cell Cycle Checkpoints; Gamma Rays; Gastrectomy; Gastrointestinal Microbiome; Gastrointestinal Stromal Tumors; Gefitinib; Gels; Gemcitabine; Gene Amplification; Gene Expression; Gene Expression Regulation; Gene Expression Regulation, Bacterial; Gene Expression Regulation, Neoplastic; Gene Expression Regulation, Plant; Gene Knockdown Techniques; Gene-Environment Interaction; Genotype; Germany; Glioma; Glomerular Filtration Rate; Glucagon; Glucocorticoids; Glycemic Control; Glycerol; Glycogen Synthase Kinase 3 beta; Glycolipids; Glycolysis; Goblet Cells; Gram-Negative Bacterial Infections; Granulocyte Colony-Stimulating Factor; Graphite; Greenhouse Effect; Guanidines; Haemophilus influenzae; HCT116 Cells; Health Knowledge, Attitudes, Practice; Health Personnel; Health Services Accessibility; Health Services Needs and Demand; Health Status Disparities; Healthy Volunteers; Heart Failure; Heart Rate; Heart Transplantation; Heart-Assist Devices; HEK293 Cells; Heme; Heme Oxygenase-1; Hemolysis; Hemorrhage; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Hepatocytes; Hexoses; High-Throughput Nucleotide Sequencing; Hippo Signaling Pathway; Histamine; Histamine Agonists; Histidine; Histone Deacetylase 2; HIV Infections; HIV Reverse Transcriptase; HIV-1; Homebound Persons; Homeodomain Proteins; Homosexuality, Male; Hospice and Palliative Care Nursing; HSP70 Heat-Shock Proteins; Humans; Hyaluronan Receptors; Hydrogen; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrolysis; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypoglycemia; Hypoglycemic Agents; Hypoxia; Idiopathic Interstitial Pneumonias; Imaging, Three-Dimensional; Imatinib Mesylate; Immunotherapy; Implementation Science; Incidence; INDEL Mutation; Induced Pluripotent Stem Cells; Industrial Waste; Infant; Infant, Newborn; Inflammation; Inflammation Mediators; Infliximab; Infusions, Intravenous; Inhibitory Concentration 50; Injections; Insecticides; Insulin-Like Growth Factor Binding Protein 5; Insulin-Secreting Cells; Interleukin-1; Interleukin-17; Interleukin-8; Internship and Residency; Intestines; Intracellular Signaling Peptides and Proteins; Ion Transport; Iridaceae; Iridoid Glucosides; Islets of Langerhans Transplantation; Isodon; Isoflurane; Isotopes; Italy; Joint Instability; Ketamine; Kidney; Kidney Failure, Chronic; Kidney Function Tests; Kidney Neoplasms; Kinetics; Klebsiella pneumoniae; Knee Joint; Kruppel-Like Factor 4; Kruppel-Like Transcription Factors; Lactate Dehydrogenase 5; Laparoscopy; Laser Therapy; Lasers, Semiconductor; Lasers, Solid-State; Laurates; Lead; Leukocyte L1 Antigen Complex; Leukocytes, Mononuclear; Light; Lipid Peroxidation; Lipopolysaccharides; Liposomes; Liver; Liver Cirrhosis; Liver Neoplasms; Liver Transplantation; Locomotion; Longitudinal Studies; Lopinavir; Lower Urinary Tract Symptoms; Lubricants; Lung; Lung Diseases, Interstitial; Lung Neoplasms; Lymphocyte Activation; Lymphocytes, Tumor-Infiltrating; Lymphoma, Mantle-Cell; Lysosomes; Macrophages; Male; Manganese Compounds; MAP Kinase Kinase 4; Mass Screening; Maternal Health; Medicine, Chinese Traditional; Melanoma, Experimental; Memantine; Membrane Glycoproteins; Membrane Proteins; Mesenchymal Stem Cell Transplantation; Metal Nanoparticles; Metalloendopeptidases; Metalloporphyrins; Methadone; Methane; Methicillin-Resistant Staphylococcus aureus; Mexico; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Inbred ICR; Mice, Knockout; Mice, Nude; Mice, SCID; Mice, Transgenic; Microarray Analysis; Microbial Sensitivity Tests; Microbiota; Micronutrients; MicroRNAs; Microscopy, Confocal; Microsomes, Liver; Middle Aged; Milk; Milk, Human; Minority Groups; Mitochondria; Mitochondrial Membranes; Mitochondrial Proteins; Models, Animal; Models, Molecular; Molecular Conformation; Molecular Docking Simulation; Molecular Dynamics Simulation; Molecular Epidemiology; Molecular Structure; Molecular Weight; Multilocus Sequence Typing; Multimodal Imaging; Muscle Strength; Muscle, Skeletal; Muscular Diseases; Mutation; Mycobacterium tuberculosis; Myocardial Stunning; Myristates; NAD(P)H Dehydrogenase (Quinone); Nanocomposites; Nanogels; Nanoparticles; Nanotechnology; Naphthalenes; Nasal Cavity; National Health Programs; Necrosis; Needs Assessment; Neoadjuvant Therapy; Neonicotinoids; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasm Proteins; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasm Transplantation; Neoplasms; Neoplastic Stem Cells; Netherlands; Neuroblastoma; Neuroprotective Agents; Neutrophils; NF-kappa B; NFATC Transcription Factors; Nicotiana; Nicotine; Nitrates; Nitrification; Nitrites; Nitro Compounds; Nitrogen; Nitrogen Dioxide; North Carolina; Nuclear Magnetic Resonance, Biomolecular; Nuclear Proteins; Nucleic Acid Hybridization; Nucleosomes; Nutrients; Obesity; Obesity, Morbid; Oceans and Seas; Oncogene Protein v-akt; Oncogenes; Oocytes; Open Reading Frames; Osteoclasts; Osteogenesis; Osteoporosis; Osteoporosis, Postmenopausal; Outpatients; Ovarian Neoplasms; Ovariectomy; Overweight; Oxazines; Oxidants; Oxidation-Reduction; Oxidative Stress; Oxides; Oxidoreductases; Oxygen; Oxygen Inhalation Therapy; Oxygenators, Membrane; Ozone; Paclitaxel; Paenibacillus; Pain Measurement; Palliative Care; Pancreatic Neoplasms; Pandemics; Parasympathetic Nervous System; Particulate Matter; Pasteurization; Patient Preference; Patient Satisfaction; Pediatric Obesity; Permeability; Peroxiredoxins; Peroxynitrous Acid; Pharmaceutical Services; Pharmacists; Pharmacy; Phaseolus; Phenotype; Phoeniceae; Phosphates; Phosphatidylinositol 3-Kinases; Phospholipid Transfer Proteins; Phospholipids; Phosphorus; Phosphorylation; Photoperiod; Photosynthesis; Phylogeny; Physical Endurance; Physicians; Pilot Projects; Piperidines; Pituitary Adenylate Cyclase-Activating Polypeptide; Plant Extracts; Plant Leaves; Plant Proteins; Plant Roots; Plaque, Atherosclerotic; Pneumonia; Pneumonia, Viral; Point-of-Care Testing; Polyethylene Glycols; Polymers; Polysorbates; Pore Forming Cytotoxic Proteins; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Postprandial Period; Poverty; Pre-Exposure Prophylaxis; Prediabetic State; Predictive Value of Tests; Pregnancy; Pregnancy Trimester, First; Pregnancy, High-Risk; Prenatal Exposure Delayed Effects; Pressure; Prevalence; Primary Graft Dysfunction; Primary Health Care; Professional Role; Professionalism; Prognosis; Progression-Free Survival; Prolactin; Promoter Regions, Genetic; Proof of Concept Study; Proportional Hazards Models; Propylene Glycol; Prospective Studies; Prostate; Protein Binding; Protein Biosynthesis; Protein Isoforms; Protein Kinase Inhibitors; Protein Phosphatase 2; Protein Processing, Post-Translational; Protein Serine-Threonine Kinases; Protein Structure, Tertiary; Protein Transport; Proteoglycans; Proteome; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-myc; Proto-Oncogene Proteins c-ret; Proto-Oncogene Proteins p21(ras); Proton Pumps; Protons; Protoporphyrins; Pseudomonas aeruginosa; Pseudomonas fluorescens; Pulmonary Artery; Pulmonary Disease, Chronic Obstructive; Pulmonary Gas Exchange; Pulmonary Veins; Pyrazoles; Pyridines; Pyrimidines; Qualitative Research; Quinoxalines; Rabbits; Random Allocation; Rats; Rats, Sprague-Dawley; Rats, Wistar; Receptors, Histamine H3; Receptors, Immunologic; Receptors, Transferrin; Recombinant Proteins; Recurrence; Reference Values; Referral and Consultation; Regional Blood Flow; Registries; Regulon; Renal Insufficiency, Chronic; Reperfusion Injury; Repressor Proteins; Reproducibility of Results; Republic of Korea; Research Design; Resistance Training; Respiration, Artificial; Respiratory Distress Syndrome; Respiratory Insufficiency; Resuscitation; Retinal Dehydrogenase; Retreatment; Retrospective Studies; Reverse Transcriptase Inhibitors; Rhinitis, Allergic; Ribosomal Proteins; Ribosomes; Risk Assessment; Risk Factors; Ritonavir; Rivers; RNA Interference; RNA-Seq; RNA, Messenger; RNA, Ribosomal, 16S; RNA, Small Interfering; Rosuvastatin Calcium; Rural Population; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salivary Ducts; Salivary Gland Neoplasms; San Francisco; SARS-CoV-2; Satiation; Satiety Response; Schools; Schools, Pharmacy; Seasons; Seawater; Selection, Genetic; Sequence Analysis, DNA; Serine-Threonine Kinase 3; Sewage; Sheep; Sheep, Domestic; Shock, Hemorrhagic; Signal Transduction; Silver; Silymarin; Single Photon Emission Computed Tomography Computed Tomography; Sirolimus; Sirtuin 1; Skin; Skin Neoplasms; Skin Physiological Phenomena; Sleep Initiation and Maintenance Disorders; Social Class; Social Participation; Social Support; Soil; Soil Microbiology; Solutions; Somatomedins; Soot; Specimen Handling; Spectrophotometry, Ultraviolet; Spectroscopy, Fourier Transform Infrared; Spectrum Analysis; Spinal Fractures; Spirometry; Staphylococcus aureus; STAT1 Transcription Factor; STAT3 Transcription Factor; Streptomyces coelicolor; Stress, Psychological; Stroke; Stroke Volume; Structure-Activity Relationship; Students, Medical; Students, Pharmacy; Substance Abuse Treatment Centers; Sulfur Dioxide; Surface Properties; Surface-Active Agents; Surveys and Questionnaires; Survival Analysis; Survival Rate; Survivin; Sweden; Swine; Swine, Miniature; Sympathetic Nervous System; T-Lymphocytes, Regulatory; Talaromyces; Tandem Mass Spectrometry; tau Proteins; Telemedicine; Telomerase; Telomere; Telomere Homeostasis; Temperature; Terminally Ill; Th1 Cells; Thiamethoxam; Thiazoles; Thiophenes; Thioredoxin Reductase 1; Thrombosis; Thulium; Thyroid Cancer, Papillary; Thyroid Carcinoma, Anaplastic; Thyroid Neoplasms; Time Factors; Titanium; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Transcription Factor AP-1; Transcription Factors; Transcription, Genetic; Transcriptional Activation; Transcriptome; Transforming Growth Factor beta1; Transistors, Electronic; Translational Research, Biomedical; Transplantation Tolerance; Transplantation, Homologous; Transportation; Treatment Outcome; Tretinoin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Tubulin Modulators; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Twins; Ultrasonic Therapy; Ultrasonography; Ultraviolet Rays; United States; Up-Regulation; Uranium; Urethra; Urinary Bladder; Urodynamics; Uromodulin; Uveitis; Vasoconstrictor Agents; Ventricular Function, Left; Vero Cells; Vesicular Transport Proteins; Viral Nonstructural Proteins; Visual Acuity; Vital Capacity; Vitamin D; Vitamin D Deficiency; Vitamin K 2; Vitamins; Volatilization; Voriconazole; Waiting Lists; Waste Disposal, Fluid; Wastewater; Water Pollutants, Chemical; Whole Genome Sequencing; Wine; Wnt Signaling Pathway; Wound Healing; Wounds and Injuries; WW Domains; X-linked Nuclear Protein; X-Ray Diffraction; Xanthines; Xenograft Model Antitumor Assays; YAP-Signaling Proteins; Yogurt; Young Adult; Zebrafish; Zebrafish Proteins; Ziziphus | 2016 |
Baseline Characteristics of Study Participants in the Early Life Interventions for Childhood Growth and Development in Tanzania (ELICIT) Trial.
Topics: Adult; Azithromycin; Body Weight; Child Health; Child Nutrition Disorders; Child, Preschool; Cohort Studies; Early Medical Intervention; Female; Humans; Infant; Infant, Newborn; Male; Mothers; Neonatal Sepsis; Niacinamide; Nitro Compounds; Poverty; Respiratory Tract Infections; Rural Population; Seasons; Surveys and Questionnaires; Tanzania; Thiazoles; Young Adult | 2020 |
Long-term metabolic effects of aripiprazole, ziprasidone and quetiapine: a pragmatic clinical trial in drug-naïve patients with a first-episode of non-affective psychosis.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Blood Glucose; Body Mass Index; Body Weight; Cholesterol; Dibenzothiazepines; Female; Humans; Male; Middle Aged; Piperazines; Psychotic Disorders; Quetiapine Fumarate; Quinolones; Thiazoles; Triglycerides; Young Adult | 2018 |
Efficacy and safety of lurasidone 80 mg/day and 160 mg/day in the treatment of schizophrenia: a randomized, double-blind, placebo- and active-controlled trial.
Topics: Adolescent; Adult; Aged; Akathisia, Drug-Induced; Analysis of Variance; Antipsychotic Agents; Basal Ganglia Diseases; Body Mass Index; Body Weight; Dibenzothiazepines; Dose-Response Relationship, Drug; Double-Blind Method; Electrocardiography; Female; Humans; Isoindoles; Lurasidone Hydrochloride; Male; Middle Aged; Models, Statistical; Prospective Studies; Psychiatric Status Rating Scales; Quetiapine Fumarate; Schizophrenia; Severity of Illness Index; Thiazoles; Time Factors; Waist Circumference; Young Adult | 2013 |
Effects of meloxicam on milk production, behavior, and feed intake in dairy cows following assisted calving.
Topics: 3-Hydroxybutyric Acid; Animals; Anti-Inflammatory Agents, Non-Steroidal; Behavior, Animal; Body Weight; Cattle; Cattle Diseases; Dystocia; Eating; Fatty Acids, Nonesterified; Feeding Behavior; Female; Lactation; Meloxicam; Milk; Pain; Parturition; Placebos; Pregnancy; Thiazines; Thiazoles | 2013 |
Effects of ziprasidone and olanzapine on body composition and metabolic parameters: an open-label comparative pilot study.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Appetite; Benzodiazepines; Body Composition; Body Weight; Cholesterol, HDL; Cholesterol, LDL; Energy Metabolism; Female; Humans; Male; Middle Aged; Olanzapine; Pilot Projects; Piperazines; Psychotic Disorders; Schizophrenia; Thiazoles; Weight Gain; Young Adult | 2013 |
Effects of meloxicam administration on physiological and performance responses of transported feeder cattle.
Topics: Administration, Oral; Animals; Body Weight; Cattle; Ceruloplasmin; Diet; Haptoglobins; Meloxicam; Thiazines; Thiazoles; Transportation | 2014 |
Efficacy of a buccal meloxicam formulation for pain relief in Merino lambs undergoing knife castration and tail docking in a randomised field trial.
Topics: Administration, Buccal; Animals; Anti-Inflammatory Agents, Non-Steroidal; Behavior, Animal; Body Weight; Cohort Studies; Female; Male; Meloxicam; Orchiectomy; Pain; Sheep; Single-Blind Method; Statistics, Nonparametric; Thiazines; Thiazoles; Wound Healing | 2014 |
Effect of castration timing and oral meloxicam administration on growth performance, inflammation, behavior, and carcass quality of beef calves.
Topics: Acute-Phase Reaction; Administration, Oral; Age Factors; Animals; Anti-Inflammatory Agents, Non-Steroidal; Behavior, Animal; Body Composition; Body Weight; Cattle; Haptoglobins; Inflammation; Male; Meloxicam; Orchiectomy; Thiazines; Thiazoles; Time Factors | 2015 |
Weight change in the management of youth-onset type 2 diabetes: the TODAY clinical trial experience.
Topics: Adolescent; Anthropometry; Blood Glucose; Body Weight; Child; Diabetes Mellitus, Type 2; Drug Combinations; Female; Humans; Hypoglycemic Agents; Life Style; Male; Metformin; Risk Factors; Thiazoles; Treatment Outcome | 2017 |
Population Pharmacokinetic and Pharmacodynamic Modeling of Lusutrombopag, a Newly Developed Oral Thrombopoietin Receptor Agonist, in Healthy Subjects.
Topics: Adult; Age Factors; Area Under Curve; Body Weight; Cinnamates; Dose-Response Relationship, Drug; Double-Blind Method; Female; Healthy Volunteers; Humans; Male; Middle Aged; Models, Biological; Racial Groups; Receptors, Thrombopoietin; Sex Factors; Thiazoles; White People | 2016 |
In search of moderators and mediators of hyperglycemia with atypical antipsychotic treatment.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Blood Glucose; Blood Pressure; Body Mass Index; Body Weight; Dose-Response Relationship, Drug; Female; Humans; Hyperglycemia; Lipid Metabolism; Lipoproteins, HDL; Male; Middle Aged; Olanzapine; Piperazines; Prediabetic State; Predictive Value of Tests; Randomized Controlled Trials as Topic; Schizophrenia; Thiazoles; Time Factors; Treatment Outcome | 2009 |
Ziprasidone vs clozapine in schizophrenia patients refractory to multiple antipsychotic treatments: the MOZART study.
Topics: Adult; Analysis of Variance; Antipsychotic Agents; Body Weight; Clozapine; Disease Progression; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Glucose; Humans; Italy; Lipids; Male; Middle Aged; Patient Compliance; Piperazines; Psychiatric Status Rating Scales; Quality of Life; Schizophrenia; Schizophrenic Psychology; Thiazoles; Young Adult | 2009 |
Ziprasidone as an adjuvant for clozapine- or olanzapine-associated medical morbidity in chronic schizophrenia.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Blood Glucose; Body Mass Index; Body Weight; Chronic Disease; Clozapine; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hyperglycemia; Insulin Resistance; Male; Middle Aged; Morbidity; Olanzapine; Piperazines; Schizophrenia; Thiazoles; Time Factors | 2009 |
Ziprasidone vs olanzapine in recent-onset schizophrenia and schizoaffective disorder: results of an 8-week double-blind randomized controlled trial.
Topics: Adult; Alanine Transaminase; Antipsychotic Agents; Aspartate Aminotransferases; Basal Ganglia Diseases; Benzodiazepines; Biperiden; Blood Glucose; Body Weight; Cholesterol; Chronic Disease; Electrocardiography; Female; Humans; Male; Muscarinic Antagonists; Olanzapine; Piperazines; Prolactin; Psychiatric Status Rating Scales; Psychometrics; Psychotic Disorders; Schizophrenia; Schizophrenic Psychology; Thiazoles; Triglycerides; Young Adult | 2011 |
Ziprasidone vs clozapine in schizophrenia patients refractory to multiple antipsychotic treatments: the MOZART study.
Topics: Adult; Analysis of Variance; Antipsychotic Agents; Body Weight; Clozapine; Disease Progression; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Glucose; Humans; Italy; Lipids; Male; Middle Aged; Patient Compliance; Piperazines; Psychiatric Status Rating Scales; Quality of Life; Schizophrenia; Schizophrenic Psychology; Thiazoles; Young Adult | 2009 |
Nonsteroidal anti-inflammatory drug therapy for neonatal calf diarrhea complex: Effects on calf performance.
Topics: Animals; Animals, Newborn; Anti-Inflammatory Agents, Non-Steroidal; Body Weight; Cattle; Cattle Diseases; Diarrhea; Double-Blind Method; Eating; Male; Meloxicam; Regression Analysis; Thiazines; Thiazoles | 2010 |
Effectiveness of switching from aripiprazole to ziprasidone in patients with schizophrenia.
Topics: Adolescent; Adult; Antipsychotic Agents; Aripiprazole; Blood Glucose; Body Size; Body Weight; Diagnostic and Statistical Manual of Mental Disorders; Female; Hip; Humans; Hyperprolactinemia; Liver Function Tests; Male; Middle Aged; Piperazines; Psychiatric Status Rating Scales; Quinolones; Schizophrenia; Thiazoles; Treatment Outcome; Waist Circumference; Wakefulness; Young Adult | 2010 |
Switching from quetiapine to ziprasidone: a sixteen-week, open-label, multicenter study evaluating the effectiveness and safety of ziprasidone in outpatient subjects with schizophrenia or schizoaffective disorder.
Topics: Adolescent; Adult; Antipsychotic Agents; Blood Glucose; Body Weight; Cholesterol; Cognition; Dibenzothiazepines; Drug Administration Schedule; Female; Glycated Hemoglobin; Humans; Male; Middle Aged; Outpatients; Piperazines; Psychiatric Status Rating Scales; Psychotic Disorders; Quetiapine Fumarate; Schizophrenia; Thiazoles; Treatment Outcome; Triglycerides; Young Adult | 2011 |
Ziprasidone with adjunctive mood stabilizer in the maintenance treatment of bipolar I disorder: long-term changes in weight and metabolic profiles.
Topics: Adjuvants, Immunologic; Antipsychotic Agents; Bipolar Disorder; Body Weight; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Lithium Chloride; Longitudinal Studies; Male; Metabolic Diseases; Metabolome; Piperazines; Psychiatric Status Rating Scales; Thiazoles; Valproic Acid | 2012 |
Double-blind comparison of the safety and efficacy of lurasidone and ziprasidone in clinically stable outpatients with schizophrenia or schizoaffective disorder.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Body Weight; Cholesterol; Diagnostic and Statistical Manual of Mental Disorders; Double-Blind Method; Female; Humans; Isoindoles; Lurasidone Hydrochloride; Male; Middle Aged; Outpatients; Piperazines; Psychiatric Status Rating Scales; Psychotic Disorders; Schizophrenia; Thiazoles; Time Factors; Treatment Outcome; Triglycerides; Young Adult | 2011 |
Efficacy and safety of ziprasidone in the treatment of first-episode psychosis: an 8-week, open-label, multicenter trial.
Topics: Adolescent; Adult; Akathisia, Drug-Induced; Antipsychotic Agents; Body Weight; Female; Humans; Lipids; Male; Middle Aged; Patient Dropouts; Piperazines; Prolactin; Psychiatric Status Rating Scales; Psychotic Disorders; Thiazoles | 2012 |
Comparison of metabolic effects of ziprasidone versus olanzapine treatment in patients with first-episode schizophrenia.
Topics: Adolescent; Adult; Antipsychotic Agents; Benzodiazepines; Body Weight; Female; Glucose; Humans; Insulin; Lipid Metabolism; Male; Middle Aged; Olanzapine; Piperazines; Schizophrenia; Thiazoles; Young Adult | 2013 |
Single dose pharmacokinetics and absolute bioavailability of mirabegron, a β₃-adrenoceptor agonist for treatment of overactive bladder.
Topics: Acetanilides; Administration, Oral; Adolescent; Adrenergic beta-3 Receptor Agonists; Adult; Area Under Curve; Biological Availability; Biotransformation; Body Weight; Cross-Over Studies; Female; Humans; Infusions, Intravenous; Linear Models; Male; Metabolic Clearance Rate; Middle Aged; Models, Biological; Netherlands; Sex Factors; Thiazoles; Urinary Bladder, Overactive; Washington; Young Adult | 2012 |
[Effect of rosiglitazone on insulin resistance and hyperandrogenism in polycystic ovary syndrome].
Topics: Administration, Oral; Adult; Androstenedione; Blood Glucose; Body Weight; Female; Follicle Stimulating Hormone; Humans; Hyperandrogenism; Hypoglycemic Agents; Insulin; Insulin Resistance; Leptin; Lipids; Luteinizing Hormone; Menstruation; Neuropeptide Y; Ovulation; Polycystic Ovary Syndrome; Rosiglitazone; Testosterone; Thiazoles; Thiazolidinediones; Treatment Outcome | 2002 |
[The efficacy and safety of pioglitazone hydrochloride in combination with sulphonylureas and metfomin in the treatment of type 2 diabetes mellitus a 12-week randomized multi-centres placebo-controlled parallel study].
Topics: Blood Pressure; Body Weight; Cholesterol; Consumer Product Safety; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Heart Rate; Humans; Hypoglycemic Agents; Insulin; Male; Metformin; Pioglitazone; Sulfonylurea Compounds; Thiazoles; Thiazolidinediones; Time Factors; Treatment Outcome; Triglycerides | 2002 |
Effect of rosiglitazone treatment on nontraditional markers of cardiovascular disease in patients with type 2 diabetes mellitus.
Topics: Biomarkers; Body Weight; C-Reactive Protein; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Double-Blind Method; Female; Humans; Interleukin-6; Leukocyte Count; Male; Matrix Metalloproteinase 9; Middle Aged; Receptors, Cytoplasmic and Nuclear; Risk Factors; Rosiglitazone; Thiazoles; Thiazolidinediones; Transcription Factors | 2002 |
The effect of thiazolidinediones on plasma adiponectin levels in normal, obese, and type 2 diabetic subjects.
Topics: Adiponectin; Adult; Animals; Body Weight; Diabetes Mellitus; Diabetes Mellitus, Type 2; Female; Glucose Clamp Technique; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Intercellular Signaling Peptides and Proteins; Lipids; Male; Middle Aged; Obesity; Proteins; Rats; Thiazoles; Thiazolidinediones | 2002 |
Rosiglitazone but not metformin enhances insulin- and exercise-stimulated skeletal muscle glucose uptake in patients with newly diagnosed type 2 diabetes.
Topics: Blood Glucose; Body Weight; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Exercise; Fasting; Female; Glucose; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Leg; Male; Metformin; Middle Aged; Muscle, Skeletal; Oxygen Consumption; Radionuclide Imaging; Rosiglitazone; Thiazoles; Thiazolidinediones | 2002 |
Differential effects of rosiglitazone and metformin on adipose tissue distribution and glucose uptake in type 2 diabetic subjects.
Topics: Adipose Tissue; Aged; Blood Glucose; Body Weight; Diabetes Mellitus, Type 2; Female; Fluorodeoxyglucose F18; Glucose; Humans; Hypoglycemic Agents; Insulin; Kinetics; Lactates; Lipids; Male; Metformin; Middle Aged; Placebos; Radiopharmaceuticals; Rosiglitazone; Thiazoles; Thiazolidinediones; Tomography, Emission-Computed; Weight Loss | 2003 |
Weight, lipids, glucose, and behavioral measures with ziprasidone treatment in a population with mental retardation.
Topics: Antipsychotic Agents; Blood Glucose; Body Weight; Cholesterol; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Intellectual Disability; Lipids; Male; Mental Disorders; Middle Aged; Piperazines; Psychiatric Status Rating Scales; Thiazoles; Treatment Outcome; Triglycerides | 2003 |
Improvement in indices of health status in outpatients with schizophrenia switched to ziprasidone.
Topics: Adolescent; Adult; Antipsychotic Agents; Basal Ganglia Diseases; Benzodiazepines; Body Weight; Female; Health Status Indicators; Humans; Male; Middle Aged; Olanzapine; Piperazines; Prolactin; Psychotic Disorders; Risperidone; Schizophrenia; Thiazoles; Withholding Treatment | 2003 |
Evaluation of interethnic differences in repinotan pharmacokinetics by using population approach.
Topics: Adult; Aged; Asian People; Benzopyrans; Body Weight; Brain Injuries; Ethnicity; Female; Humans; Male; Middle Aged; Models, Statistical; Population; Serotonin Receptor Agonists; Sex Characteristics; Thiazoles; White People | 2006 |
Effectiveness of olanzapine, quetiapine, risperidone, and ziprasidone in patients with chronic schizophrenia following discontinuation of a previous atypical antipsychotic.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Body Weight; Chronic Disease; Cross-Over Studies; Dibenzothiazepines; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Olanzapine; Patient Dropouts; Piperazines; Proportional Hazards Models; Quetiapine Fumarate; Risperidone; Schizophrenia; Schizophrenic Psychology; Survival Analysis; Thiazoles; Time Factors; Treatment Outcome | 2006 |
Early changes of plasma lipids during treatment with atypical antipsychotics.
Topics: Adolescent; Adult; Aged; Amisulpride; Analysis of Variance; Antipsychotic Agents; Benzodiazepines; Body Mass Index; Body Weight; Cholesterol; Clozapine; Humans; Lipids; Middle Aged; Olanzapine; Piperazines; Prospective Studies; Schizophrenia; Sulpiride; Thiazoles; Time Factors; Triglycerides | 2006 |
Ziprasidone outcome and tolerability: a practical clinical trial with plasma drug levels.
Topics: Adult; Antipsychotic Agents; Basal Ganglia Diseases; Body Weight; Chromatography, High Pressure Liquid; Electrocardiography; Female; Humans; Male; Middle Aged; Piperazines; Schizophrenia; Thiazoles | 2007 |
Long-term changes in weight and plasma lipids during maintenance treatment with ziprasidone.
Topics: Antipsychotic Agents; Benzodiazepines; Body Mass Index; Body Weight; Brief Psychiatric Rating Scale; Cross-Sectional Studies; Female; Follow-Up Studies; Humans; Lipids; Male; Mental Disorders; Olanzapine; Piperazines; Retrospective Studies; Single-Blind Method; Thiazoles; Time Factors | 2008 |
Effectiveness, safety, and tolerability of ziprasidone for treating schizophrenia patients undergoing usual care: a 12-month, open-label, flexible-dose, naturalistic observational trial.
Topics: Adult; Antipsychotic Agents; Body Weight; Chronic Disease; Female; Humans; Male; Middle Aged; Piperazines; Psychiatric Status Rating Scales; Schizophrenia; Thiazoles | 2007 |
A prospective open-label treatment trial of ziprasidone monotherapy in children and adolescents with bipolar disorder.
Topics: Antipsychotic Agents; Bipolar Disorder; Body Weight; Evaluation Studies as Topic; Female; Humans; Male; Pediatrics; Piperazines; Prospective Studies; Psychiatric Status Rating Scales; Severity of Illness Index; Thiazoles | 2007 |
Effects of troglitazone: a new hypoglycemic agent in patients with NIDDM poorly controlled by diet therapy.
Topics: Adult; Aged; Aged, 80 and over; Blood Pressure; Body Weight; Cholesterol; Chromans; Diabetes Mellitus, Type 2; Diet, Diabetic; Double-Blind Method; Female; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Male; Middle Aged; Placebos; Thiazoles; Thiazolidinediones; Triglycerides; Troglitazone | 1996 |
Troglitazone decreases the proportion of small, dense LDL and increases the resistance of LDL to oxidation in obese subjects.
Topics: Adult; Blood Glucose; Body Weight; Cholesterol, LDL; Chromans; Cross-Over Studies; Double-Blind Method; Fasting; Female; Glucose; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Lipid Peroxidation; Lipids; Male; Obesity; Oxidation-Reduction; Thiazoles; Thiazolidinediones; Troglitazone | 1998 |
Troglitazone in combination with sulfonylurea restores glycemic control in patients with type 2 diabetes. The Troglitazone Study Group.
Topics: Blood Glucose; Body Weight; C-Peptide; Chromans; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Therapy, Combination; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Lipids; Sulfonylurea Compounds; Thiazoles; Thiazolidinediones; Treatment Outcome; Troglitazone | 1998 |
Effects of a thiazolidinedione compound on body fat and fat distribution of patients with type 2 diabetes.
Topics: Abdomen; Adipose Tissue; Adult; Aged; Body Weight; Calibration; Chromans; Double-Blind Method; Female; Humans; Hypoglycemic Agents; Magnetic Resonance Imaging; Male; Middle Aged; Placebos; Thiazoles; Thiazolidinediones; Troglitazone | 1999 |
A comparison of troglitazone and metformin on insulin requirements in euglycemic intensively insulin-treated type 2 diabetic patients.
Topics: Blood Glucose; Body Weight; C-Peptide; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Chromans; Circadian Rhythm; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Drug Therapy, Combination; Fatty Acids, Nonesterified; Female; Fructosamine; Humans; Hypoglycemic Agents; Insulin; Insulin Infusion Systems; Male; Metformin; Middle Aged; Thiazoles; Thiazolidinediones; Triglycerides; Troglitazone | 1999 |
Lack of effects of the beta3-adrenoreceptor agonist UL-TG 307 on insulin sensitivity and insulin secretion in Type 2 diabetic patients.
Topics: Adrenergic beta-Agonists; Adult; Body Weight; Cross-Over Studies; Diabetes Mellitus, Type 2; Double-Blind Method; Fatty Acids, Nonesterified; Glycerol; Humans; Insulin; Insulin Resistance; Insulin Secretion; Lipids; Male; Middle Aged; Thiazoles | 1999 |
Effects of troglitazone on insulin sensitivity in HIV-infected patients with protease inhibitor-associated diabetes mellitus.
Topics: Adipose Tissue; Adult; Anti-HIV Agents; Blood Glucose; Body Weight; Chromans; Diabetes Mellitus; HIV Infections; Humans; Hypoglycemic Agents; Insulin Resistance; Lipids; Male; Middle Aged; Pilot Projects; Thiazoles; Thiazolidinediones; Troglitazone | 2000 |
A comparison in a clinical setting of the efficacy and side effects of three thiazolidinediones.
Topics: Body Weight; Cholesterol, LDL; Chromans; Diabetes Mellitus, Type 2; Edema; Female; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Male; Middle Aged; Pioglitazone; Rosiglitazone; Thiazoles; Thiazolidinediones; Triglycerides; Troglitazone | 2000 |
Rosiglitazone monotherapy improves glycaemic control in patients with type 2 diabetes: a twelve-week, randomized, placebo-controlled study.
Topics: Adult; Aged; Aged, 80 and over; Blood Glucose; Body Weight; C-Peptide; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Fructosamine; Glycated Hemoglobin; Humans; Insulin; Lipids; Male; Middle Aged; Placebos; Rosiglitazone; Thiazoles; Thiazolidinediones | 1999 |
The apparent effects of ziprasidone on plasma lipids and glucose.
Topics: Adult; Analysis of Variance; Antipsychotic Agents; Blood Glucose; Body Mass Index; Body Weight; Cholesterol; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Lipids; Male; Outcome Assessment, Health Care; Piperazines; Psychotic Disorders; Schizophrenia; Thiazoles; Triglycerides | 2001 |
[Studies on the diuretic effects of etozolin (Elkapin) in heart failure - a comparison with the loop diuretic agent furosemide (author's transl)].
Topics: Blood Cell Count; Blood Pressure; Body Weight; Diuretics; Electrolytes; Furosemide; Heart Failure; Heart Rate; Humans; Piperidines; Thiazoles | 1979 |
279 other study(ies) available for thiazoles and Body Weight
Article | Year |
---|---|
Hepatotoxicity of the pesticides imazalil, thiacloprid and clothianidin - Individual and mixture effects in a 28-day study in female Wistar rats.
Topics: Animals; Body Weight; Chemical and Drug Induced Liver Injury; Female; Guanidines; Imidazoles; Kidney; Liver; Neonicotinoids; No-Observed-Adverse-Effect Level; Organ Size; Pesticides; Rats; Rats, Wistar; Risk Assessment; Thiazines; Thiazoles | 2020 |
Pharmacological modulation of RORα controls fat browning, adaptive thermogenesis, and body weight in mice.
Topics: Adipocytes; Adipose Tissue, Brown; Adipose Tissue, White; Adult; Animals; Benzamides; Body Weight; Cell Transdifferentiation; Cells, Cultured; Cold-Shock Response; Female; Humans; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Nuclear Receptor Subfamily 1, Group F, Member 1; Sulfonamides; Thermogenesis; Thiazoles; Thiophenes | 2021 |
Lithium Chloride Protects against Sepsis-Induced Skeletal Muscle Atrophy and Cancer Cachexia.
Topics: Animals; Body Weight; Cachexia; Cell Differentiation; Cell Proliferation; Culture Media, Conditioned; Glycogen Synthase Kinase 3 beta; Inflammation; Lipopolysaccharides; Lithium Chloride; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Muscle Contraction; Muscle Fibers, Skeletal; Muscle Proteins; Muscle, Skeletal; Muscular Atrophy; Neoplasms; RAW 264.7 Cells; RNA, Small Interfering; Sepsis; SKP Cullin F-Box Protein Ligases; Tetrazolium Salts; Thiazoles | 2021 |
PPARα Agonist, MHY3200, Alleviates Renal Inflammation during Aging via Regulating ROS/Akt/FoxO1 Signaling.
Topics: Acetates; Aging; Animals; Body Weight; Gene Expression Regulation; Hypoglycemic Agents; Inflammation; Insulin; Kidney; Male; Nerve Tissue Proteins; Phosphorylation; PPAR alpha; Protein Binding; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Signal Transduction; Thiazoles; Time Factors; Triglycerides | 2021 |
Salvia plebeia R. Br. polysaccharides (SPP) against RSV (respiratory syncytial virus) infection: Antiviral effect and mechanisms of action.
Topics: Animals; Antiviral Agents; Body Weight; Cell Line; Cytokines; Eating; Humans; Lung; Mice; Mice, Inbred BALB C; Plant Extracts; Polysaccharides; Respiratory Function Tests; Respiratory Syncytial Virus Infections; Respiratory Syncytial Virus, Human; Ribavirin; Salvia; Tetrazolium Salts; Thiazoles; Toll-Like Receptors | 2021 |
"2-(4-Fluorobenzamido)-4-methylthiazole-5-carboxylic acid" a novel thiazole compound, ameliorates insulin sensitivity and hyperlipidaemia in streptozotocin-induced diabetic rats: Plausible role of inflammatory and oxidative stress markers.
Topics: Animals; Benzamides; Biomarkers; Blood Glucose; Body Weight; Cytokines; Diabetes Mellitus, Experimental; Drinking; Feeding Behavior; Glucose Intolerance; Glycated Hemoglobin; Hyperlipidemias; Inflammation; Inflammation Mediators; Insulin; Insulin Resistance; Kidney; Lipids; Liver; Organ Size; Oxidative Stress; Pancreas; Rats, Wistar; Streptozocin; Thiazoles; Toxicity Tests, Acute | 2017 |
GW0742 (PPAR-beta agonist) attenuates hepatic endoplasmic reticulum stress by improving hepatic energy metabolism in high-fat diet fed mice.
Topics: Alanine Transaminase; Animals; Apoptosis; Body Weight; Cholesterol; Diet, High-Fat; Endoplasmic Reticulum Stress; Energy Intake; Energy Metabolism; Fatty Liver; Feeding Behavior; Glucose Tolerance Test; Hepatocytes; Inflammation; Insulin Resistance; Lipogenesis; Liver; Male; Mice, Inbred C57BL; Oxidation-Reduction; PPAR-beta; Protein Isoforms; Thiazoles | 2018 |
The adiponectin promoter activator NP-1 induces high levels of circulating TNFα and weight loss in obese (fa/fa) Zucker rats.
Topics: Adiponectin; Adipose Tissue, Brown; Animals; Body Weight; DNA (Cytosine-5-)-Methyltransferase 1; Dyslipidemias; Feeding Behavior; Gene Expression Regulation; Hypothalamus; Liver; Male; Obesity; Promoter Regions, Genetic; Rats; Rats, Zucker; Thiazoles; Thinness; Tumor Necrosis Factor-alpha; Weight Loss | 2018 |
Beneficial Metabolic Effects of Mirabegron In Vitro and in High-Fat Diet-Induced Obese Mice.
Topics: 3T3-L1 Cells; Acetanilides; Adipocytes; Adipocytes, Brown; Animals; Body Weight; Diet, High-Fat; Gene Expression Regulation; Glucose; Homeostasis; Male; Mice; Mice, Obese; Obesity; Thiazoles; Uncoupling Protein 1 | 2019 |
Paclitaxel-loaded poly(glycolide-co-ε-caprolactone)-b-D-α-tocopheryl polyethylene glycol 2000 succinate nanoparticles for lung cancer therapy.
Topics: Animals; Antineoplastic Agents; Body Weight; Cell Line, Tumor; Cell Survival; Coumarins; Drug Delivery Systems; Humans; Lung Neoplasms; Mice; Mice, Nude; Nanoparticles; Neoplasms, Experimental; Paclitaxel; Polyesters; Polyethylene Glycols; Thiazoles; Vitamin E; Xenograft Model Antitumor Assays | 2013 |
Assessing insecticide hazard to bumble bees foraging on flowering weeds in treated lawns.
Topics: Analysis of Variance; Animals; Bees; Body Weight; Feeding Behavior; Guanidines; Insecticides; Kentucky; Medicago; Neonicotinoids; ortho-Aminobenzoates; Plant Nectar; Plant Weeds; Reproduction; Thiazoles | 2013 |
Switching to ziprasidone in the clinical practice setting: an open-label study.
Topics: Adult; Antipsychotic Agents; Body Weight; Brief Psychiatric Rating Scale; Drug Substitution; Female; Follow-Up Studies; Humans; Male; Middle Aged; Piperazines; Psychometrics; Psychotic Disorders; Quality of Life; Schizophrenia; Schizophrenic Psychology; Thiazoles; Treatment Outcome | 2013 |
Effects of multimodal analgesia with LowDose buprenorphine and meloxicam on fecal glucocorticoid metabolites after surgery in New Zealand white rabbits (Oryctolagus cuniculus).
Topics: Analgesia; Analgesics, Opioid; Anesthetics, Local; Animals; Anti-Inflammatory Agents, Non-Steroidal; Body Weight; Bupivacaine; Buprenorphine; Corticosterone; Drug Therapy, Combination; Feces; Glucocorticoids; Male; Meloxicam; Minimally Invasive Surgical Procedures; Pain, Postoperative; Rabbits; Thiazines; Thiazoles | 2013 |
Optimization of brain penetrant 11β-hydroxysteroid dehydrogenase type I inhibitors and in vivo testing in diet-induced obese mice.
Topics: 11-beta-Hydroxysteroid Dehydrogenase Type 1; Adamantane; Animals; Blood Glucose; Body Weight; Brain; Crystallography, X-Ray; Cyclopropanes; Diabetes Mellitus, Type 2; Dietary Fats; Humans; Hypoglycemic Agents; Insulin; Isoenzymes; Liver; Male; Metabolic Syndrome; Mice; Mice, Inbred C57BL; Mice, Obese; Models, Molecular; Pyrazoles; Rats; Stereoisomerism; Structure-Activity Relationship; Thiazoles | 2014 |
Xanthine oxidase inhibition by febuxostat attenuates experimental atherosclerosis in mice.
Topics: Animals; Aorta; Apolipoproteins E; Atherosclerosis; Body Weight; Cholesterol; Cytokines; Disease Models, Animal; Endothelial Cells; Febuxostat; Gout Suppressants; Inflammation; L-Lactate Dehydrogenase; Macrophages; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Oxidative Stress; Plaque, Atherosclerotic; Reactive Oxygen Species; Thiazoles; Xanthine Oxidase | 2014 |
Population pharmacokinetics and pharmacodynamics of ponesimod, a selective S1P1 receptor modulator.
Topics: Adolescent; Adult; Aged; Body Weight; Circadian Rhythm; Female; Humans; Intestinal Absorption; Lymphocyte Count; Male; Middle Aged; Models, Statistical; Multiple Sclerosis; Population; Receptors, Lysosphingolipid; Thiazoles; Young Adult | 2014 |
Pharmacological effects of JTT-551, a novel protein tyrosine phosphatase 1B inhibitor, in diet-induced obesity mice.
Topics: Animals; Blood Glucose; Body Weight; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Glucose; Glycine; Hypothalamus; Leptin; Lipid Metabolism; Male; Mice; Mice, Inbred C57BL; Mice, Obese; Obesity; Protein Tyrosine Phosphatase, Non-Receptor Type 1; Protein Tyrosine Phosphatases; Signal Transduction; STAT3 Transcription Factor; Thiazoles | 2014 |
Toxicity studies of coumarin 6-encapsulated polystyrene nanospheres conjugated with peanut agglutinin and poly(N-vinylacetamide) as a colonoscopic imaging agent in rats.
Topics: Acetamides; Animals; Body Weight; Caco-2 Cells; CHO Cells; Colon; Colonoscopy; Colorectal Neoplasms; Coumarins; Cricetulus; Drinking; Eating; Fluorescent Dyes; Humans; Male; Nanospheres; Peanut Agglutinin; Polystyrenes; Polyvinyls; Rats; Rectum; Thiazoles | 2015 |
Febuxostat ameliorates doxorubicin-induced cardiotoxicity in rats.
Topics: Animals; Antibiotics, Antineoplastic; Apoptosis; Biomarkers; Body Weight; Doxorubicin; Febuxostat; Heart; Male; Organ Size; Rats; Rats, Wistar; Superoxide Dismutase; Thiazoles; Thiobarbituric Acid Reactive Substances; Xanthine Oxidase | 2015 |
NPs/NPRs Signaling Pathways May Be Involved in Depression-Induced Loss of Gastric ICC by Decreasing the Production of mSCF.
Topics: Animals; Body Weight; Cell Proliferation; Depression; Down-Regulation; Gastric Mucosa; Gene Expression Regulation; Interstitial Cells of Cajal; Male; Myocytes, Smooth Muscle; Natriuretic Peptides; Proto-Oncogene Proteins c-kit; Rats; Rats, Sprague-Dawley; Receptors, Atrial Natriuretic Factor; Signal Transduction; Stem Cell Factor; Tetrazolium Salts; Thiazoles; Up-Regulation | 2016 |
Postoperative Analgesia Due to Sustained-Release Buprenorphine, Sustained-Release Meloxicam, and Carprofen Gel in a Model of Incisional Pain in Rats (Rattus norvegicus).
Topics: Analgesics; Animals; Body Weight; Buprenorphine; Carbazoles; Delayed-Action Preparations; Male; Meloxicam; Pain, Postoperative; Random Allocation; Rats; Rats, Sprague-Dawley; Thiazines; Thiazoles | 2016 |
Polymeric nanocapsules as a technological alternative to reduce the toxicity caused by meloxicam in mice.
Topics: Animals; Body Weight; Caproates; Dose-Response Relationship, Drug; Gastric Mucosa; Lactones; Lipid Peroxidation; Liver; Male; Meloxicam; Mice; Nanocapsules; Organ Size; Polysorbates; Stomach; Structure-Activity Relationship; Thiazines; Thiazoles | 2016 |
Long-term treatment with the beta-3 adrenoceptor agonist, mirabegron ameliorates detrusor overactivity and restores cyclic adenosine monophosphate (cAMP) levels in obese mice.
Topics: Acetanilides; Adrenergic beta-3 Receptor Agonists; Animals; Body Weight; Carbachol; Cyclic AMP; Cyclic Nucleotide Phosphodiesterases, Type 4; Male; Mice; Mice, Inbred C57BL; Mice, Obese; Muscle Contraction; Muscle, Smooth; Obesity; Thiazoles; Urinary Bladder; Urinary Bladder, Overactive; Urination | 2017 |
PI3Kα inhibition reduces obesity in mice.
Topics: Animals; Body Weight; Energy Metabolism; Male; Mice; Obesity; Phosphoinositide-3 Kinase Inhibitors; Protein Kinase Inhibitors; Thiazoles; Treatment Outcome | 2016 |
Differences in Aβ brain networks in Alzheimer's disease and healthy controls.
Topics: Age Factors; Aged; Alzheimer Disease; Amyloid beta-Peptides; Aniline Compounds; Benzothiazoles; Body Weight; Brain; Brain Mapping; Cluster Analysis; Datasets as Topic; Female; Humans; Male; Neural Pathways; Positron-Emission Tomography; Radiopharmaceuticals; Regression Analysis; ROC Curve; Sex Factors; Signal Processing, Computer-Assisted; Thiazoles | 2017 |
Evaluation of tumour promoting potency of fish borne toxaphene residues, as compared to technical toxaphene and UV-irradiated toxaphene.
Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Body Weight; Carcinogens; Cell Communication; Gadus morhua; Gap Junctions; Glutathione Peroxidase; Insecticides; Liver; Liver Neoplasms; Meat; Organ Size; Pesticide Residues; Rats; Tetrazolium Salts; Thiazoles; Thymus Gland; Toxaphene; Ultraviolet Rays | 2008 |
Synergistic immunostimulating activity of pidotimod and red ginseng acidic polysaccharide against cyclophosphamide-induced immunosuppression.
Topics: Adjuvants, Immunologic; Animals; Body Weight; C-Reactive Protein; Cell Proliferation; Cell Survival; Cyclophosphamide; Drug Synergism; Immunosuppressive Agents; Killer Cells, Natural; Macrophages, Peritoneal; Male; Mice; Mice, Inbred BALB C; Nitric Oxide; Organ Size; Panax; Polysaccharides; Pyrrolidonecarboxylic Acid; Spleen; Tetrazolium Salts; Thiazoles; Thiazolidines | 2008 |
Prophylactic neuroprotective property of Centella asiatica against 3-nitropropionic acid induced oxidative stress and mitochondrial dysfunctions in brain regions of prepubertal mice.
Topics: Analysis of Variance; Animals; Body Weight; Brain; Centella; Dose-Response Relationship, Drug; Eating; Edema; Glutathione; Lipid Peroxidation; Male; Malondialdehyde; Mice; Mitochondria; Nitro Compounds; Oxidative Stress; Plant Extracts; Protein Carbonylation; Reactive Oxygen Species; Tetrazolium Salts; Thiazoles; Triterpenes | 2008 |
Automated analysis of postoperative behaviour: assessment of HomeCageScan as a novel method to rapidly identify pain and analgesic effects in mice.
Topics: Analgesics; Animals; Behavior, Animal; Body Weight; Male; Meloxicam; Mice; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred Strains; Pain Measurement; Pain, Postoperative; Postoperative Period; Sensitivity and Specificity; Software; Thiazines; Thiazoles; Vasectomy | 2009 |
Preclinical toxicokinetic evaluation of phortress [2-(4-amino-3-methylphenyl)-5-fluorobenzothiazole lysylamide dihydrochloride] in two rodent species.
Topics: Alkaline Phosphatase; Animals; beta-Galactosidase; Body Weight; Cytochrome P-450 CYP1A1; DNA Adducts; Drug Evaluation, Preclinical; Female; Genes, Reporter; Kidney; Liver; Lung; Male; Maximum Tolerated Dose; Mice; Mice, Inbred ICR; Organ Size; Prodrugs; Rats; Rats, Sprague-Dawley; Thiazoles | 2009 |
Correlation between body weight changes and postoperative pain in rats treated with meloxicam or buprenorphine.
Topics: Analgesia; Analgesics, Opioid; Animals; Anti-Inflammatory Agents, Non-Steroidal; Body Weight; Buprenorphine; Intubation, Intratracheal; Meloxicam; Pain, Postoperative; Rats; Rats, Inbred Lew; Thiazines; Thiazoles; Thoracotomy; Weight Gain | 2009 |
Cyclooxygenase-2 inhibition reverts the decrease in adiponectin levels and attenuates the loss of white adipose tissue during chronic inflammation.
Topics: Adiponectin; Adipose Tissue, White; Animals; Arthritis, Experimental; Body Weight; Chronic Disease; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Insulin-Like Growth Factor I; Male; Meloxicam; Rats; Rats, Wistar; RNA, Messenger; Severity of Illness Index; Thiazines; Thiazoles; Tumor Necrosis Factor-alpha | 2009 |
Comparison of side effects between buprenorphine and meloxicam used postoperatively in Dutch belted rabbits (Oryctolagus cuniculus).
Topics: Analgesics, Opioid; Animals; Anti-Inflammatory Agents, Non-Steroidal; Blood Chemical Analysis; Body Temperature; Body Weight; Buprenorphine; Cyclooxygenase Inhibitors; Meloxicam; Postoperative Period; Rabbits; Thiazines; Thiazoles; Treatment Outcome | 2009 |
Synergistic interaction between neuropeptide Y1 and Y5 receptor pathways in regulation of energy homeostasis.
Topics: Animals; Anti-Obesity Agents; Body Weight; Dietary Fats; Drug Synergism; Eating; Energy Metabolism; Homeostasis; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Morpholines; Obesity; Pyridines; Receptors, Neuropeptide Y; Spiro Compounds; Thiazoles | 2009 |
Mouse carnitine-acylcarnitine translocase (CACT) is transcriptionally regulated by PPARalpha and PPARdelta in liver cells.
Topics: Animals; Base Sequence; Body Weight; Carnitine Acyltransferases; Carnitine O-Palmitoyltransferase; Cell Line, Tumor; Cytochrome P-450 Enzyme System; Fasting; Female; Gene Expression Regulation, Enzymologic; Humans; Liver; Luciferases; Male; Mice; Mice, Knockout; Molecular Sequence Data; Mutation; PPAR alpha; PPAR delta; Promoter Regions, Genetic; Pyrimidines; Reverse Transcriptase Polymerase Chain Reaction; Thiazoles; Transcription, Genetic | 2009 |
Anti-fibrotic effects of a methylenedioxybenzene compound, CW209292 on dimethylnitrosamine-induced hepatic fibrosis in rats.
Topics: Animals; Benzodioxoles; Body Weight; Cell Proliferation; Dimethylnitrosamine; Disease Models, Animal; Female; Hepatic Stellate Cells; Hydroxyproline; Immunohistochemistry; Liver; Liver Cirrhosis; Male; Molecular Structure; Prothrombin Time; Rats; Rats, Sprague-Dawley; Survival Analysis; Thiazoles | 2009 |
A small molecule that blocks fat synthesis by inhibiting the activation of SREBP.
Topics: Animals; Blood Glucose; Body Weight; CHO Cells; Cricetinae; Cricetulus; Fatty Acids; Humans; Intracellular Signaling Peptides and Proteins; Membrane Proteins; Mice; Mice, Obese; Protein Binding; Protein Structure, Tertiary; Pyridines; Sterol Regulatory Element Binding Proteins; Thiazoles; Transcription, Genetic | 2009 |
Platonin improves survival of skin allografts.
Topics: Animals; Body Weight; Cytokines; Graft Rejection; Graft Survival; Immunologic Factors; Kidney; Leukocyte Count; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; NF-kappa B; Nitric Oxide Synthase Type II; Skin Transplantation; Thiazoles; Transplantation, Homologous | 2010 |
Lycopene modulates nitric oxide pathways against 3-nitropropionic acid-induced neurotoxicity.
Topics: Animals; Anticarcinogenic Agents; Body Weight; Carotenoids; Catalase; Coloring Agents; Electron Transport Complex IV; Huntington Disease; Lipid Peroxidation; Lycopene; Male; Motor Activity; NADH Dehydrogenase; Neuroprotective Agents; Neurotoxicity Syndromes; Neurotoxins; Nitric Oxide; Nitrites; Nitro Compounds; Oxidative Stress; Propionates; Rats; Rats, Wistar; Signal Transduction; Succinate Dehydrogenase; Superoxide Dismutase; Tetrazolium Salts; Thiazoles | 2009 |
Effects of atypical antipsychotic drugs on body weight and food intake in dopamine D2 receptor knockout mice.
Topics: Adipose Tissue; Animals; Antipsychotic Agents; Benzodiazepines; Body Weight; Eating; Male; Mice; Mice, Knockout; Motor Activity; Olanzapine; Piperazines; Receptors, Dopamine D2; Risperidone; Thiazoles; Weight Gain | 2010 |
Prevention of ovarian hyperstimulation syndrome in a rat model: efficacy comparison between cabergoline and meloxicam.
Topics: Analysis of Variance; Animals; Biopsy, Needle; Body Weight; Cabergoline; Chorionic Gonadotropin; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Ergolines; Female; Immunohistochemistry; Injections, Intramuscular; Meloxicam; Organ Size; Ovarian Hyperstimulation Syndrome; Ovary; Ovulation Induction; Pregnancy; Pregnancy, Animal; Probability; Random Allocation; Rats; Rats, Wistar; Thiazines; Thiazoles; Vascular Endothelial Growth Factor A | 2010 |
Protective effect of montelukast against quinolinic acid/malonic acid induced neurotoxicity: possible behavioral, biochemical, mitochondrial and tumor necrosis factor-α level alterations in rats.
Topics: Acetates; Analysis of Variance; Animals; Behavior, Animal; Body Weight; Brain; Brain Chemistry; Catalase; Cyclopropanes; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Gene Expression Regulation; Lipid Peroxidation; Male; Malonates; Mitochondria; Motor Activity; Neuroprotective Agents; Neurotoxicity Syndromes; Nitrites; Quinolines; Quinolinic Acid; Rats; Rats, Wistar; Sulfides; Superoxide Dismutase; Tetrazolium Salts; Thiazoles; Tumor Necrosis Factor-alpha | 2010 |
Design and synthesis of a new class of malonyl-CoA decarboxylase inhibitors with anti-obesity and anti-diabetic activities.
Topics: Animals; Anti-Obesity Agents; Blood Glucose; Body Weight; Carboxy-Lyases; Diabetes Mellitus, Type 2; Drug Design; Eating; Humans; Hypoglycemic Agents; Mice; Mice, Inbred C57BL; Obesity; Propanols; Thiazoles | 2010 |
Comparison of buprenorphine and meloxicam for postsurgical analgesia in rats: effects on body weight, locomotor activity, and hemodynamic parameters.
Topics: Analgesia; Analgesics, Opioid; Animals; Anti-Inflammatory Agents, Non-Steroidal; Blood Pressure; Body Weight; Buprenorphine; Feeding Behavior; Heart Rate; Male; Meloxicam; Motor Activity; Pain Measurement; Pain, Postoperative; Random Allocation; Rats; Rats, Sprague-Dawley; Thiazines; Thiazoles; Treatment Outcome | 2010 |
Experimental diabetes attenuates calcium mobilization and proliferative response in splenic lymphocytes from mice.
Topics: Animals; Blood Glucose; Body Weight; Calcium; Calcium Channels, L-Type; Concanavalin A; Diabetes Mellitus, Experimental; Fura-2; Lipopolysaccharides; Lymphocyte Activation; Lymphocytes; Male; Mice; Spleen; Tetrazolium Salts; Thiazoles; Verapamil | 2011 |
Pharmacokinetics of meloxicam following intravenous and oral administration in green iguanas (Iguana iguana).
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents, Non-Steroidal; Area Under Curve; Blood Cells; Body Weight; Female; Iguanas; Injections, Intravenous; Kidney; Male; Meloxicam; Pain; Stomach; Thiazines; Thiazoles | 2010 |
Effects of risperidone, quetiapine and ziprasidone on ethanol withdrawal syndrome in rats.
Topics: Alcoholism; Animals; Antipsychotic Agents; Behavior, Animal; Body Weight; Central Nervous System Depressants; Comorbidity; Dibenzothiazepines; Ethanol; Humans; Hyperkinesis; Male; Motor Activity; Piperazines; Psychomotor Agitation; Quetiapine Fumarate; Rats; Rats, Wistar; Risperidone; Schizophrenia; Substance Withdrawal Syndrome; Thiazoles; Time Factors | 2011 |
Effect of rare earth elements on beef cattle growth performance, blood clinical chemical parameters and mitogen stimulated proliferation of bovine peripheral blood mononuclear cells in vitro and ex vivo.
Topics: Animal Feed; Animal Nutritional Physiological Phenomena; Animals; Blood Chemical Analysis; Body Weight; Cattle; Cell Proliferation; Cell Separation; Coloring Agents; Growth; In Vitro Techniques; Male; Metals, Rare Earth; Mitogens; Monocytes; Tetrazolium Salts; Thiazoles; Weight Gain | 2011 |
Adipose tissue-targeted 11β-hydroxysteroid dehydrogenase type 1 inhibitor protects against diet-induced obesity.
Topics: 11-beta-Hydroxysteroid Dehydrogenase Type 1; Adipocytes; Adiponectin; Adipose Tissue; Animals; Body Weight; Dietary Fats; Disease Models, Animal; Enzyme Inhibitors; Glucose Intolerance; Injections, Subcutaneous; Male; Mice; Mice, Inbred C57BL; Nicotinamide Phosphoribosyltransferase; Obesity; Piperazines; Sulfonamides; Thiazoles | 2011 |
Toxicities and sublethal effects of seven neonicotinoid insecticides on survival, growth and reproduction of imidacloprid-resistant cotton aphid, Aphis gossypii.
Topics: Animals; Aphids; Body Weight; Fertility; Guanidines; Imidazoles; Insecticide Resistance; Longevity; Neonicotinoids; Nitriles; Nitro Compounds; Oxazines; Pyrimidines; Reproduction; Survival Analysis; Thiamethoxam; Thiazoles; Toxicity Tests | 2011 |
Experimental treatment of Neospora caninum-infected mice with the arylimidamide DB750 and the thiazolide nitazoxanide.
Topics: Administration, Oral; Amidines; Animals; Body Weight; Brain; Cell Line; Chlorocebus aethiops; Coccidiosis; Coccidiostats; Disease Models, Animal; DNA, Protozoan; Female; Fibroblasts; Humans; Injections, Intraperitoneal; Mice; Mice, Inbred BALB C; Neospora; Nitro Compounds; Polymerase Chain Reaction; Pyridines; Random Allocation; Thiazoles; Vero Cells | 2011 |
Ziprasidone's effect on metabolic markers in patients with diabetes and chronic schizophrenia.
Topics: Analysis of Variance; Antipsychotic Agents; Biomarkers; Blood Glucose; Body Mass Index; Body Weight; Chronic Disease; Diabetes Mellitus, Type 2; Female; Follow-Up Studies; Humans; Insulin; Lipids; Male; Metabolic Syndrome; Middle Aged; Piperazines; Polypharmacy; Prospective Studies; Psychiatric Status Rating Scales; Schizophrenia; Thiazoles; Treatment Outcome | 2012 |
The effect of ziprasidone on body weight and energy expenditure in female rats.
Topics: Abdominal Fat; Adiposity; Animals; Antipsychotic Agents; Body Temperature; Body Weight; Eating; Energy Metabolism; Female; Motor Activity; Piperazines; Rats; Rats, Sprague-Dawley; Thiazoles | 2012 |
Adiponectin promoter activator NP-1 reduces body weight and hepatic steatosis in high-fat diet-fed animals.
Topics: Adiponectin; Analysis of Variance; Animals; Avoidance Learning; Blotting, Western; Body Weight; Cell Line; Diet, High-Fat; Dietary Fats; Eating; Fatty Liver; Glucose Tolerance Test; Lipid Metabolism; Liver; Male; Myoblasts; Non-alcoholic Fatty Liver Disease; Rats; Rats, Wistar; Real-Time Polymerase Chain Reaction; RNA; Taste; Thiazoles; Weight Gain | 2012 |
Reproductive and neurobehavioral effects of clothianidin administered to mice in the diet.
Topics: Animals; Behavior, Animal; Body Weight; Diet; Dose-Response Relationship, Drug; Exploratory Behavior; Female; Guanidines; Lactation; Litter Size; Male; Mice; Motor Activity; Neonicotinoids; Reproduction; Sex Ratio; Thiazoles; Toxicity Tests | 2012 |
Protective effect of meloxicam-loaded nanocapsules against amyloid-β peptide-induced damage in mice.
Topics: Amyloid beta-Peptides; Analysis of Variance; Animals; Anti-Inflammatory Agents, Non-Steroidal; Avoidance Learning; Behavior, Animal; Body Weight; Brain; Catalase; Disease Models, Animal; Exploratory Behavior; Glutathione; Glutathione Peroxidase; Glutathione Reductase; Glutathione Transferase; Learning Disabilities; Male; Maze Learning; Meloxicam; Memory Disorders; Mice; Nanocapsules; Peptide Fragments; Superoxide Dismutase; Thiazines; Thiazoles; Time Factors | 2012 |
Design, synthesis and biological evaluation of thiazole- and indole-based derivatives for the treatment of type II diabetes.
Topics: Administration, Oral; Alanine Transaminase; Animals; Blood Glucose; Body Weight; Cell Line; Cholesterol; Diabetes Mellitus, Type 2; Drug Design; Fatty Acid-Binding Proteins; Hypoglycemic Agents; Indoles; Insulin; Lipopolysaccharides; Male; Mice; Models, Molecular; Protein Conformation; Rats; Structure-Activity Relationship; Thiazoles; Triglycerides; Tumor Necrosis Factor-alpha | 2012 |
BVT.2733, a selective 11β-hydroxysteroid dehydrogenase type 1 inhibitor, attenuates obesity and inflammation in diet-induced obese mice.
Topics: 11-beta-Hydroxysteroid Dehydrogenase Type 1; 3T3-L1 Cells; Adipose Tissue; Animals; Body Weight; Chemokine CCL2; Diet; Enzyme Inhibitors; Glucocorticoids; Inflammation; Inflammation Mediators; Insulin Resistance; Macrophages; Male; Mice; Obesity; Piperazines; Sulfonamides; Thiazoles; Tumor Necrosis Factor-alpha | 2012 |
Effects of pubertal exposure to thiazole-Zn on thyroid function and development in female rats.
Topics: Animals; Body Weight; Female; Hypertrophy; Organ Size; Rats; Rats, Sprague-Dawley; Thiazoles; Thyroid Gland; Thyrotropin; Triiodothyronine; Vagina; Zinc | 2013 |
Anti-obesity effects of 3-hydroxychromone derivative, a novel small-molecule inhibitor of glycogen synthase kinase-3.
Topics: 3T3-L1 Cells; Adipocytes; Adipogenesis; Adiposity; Aminophenols; Animals; Anti-Obesity Agents; beta Catenin; Body Weight; Cell Differentiation; Chromones; Glycogen Synthase Kinase 3; HEK293 Cells; Hep G2 Cells; Humans; Lipid Metabolism; Lithium Chloride; Male; Maleimides; Mice; Mice, Inbred C57BL; Obesity; Protein Stability; Thiazoles | 2013 |
Matrix metalloproteinase inhibitor, marimastat, decreases peritoneal spread of gastric carcinoma in nude mice.
Topics: Animals; Antibiotics, Antineoplastic; Antineoplastic Agents; Body Weight; Cell Survival; Coloring Agents; Dose-Response Relationship, Drug; Enzyme Inhibitors; Humans; Hydroxamic Acids; Male; Matrix Metalloproteinase Inhibitors; Mice; Mice, Inbred BALB C; Mice, Nude; Mitomycin; Models, Chemical; Neoplasm Metastasis; Neoplasm Transplantation; Peritoneum; Stomach Neoplasms; Tetrazolium Salts; Thiazoles; Time Factors; Tumor Cells, Cultured | 2002 |
Decreases in serum uric acid by amelioration of insulin resistance in overweight hypertensive patients: effect of a low-energy diet and an insulin-sensitizing agent.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers; Blood Pressure; Body Weight; Caloric Restriction; Chromans; Data Interpretation, Statistical; Female; Glucose Tolerance Test; Humans; Hypertension; Hypoglycemic Agents; Insulin; Insulin Resistance; Male; Middle Aged; Obesity; Thiazoles; Thiazolidinediones; Troglitazone; Uric Acid | 2002 |
Dual PPARalpha /gamma activation provides enhanced improvement of insulin sensitivity and glycemic control in ZDF rats.
Topics: Animals; Body Composition; Body Weight; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Eating; Fatty Acids, Nonesterified; Glucose Clamp Technique; Glycated Hemoglobin; Glycogen; Hypoglycemic Agents; Insulin Resistance; Islets of Langerhans; Liver; Male; Oxazines; Phenylpropionates; Rats; Rats, Zucker; Receptors, Cytoplasmic and Nuclear; Rosiglitazone; Thiazoles; Thiazolidinediones; Transcription Factors | 2003 |
Apolipoprotein A-I expression in rats is not altered by troglitazone.
Topics: Animals; Apolipoprotein A-I; Body Weight; Chromans; Gene Expression Regulation; Male; Rats; Rats, Inbred F344; RNA, Messenger; Thiazoles; Thiazolidinediones; Troglitazone | 2002 |
Gender and pramipexole effects on levodopa pharmacokinetics and pharmacodynamics.
Topics: Antiparkinson Agents; Area Under Curve; Benzothiazoles; Biological Availability; Body Weight; Drug Interactions; Female; Humans; Levodopa; Male; Pramipexole; Sex Characteristics; Thiazoles | 2002 |
Effect of peroxisome proliferator-activated receptor-alpha and -gamma activators on vascular remodeling in endothelin-dependent hypertension.
Topics: Animals; Blood Pressure; Body Weight; Endothelin-1; Endothelins; Extracellular Matrix; Fenofibrate; Hypertension; In Vitro Techniques; Male; Mesenteric Arteries; Oxygen; Protein Precursors; Rats; Rats, Inbred Dahl; Rats, Sprague-Dawley; Receptors, Cytoplasmic and Nuclear; RNA, Messenger; Rosiglitazone; Thiazoles; Thiazolidinediones; Transcription Factors; Tunica Media; Vascular Resistance; Vasodilator Agents | 2003 |
Is programming of glucocorticoid receptor expression by prenatal dexamethasone in the rat secondary to metabolic derangement in adulthood?
Topics: Animals; Appetite; Body Weight; Corticosterone; Dexamethasone; Female; Gene Expression; Glucocorticoids; Hyperinsulinism; Hypoglycemic Agents; Insulin Resistance; Metformin; Organ Size; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Rats, Wistar; Receptors, Glucocorticoid; RNA, Messenger; Rosiglitazone; Thiazoles; Thiazolidinediones | 2003 |
A breaker of advanced glycation end products attenuates diabetes-induced myocardial structural changes.
Topics: Animals; Blood Pressure; Body Weight; Collagen; Cytokines; Diabetes Mellitus, Experimental; Gene Expression Regulation; Glycation End Products, Advanced; Heart Ventricles; Hypertrophy, Left Ventricular; Immunohistochemistry; Male; Myocardium; Natriuretic Peptide, Brain; Organ Size; Rats; Rats, Sprague-Dawley; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Thiazoles | 2003 |
Improvement of aortic wall distensibility and reduction of oxidative stress by pioglitazone in pre-diabetic stage of Otsuka Long-Evans Tokushima fatty rats.
Topics: Age Factors; Animals; Aorta; Body Weight; Collagen; Diabetes Mellitus, Type 2; Hemodynamics; Hypoglycemic Agents; Male; Oxidative Stress; Pioglitazone; Rats; Rats, Inbred OLETF; Thiazoles; Thiazolidinediones | 2002 |
Combination therapy with PPARgamma and PPARalpha agonists increases glucose-stimulated insulin secretion in db/db mice.
Topics: Animals; Bezafibrate; Body Weight; Diabetes Mellitus; Drug Therapy, Combination; Glucose; Glucose Transporter Type 2; Insulin; Insulin Secretion; Islets of Langerhans; Male; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Monosaccharide Transport Proteins; Pancreas; Pioglitazone; Receptors, Cytoplasmic and Nuclear; Thiazoles; Thiazolidinediones; Thiazolidines; Transcription Factors | 2003 |
Pioglitazone, a PPAR-gamma ligand, provides protection from dextran sulfate sodium-induced colitis in mice in association with inhibition of the NF-kappaB-cytokine cascade.
Topics: Animals; Anticoagulants; Body Weight; Colitis; Colon; Dextran Sulfate; DNA; Female; Hypoglycemic Agents; Inflammation; Ligands; Mice; Mice, Inbred BALB C; NF-kappa B; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Pioglitazone; Protein Binding; Receptors, Cytoplasmic and Nuclear; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Thiazoles; Thiazolidinediones; Thiobarbituric Acid Reactive Substances; Time Factors; Transcription Factors | 2002 |
Peroxisome-proliferator-activated receptor delta activates fat metabolism to prevent obesity.
Topics: Adipose Tissue; Adipose Tissue, Brown; Animals; Body Weight; Dietary Fats; Energy Metabolism; Fatty Acids; Food, Formulated; Genetic Vectors; Lipid Metabolism; Mice; Mice, Knockout; Mice, Transgenic; Obesity; Receptors, Cell Surface; Receptors, Cytoplasmic and Nuclear; Receptors, Leptin; Recombinant Fusion Proteins; Thiazoles; Transcription Factors; Transgenes; Triglycerides | 2003 |
Marked improvement of glycaemic control with pioglitazone in a Type 2 diabetic patient associated with Charcot-Marie-Tooth disease.
Topics: Body Weight; Charcot-Marie-Tooth Disease; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Humans; Hypoglycemic Agents; Insulin Resistance; Male; Middle Aged; Pioglitazone; Thiazoles; Thiazolidinediones; Treatment Outcome | 2003 |
L-2-oxothiazolidine-4-carboxylate supplementation in murine gamma-GT deficiency.
Topics: Animals; Body Weight; Dietary Supplements; gamma-Glutamyltransferase; Genotype; Glutathione; Growth Disorders; Liver; Mice; Mice, Knockout; Pyrrolidonecarboxylic Acid; Reproduction; Thiazoles; Thiazolidines | 2003 |
Differential effects of rosiglitazone on skeletal muscle and liver insulin resistance in A-ZIP/F-1 fatless mice.
Topics: Adipocytes; Adipose Tissue; Animals; Blood Glucose; Body Weight; Female; Glucose Clamp Technique; Hypoglycemic Agents; Insulin; Insulin Resistance; Liver; Male; Mice; Mice, Mutant Strains; Muscle, Skeletal; Rosiglitazone; Thiazoles; Thiazolidinediones | 2003 |
Peroxisome proliferator-activated receptor-alpha and receptor-gamma activators prevent cardiac fibrosis in mineralocorticoid-dependent hypertension.
Topics: Animals; Blood Pressure; Body Weight; Cardiomegaly; Collagen; Desoxycorticosterone; Endothelin-1; Endothelins; Fenofibrate; Fibrosis; Heart; Heart Ventricles; Hypertension; Myocardium; Protein Precursors; Rats; Rats, Sprague-Dawley; Receptors, Cytoplasmic and Nuclear; RNA, Messenger; Rosiglitazone; Thiazoles; Thiazolidinediones; Transcription Factors; Ventricular Remodeling | 2003 |
Effect of troglitazone on vascular and glucose metabolic actions of insulin in high-sucrose-fed rats.
Topics: Animals; Biological Transport, Active; Blood Pressure; Blood Vessels; Body Weight; Chromans; Diet; Eating; Glucose; Glucose Clamp Technique; Heart Rate; Hypoglycemic Agents; In Vitro Techniques; Insulin; Male; Muscle, Skeletal; Rats; Rats, Sprague-Dawley; Regional Blood Flow; Sucrose; Thiazoles; Thiazolidinediones; Troglitazone; Vasodilation | 2003 |
Rosiglitazone improves muscle insulin sensitivity, irrespective of increased triglyceride content, in ob/ob mice.
Topics: Animals; Blood Glucose; Body Weight; Cholesterol; Diet; Fatty Acids, Nonesterified; Glucose Clamp Technique; Glucose Tolerance Test; Heart; Hypoglycemic Agents; Insulin Resistance; Mice; Mice, Inbred C57BL; Muscle, Skeletal; Myocardium; Rosiglitazone; Thiazoles; Thiazolidinediones; Triglycerides | 2003 |
Evaluation of a short duration behaviour-based post-operative pain scoring system in rats.
Topics: Abdominal Pain; Analgesics, Non-Narcotic; Animals; Anti-Inflammatory Agents, Non-Steroidal; Behavior, Animal; Body Weight; Carbazoles; Disease Models, Animal; Exploratory Behavior; Male; Meloxicam; Motor Activity; Pain Measurement; Pain, Postoperative; Rats; Rats, Inbred F344; Thiazines; Thiazoles; Time Factors | 2003 |
The effect of 2-amino-5-nitrothiazole (enheptin) on fertility, organ weight, body weight,estrous cycle, and pituitary hormones in the rat.
Topics: Animals; Body Weight; Estrous Cycle; Estrus; Female; Fertility; Organ Size; Pituitary Gland; Pituitary Hormones; Rats; Thiazoles | 1960 |
Novel PPARgamma-dependent and independent effects for thiazolidinediones.
Topics: Animals; Bezafibrate; Body Weight; Chromans; Diabetes Mellitus, Type 2; Gene Expression; Humans; Insulin-Like Growth Factor Binding Protein 1; Insulin-Like Growth Factor Binding Proteins; Mice; Monocytes; Pancreas; Pioglitazone; PPAR alpha; PPAR gamma; Pregnancy Proteins; Pregnane X Receptor; Receptors, Cytoplasmic and Nuclear; Receptors, Steroid; Rosiglitazone; Thiazoles; Thiazolidinediones; Thiazolidines; Troglitazone; Tumor Necrosis Factor-alpha | 2003 |
Enhancement of chemotherapeutic response of tumor cells by a heme oxygenase inhibitor, pegylated zinc protoporphyrin.
Topics: Animals; Annexin A5; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Apoptosis; Body Weight; Camptothecin; Cell Line, Tumor; Cisplatin; Coloring Agents; Dose-Response Relationship, Drug; Doxorubicin; Drug Synergism; Etoposide; Heme Oxygenase (Decyclizing); Humans; Hydrogen Peroxide; Male; Metalloporphyrins; Mice; Mitomycin; Neoplasms; Oxidants; Oxidation-Reduction; Oxidative Stress; Oxygen; Polyethylene Glycols; Proline; Reactive Oxygen Species; Tetrazolium Salts; Thiazoles | 2004 |
Dual role of polymorphonuclear neutrophils on the growth of Ehrlich ascites tumor (EAT) in mice.
Topics: Analysis of Variance; Animals; Antibodies, Monoclonal; Body Weight; Carcinoma, Ehrlich Tumor; Cytotoxicity, Immunologic; Glycogen; Hydrogen Peroxide; Inflammation; Injections, Intraperitoneal; Male; Mice; Mice, Inbred BALB C; Neoplasm Transplantation; Neutrophils; Tetrazolium Salts; Thiazoles; Time Factors | 2004 |
Accelerated nephropathy in diabetic apolipoprotein e-knockout mouse: role of advanced glycation end products.
Topics: Actins; Animals; Apolipoproteins E; Blood Pressure; Body Weight; Collagen Type I; Collagen Type IV; Diabetic Nephropathies; Glycation End Products, Advanced; Kidney; Lipid Metabolism; Macrophages; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Organ Size; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Thiazoles; Transforming Growth Factor beta; Transforming Growth Factor beta1 | 2004 |
Tourette syndrome: efficient treatment with ziprasidone and normalization of body weight in a patient with excessive weight gain under tiapride.
Topics: Adult; Antipsychotic Agents; Body Weight; Female; Humans; Obesity; Piperazines; Thiazoles; Tiapamil Hydrochloride; Tourette Syndrome; Weight Gain | 2004 |
Improvement of glucose tolerance in Zucker diabetic fatty rats by long-term treatment with the dipeptidyl peptidase inhibitor P32/98: comparison with and combination with rosiglitazone.
Topics: Animals; Blood Glucose; Body Weight; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dipeptidyl Peptidase 4; Drinking; Drug Therapy, Combination; Drug Tolerance; Eating; Glucose Tolerance Test; Hypoglycemic Agents; Insulin; Islets of Langerhans; Male; Obesity; Pentanoic Acids; Rats; Rats, Zucker; Rosiglitazone; Thiazoles; Thiazolidinediones; Thiazolidines; Time Factors | 2005 |
Thiamethoxam induced mouse liver tumors and their relevance to humans. Part 1: mode of action studies in the mouse.
Topics: Animals; Body Weight; Carcinogens; Cell Division; Cholesterol; Diet; Dose-Response Relationship, Drug; In Situ Nick-End Labeling; Liver Neoplasms, Experimental; Male; Mice; Neonicotinoids; Nitro Compounds; Organ Size; Oxazines; Pesticides; Thiamethoxam; Thiazoles | 2005 |
Comparison of the metabolic effects observed in patients treated with ziprasidone versus olanzapine.
Topics: Adult; Aged; Aged, 80 and over; Antipsychotic Agents; Benzodiazepines; Blood Glucose; Body Weight; Cholesterol, HDL; Cholesterol, LDL; Electrocardiography; Female; Glycated Hemoglobin; Heart Rate; Humans; Hyperlipidemias; Lipids; Male; Middle Aged; Olanzapine; Piperazines; Retrospective Studies; Schizophrenia; Thiazoles; Triglycerides | 2005 |
Antipsychotic drug-induced weight gain: development of an animal model.
Topics: Animals; Antipsychotic Agents; Benzodiazepines; Body Constitution; Body Weight; Dibenzothiazepines; Eating; Male; Mice; Mice, Inbred C57BL; Models, Animal; Obesity; Olanzapine; Piperazines; Quetiapine Fumarate; Risperidone; Thiazoles | 2005 |
Investigation into the effects of the novel antipsychotic ziprasidone on weight gain and reproductive function in female rats.
Topics: Analysis of Variance; Animals; Antipsychotic Agents; Behavior, Animal; Body Weight; Dose-Response Relationship, Drug; Drinking; Female; Piperazines; Rats; Thiazoles; Time Factors | 2005 |
Oleoylethanolamide, an endogenous PPAR-alpha agonist, lowers body weight and hyperlipidemia in obese rats.
Topics: Animals; Body Weight; Butyrates; CD36 Antigens; Cholesterol; Coenzyme A Ligases; Eating; Endocannabinoids; Fatty Acid-Binding Proteins; Hepatocytes; Hyperlipidemias; Ion Channels; Liver; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Mitochondrial Proteins; Obesity; Oleic Acids; Phenylurea Compounds; PPAR alpha; Pyrimidines; Rats; Rats, Inbred WF; Rats, Zucker; RNA, Messenger; Thiazoles; Thiazolidinediones; Triglycerides; Uncoupling Protein 2 | 2005 |
The PPARdelta agonist GW0742X reduces atherosclerosis in LDLR(-/-) mice.
Topics: Animals; Aorta; Arteriosclerosis; Biomarkers; Body Weight; Eating; Inflammation; Lipids; Lipoproteins; Macrophages; Mice; Mice, Knockout; PPAR delta; Receptors, LDL; Thiazoles | 2005 |
The mitochondrial complex I inhibitor rotenone triggers a cerebral tauopathy.
Topics: alpha-Synuclein; Amyloid beta-Peptides; Analysis of Variance; Animals; Antineoplastic Combined Chemotherapy Protocols; Behavior, Animal; Benzothiazoles; Body Weight; Caspase 3; Caspases; Cell Death; Cerebral Cortex; Cytarabine; Diagnostic Imaging; Dopamine and cAMP-Regulated Phosphoprotein 32; Doxorubicin; Dystonia; Electron Transport Complex III; Enzyme Activation; Glial Fibrillary Acidic Protein; Immunohistochemistry; Locomotion; Male; Microscopy, Electron, Transmission; Mitochondria; Neurons; Phosphopyruvate Hydratase; Phosphorylation; Posture; Psychomotor Performance; Rats; Rats, Inbred Lew; Rotenone; tau Proteins; Tauopathies; Thiazoles; Time Factors; Tyrosine; Tyrosine 3-Monooxygenase; Ubiquitin; Uncoupling Agents | 2005 |
Lipid-lowering properties of 6-benzoyl-2(3H)-benzothiazolone and structurally related compounds.
Topics: Animals; Benzothiazoles; Body Weight; Diet; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Female; Hypercholesterolemia; Hypolipidemic Agents; Lipids; Mice; Molecular Structure; Organ Size; Thiazoles | 2005 |
Body weights and plasma prolactin levels in female rats treated subchronically with ziprasidone versus olanzapine.
Topics: Animals; Antipsychotic Agents; Benzodiazepines; Body Weight; Female; Olanzapine; Piperazines; Prolactin; Rats; Rats, Sprague-Dawley; Thiazoles; Weight Gain | 2006 |
Inhibition of 11beta-hydroxysteroid dehydrogenase type 1 reduces food intake and weight gain but maintains energy expenditure in diet-induced obese mice.
Topics: 11-beta-Hydroxysteroid Dehydrogenase Type 1; Animals; Blood Glucose; Body Weight; Diet; Diet, Reducing; Energy Intake; Energy Metabolism; Enzyme Inhibitors; Female; Insulin; Kinetics; Mice; Mice, Inbred C57BL; Obesity; Piperazines; Sulfonamides; Thiazoles; Weight Gain | 2006 |
A model for antipsychotic-induced obesity in the male rat.
Topics: Animals; Antipsychotic Agents; Benzodiazepines; Body Composition; Body Weight; Circadian Rhythm; Diet; Disease Models, Animal; Dose-Response Relationship, Drug; Eating; Feeding Behavior; Haloperidol; Male; Obesity; Olanzapine; Piperazines; Rats; Rats, Sprague-Dawley; Thiazoles; Time Factors; Weight Gain | 2006 |
Improvement in antipsychotic-related metabolic disturbances in patients with schizophrenia switched to ziprasidone.
Topics: Adult; Antipsychotic Agents; Blood Glucose; Body Weight; Cholesterol; Female; Humans; Male; Metabolic Diseases; Piperazines; Prospective Studies; Psychiatric Status Rating Scales; Retrospective Studies; Schizophrenia; Severity of Illness Index; Statistics, Nonparametric; Thiazoles; Time Factors | 2007 |
Effectiveness, tolerability, and safety of ziprasidone in patients with schizophrenia or schizoaffective disorder: results of a multi-centre observational trial.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Austria; Blood Glucose; Body Weight; Brief Psychiatric Rating Scale; Dose-Response Relationship, Drug; Drug-Related Side Effects and Adverse Reactions; Female; Follow-Up Studies; Germany; Humans; Lipids; Male; Middle Aged; Patient Dropouts; Piperazines; Product Surveillance, Postmarketing; Prospective Studies; Psychotic Disorders; Quality of Life; Schizophrenia; Thiazoles; Treatment Outcome | 2007 |
Topical ER36009, a RARgamma-selective retinoid, decreases abdominal white adipose tissue and elicits changes in expression of genes related to adiposity and thermogenesis.
Topics: 11-beta-Hydroxysteroid Dehydrogenases; Adipose Tissue, Brown; Adipose Tissue, White; Adiposity; Animals; bcl-2-Associated X Protein; Blotting, Northern; Body Weight; Eating; Ion Channels; Male; Mitochondrial Proteins; PPAR gamma; Proto-Oncogene Proteins c-bcl-2; Quinoxalines; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Thermogenesis; Thiazoles; Uncoupling Protein 1; Uncoupling Protein 3; Up-Regulation | 2006 |
Effects of vasectomy surgery and meloxicam treatment on faecal corticosterone levels and behaviour in two strains of laboratory mouse.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Behavior, Animal; Body Weight; Corticosterone; Feces; Male; Meloxicam; Mice; Mice, Inbred C3H; Mice, Inbred C57BL; Pain Measurement; Pain, Postoperative; Species Specificity; Stress, Physiological; Thiazines; Thiazoles; Vasectomy | 2007 |
The distinct effects of subchronic antipsychotic drug treatment on macronutrient selection, body weight, adiposity, and metabolism in female rats.
Topics: Adiposity; Animals; Antipsychotic Agents; Benzodiazepines; Blood Glucose; Body Composition; Body Weight; Cholesterol; Drinking; Eating; Energy Metabolism; Fatty Acids, Nonesterified; Female; Food Preferences; Glycerol; Insulin; Leptin; Motor Activity; Olanzapine; Piperazines; Prolactin; Rats; Risperidone; Thiazoles; Triglycerides | 2007 |
Efficacy of the dipeptidyl peptidase IV inhibitor isoleucine thiazolidide (P32/98) in fatty Zucker rats with incipient and manifest impaired glucose tolerance.
Topics: Animals; Blood Glucose; Body Weight; Dipeptidyl-Peptidase IV Inhibitors; Fatty Acids, Nonesterified; Glucose; Glucose Intolerance; Incretins; Insulin; Insulin Secretion; Islets of Langerhans; Isoleucine; Male; Models, Animal; Obesity; Rats; Rats, Zucker; Thiazoles; Time Factors; Tissue Culture Techniques; Triglycerides | 2008 |
Inhibitors of advanced glycation end-products prevent loss of enteric neuronal nitric oxide synthase in diabetic rats.
Topics: Animals; Blood Glucose; Blotting, Western; Body Weight; Diabetes Mellitus, Experimental; Duodenum; Enteric Nervous System; Enzyme-Linked Immunosorbent Assay; Glycation End Products, Advanced; Guanidines; Immunohistochemistry; Male; Nitric Oxide Synthase Type III; Rats; Rats, Sprague-Dawley; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Signal Transduction; Thiazoles | 2008 |
A novel high resolution in vivo digital imaging system for the evaluation of experimental cataract in diabetic rats.
Topics: Aldehyde Reductase; Animals; Blood Glucose; Body Weight; Cataract; Diabetes Mellitus, Experimental; Drinking; Eating; Enzyme Inhibitors; Equipment Design; Image Interpretation, Computer-Assisted; Lens, Crystalline; Male; Phenylacetates; Rats; Rats, Wistar; Reproducibility of Results; Severity of Illness Index; Signal Processing, Computer-Assisted; Thiazoles; Time Factors | 2008 |
Chronic xanthine oxidase inhibition following myocardial infarction in rabbits: effects of early versus delayed treatment.
Topics: Allopurinol; Animals; Body Weight; Echocardiography; Enzyme Inhibitors; Febuxostat; Heart Failure; Male; Myocardial Infarction; Myocardium; Organ Size; Rabbits; Thiazoles; Time Factors; Xanthine Oxidase | 2008 |
Effects of febuxostat on metabolic and renal alterations in rats with fructose-induced metabolic syndrome.
Topics: Animals; Blood Pressure; Body Weight; Energy Intake; Febuxostat; Fructose; Gout Suppressants; Kidney; Male; Metabolic Syndrome; Rats; Rats, Sprague-Dawley; Renal Circulation; Thiazoles; Xanthine Oxidase | 2008 |
Arsenic interferes with the signaling transduction pathway of T cell receptor activation by increasing basal and induced phosphorylation of Lck and Fyn in spleen cells.
Topics: Animals; Apoptosis; Arsenic; Body Weight; CD28 Antigens; CD3 Complex; Cell Proliferation; Cell Survival; Cytokines; Drinking; Eating; Lymphocyte Specific Protein Tyrosine Kinase p56(lck); Male; Mice; Mice, Inbred C57BL; Monocytes; Necrosis; Phosphorylation; Proto-Oncogene Proteins c-fyn; Receptors, Antigen, T-Cell; Signal Transduction; Spleen; Tetrazolium Salts; Thiazoles | 2008 |
Antihypertensive effects of the novel converting-enzyme inhibitor YS 980 in spontaneously hypertensive rats.
Topics: 3-Mercaptopropionic Acid; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Body Weight; Bradykinin; Catecholamines; Hypertension; Male; Rats; Sulfhydryl Compounds; Thiazoles; Thiazolidines | 1981 |
Carcinogenicity of 2-amino-4-(5-nitro-2-furyl) thiazole in rats by oral and subcutaneous administration.
Topics: Animals; Body Weight; Carcinogens; Carcinoma, Squamous Cell; Diet; FANFT; Female; Histiocytoma, Benign Fibrous; Injections, Subcutaneous; Male; Neoplasms, Experimental; Rats; Skin Neoplasms; Stomach Neoplasms; Thiazoles; Urologic Neoplasms | 1982 |
A new potentiator of insulin action. Post-receptor activation in vitro.
Topics: Adipose Tissue; Animals; Biological Transport, Active; Blood Glucose; Body Weight; Deoxyglucose; Diabetes Mellitus, Experimental; Drug Synergism; Glucose; Glycolysis; Insulin; Kinetics; Obesity; Rats; Rats, Inbred Strains; Receptor, Insulin; Thiazoles; Thiazolidinediones | 1983 |
Comparison of the acute toxicities of N-nitrosothiazolidine and N-nitrosomorpholine.
Topics: Adrenal Cortex; Animals; Blood Chemical Analysis; Body Weight; Carcinogens; Female; Lethal Dose 50; Liver; Male; Mitosis; Nitrosamines; Nitroso Compounds; Organ Size; Rats; Rats, Inbred Strains; Sleep; Thiazoles | 1984 |
Efficacy of nosiheptide as a growth promotant for growing-finishing swine--a cooperative study.
Topics: Analysis of Variance; Animals; Anti-Bacterial Agents; Body Weight; Female; Food Additives; Male; Swine; Thiazoles | 1984 |
Rat-plasma metabolites of ciglitazone, a new antidiabetic agent.
Topics: Animals; Body Weight; Dose-Response Relationship, Drug; Feeding Behavior; Female; Gas Chromatography-Mass Spectrometry; Hydroxylation; Hypoglycemic Agents; Male; Mice; Mice, Obese; Rats; Rats, Inbred Strains; Stereoisomerism; Thiazoles; Thiazolidinediones | 1984 |
Long term dose response study of N-[4-(5-nitro-2-furyl)-2-thiazolyl] formamide-induced urinary bladder carcinogenesis.
Topics: Animals; Body Weight; Dose-Response Relationship, Drug; FANFT; Hyperplasia; Male; Neoplasms, Experimental; Papilloma; Prognosis; Rats; Rats, Inbred F344; Thiazoles; Time Factors; Urinary Bladder; Urinary Bladder Neoplasms | 1983 |
1-month subacute oral toxicity study of KB-944, a new calcium antagonist, in rats.
Topics: Animals; Benzothiazoles; Blood; Blood Cell Count; Blood Chemical Analysis; Body Weight; Calcium Channel Blockers; Drinking; Eating; Enzymes; Female; Male; Organ Size; Rats; Thiazoles; Time Factors | 1982 |
1-month subacute oral toxicity study of KB-944, a new calcium antagonist, in beagles.
Topics: Animals; Benzothiazoles; Blood; Blood Cell Count; Blood Chemical Analysis; Body Weight; Calcium Channel Blockers; Dogs; Drinking; Eating; Electrocardiography; Female; Male; Organ Size; Thiazoles; Urine | 1982 |
Changes in the gonads, reproduction and generations of white rats under the effect of some pesticides.
Topics: Animals; Behavior, Animal; Benomyl; Body Weight; Female; Fertility; Gonads; Male; Pesticides; Rats; Reproduction; Sulfides; Thiazoles; Thiocarbamates; Toluidines; Xylenes | 1980 |
Mutagenic evaluations of two rubber accelerators.
Topics: Animals; Benzothiazoles; Body Weight; Evaluation Studies as Topic; Female; Fetal Death; Male; Morpholines; Mutagens; Organ Size; Oxazines; Pregnancy; Rats; Rats, Inbred Strains; Rubber; Thiazoles | 1982 |
The effect of single dose N-methyl-N-nitrosourea on bladder carcinogenesis by N-[4-(5-nitro-2-furyl)-2-thiazolyl] formamide in rats.
Topics: Animals; Body Weight; Carcinoma, Papillary; Carcinoma, Transitional Cell; FANFT; Female; Hyperplasia; Methylnitrosourea; Neoplasms, Experimental; Nitrosourea Compounds; Organ Size; Rats; Thiazoles; Urinary Bladder; Urinary Bladder Neoplasms | 1981 |
Urinary diversion and systemic chemotherapy in the treatment of experimental early neoplastic lesions of the bladder.
Topics: Animals; Body Weight; Carcinogens; Carcinoma, Papillary; Cyclophosphamide; Male; Neoplasms, Experimental; Nitrofurans; Organ Size; Rats; Thiazoles; Urinary Bladder; Urinary Bladder Neoplasms; Urinary Diversion | 1981 |
Synthetic retinamides: effect on urinary bladder carcinogenesis by FANFT in Fischer rats.
Topics: Animals; Body Weight; FANFT; Female; Neoplasms, Experimental; Rats; Rats, Inbred F344; Thiazoles; Tretinoin; Urinary Bladder Neoplasms | 1981 |
Effects of chloroform and dimethylnitrosamine on renal carcinogenesis in unilaterally nephrectomized rats fed formic acid 2-[4-(5-nitro-2-furyl)-2-thiazolyl]hydrazide.
Topics: Animals; Body Weight; Carcinogens; Chloroform; Dimethylnitrosamine; Kidney Neoplasms; Male; Neoplasms, Experimental; Nephrectomy; Nitrofurans; Organ Size; Rats; Rats, Inbred F344; Thiazoles | 1981 |
Comparison between a purified and standard diet on FANFT-induced murine bladder cancer.
Topics: Animal Feed; Animals; Body Weight; Diet; FANFT; Female; Mice; Mice, Inbred C3H; Neoplasms, Experimental; Organ Size; Thiazoles; Time Factors; Urinary Bladder; Urinary Bladder Neoplasms | 1981 |
Metabolic effects of troglitazone on fat-induced insulin resistance in the rat.
Topics: Animals; Blood Pressure; Body Weight; Chromans; Dietary Fats; Eating; Glucose; Glucose Clamp Technique; Hyperinsulinism; Hypoglycemic Agents; Insulin; Insulin Resistance; Lipids; Liver; Male; Rats; Rats, Sprague-Dawley; Thiazoles; Thiazolidinediones; Troglitazone | 1995 |
Prevention of diabetic vascular dysfunction by guanidines. Inhibition of nitric oxide synthase versus advanced glycation end-product formation.
Topics: Aldehyde Reductase; Amino Acid Oxidoreductases; Animals; Arginine; Benzothiazoles; Blood Pressure; Body Weight; Capillary Permeability; Citrulline; Diabetes Mellitus, Experimental; Diabetic Angiopathies; Glycation End Products, Advanced; Guanidines; Imidazoles; Imidazolidines; Inositol; Iodine Radioisotopes; Male; Methylguanidine; Naphthalenes; Nitric Oxide Synthase; omega-N-Methylarginine; Phthalazines; Rats; Rats, Sprague-Dawley; Retina; Sciatic Nerve; Serum Albumin, Bovine; Sorbitol; Thiazoles; Uvea | 1993 |
Pioglitazone treatment for 7 days failed to correct the defect in glucose transport and glucose transporter translocation in obese Zucker rat (fa/fa) skeletal muscle plasma membranes.
Topics: Animals; Blood Glucose; Body Weight; Fatty Acids, Nonesterified; Female; Glucose; Insulin; Monosaccharide Transport Proteins; Muscles; Phosphoric Monoester Hydrolases; Pioglitazone; Rats; Rats, Mutant Strains; Sarcolemma; Thiazoles; Thiazolidinediones; Triglycerides | 1995 |
Effects of R 56865 on postischemic ventricular function in isolated rat working heart preparations obtained from healthy, diabetic and hypertensive animals.
Topics: Animals; Benzothiazoles; Blood Glucose; Blood Pressure; Body Weight; Calcium Channel Blockers; Cardiac Output; Coronary Circulation; Diabetes Mellitus, Experimental; Heart; Heart Ventricles; Hypertension; In Vitro Techniques; Male; Myocardial Ischemia; Piperidines; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Rats, Wistar; Thiazoles; Ventricular Function; Ventricular Pressure | 1994 |
Pioglitazone increases insulin sensitivity, reduces blood glucose, insulin, and lipid levels, and lowers blood pressure, in obese, insulin-resistant rhesus monkeys.
Topics: Animals; Blood Glucose; Blood Pressure; Body Weight; Eating; Fasting; Feeding Behavior; Female; Glucose Tolerance Test; Heart Rate; Hypoglycemic Agents; Insulin; Insulin Resistance; Macaca mulatta; Male; Obesity; Pioglitazone; Thiazoles; Thiazolidinediones; Tolbutamide; Triglycerides | 1994 |
Toxicity evaluations of L-cysteine and Procysteine, a cysteine prodrug, given once intravenously to neonatal rats.
Topics: Animals; Animals, Newborn; Body Weight; Cysteine; Injections, Intravenous; Organ Size; Prodrugs; Pyrrolidonecarboxylic Acid; Rats; Rats, Sprague-Dawley; Thiazoles; Thiazolidines | 1993 |
The effect of diabetes on sexual behavior and reproductive tract function in male rats.
Topics: Animals; Body Weight; Diabetes Mellitus, Experimental; Epididymis; Male; Muscle Contraction; Muscle, Smooth; Organ Size; Piperidines; Rats; Sexual Behavior, Animal; Sperm Count; Sperm Motility; Streptozocin; Testis; Testosterone; Thiazoles; Urinary Bladder | 1993 |
Antihypertensive effects of CS-045 treatment in obese Zucker rats.
Topics: Animals; Antihypertensive Agents; Blood Glucose; Blood Pressure; Body Weight; Chromans; Diuresis; Female; Hypoglycemic Agents; Insulin Resistance; Lipids; Male; Obesity; Rats; Rats, Zucker; Thiazoles; Thiazolidinediones; Troglitazone | 1993 |
In vivo administration of MKT-077 causes partial yet reversible impairment of mitochondrial function.
Topics: Animals; Antineoplastic Agents; Base Sequence; Body Weight; DNA, Mitochondrial; Female; Kidney; Mitochondria; Mitochondria, Heart; Mitochondria, Liver; Molecular Sequence Data; Oxygen Consumption; Pyridines; Rats; Rats, Sprague-Dawley; Thiazoles | 1996 |
Effect of troglitazone, a new oral antidiabetic agent, on fructose-induced insulin resistance.
Topics: Aging; Animals; Blood Glucose; Body Weight; Chromans; Fructose; Hyperinsulinism; Hypoglycemic Agents; Insulin; Insulin Resistance; Male; Rats; Rats, Sprague-Dawley; Thiazoles; Thiazolidinediones; Troglitazone | 1995 |
VLDL triglyceride kinetics in Wistar fatty rats, an animal model of NIDDM: effects of dietary fructose alone or in combination with pioglitazone.
Topics: Animals; Body Weight; Cholesterol; Diabetes Mellitus, Type 2; Dietary Carbohydrates; Disease Models, Animal; Energy Intake; Fatty Acids, Nonesterified; Fructose; Hypoglycemic Agents; Lipase; Lipoprotein Lipase; Lipoproteins, VLDL; Liver; Obesity; Pioglitazone; Rats; Rats, Wistar; Thiazoles; Thiazolidinediones; Thinness; Triglycerides | 1996 |
Pioglitazone improves insulin signaling defects in skeletal muscle from Wistar fatty (fa/fa) rats.
Topics: Animals; Blood Glucose; Body Weight; Gene Expression; Hindlimb; Hypoglycemic Agents; Insulin; Insulin Receptor Substrate Proteins; Male; Muscle, Skeletal; Obesity; Phosphatidylinositol 3-Kinases; Phosphoproteins; Phosphorylation; Phosphotransferases (Alcohol Group Acceptor); Phosphotyrosine; Pioglitazone; Rats; Rats, Mutant Strains; Rats, Wistar; Receptor, Insulin; Reference Values; Signal Transduction; Thiazoles; Thiazolidinediones; Triglycerides | 1996 |
Semotiadil improves survival of rats with monocrotaline-induced pulmonary hypertension: comparison with diltiazem.
Topics: Animals; Blood Pressure; Body Weight; Calcium Channel Blockers; Diltiazem; Dose-Response Relationship, Drug; Heart; Hypertension, Pulmonary; Male; Monocrotaline; Rats; Rats, Wistar; Thiazoles | 1996 |
Cardioprotective effects of troglitazone in streptozotocin-induced diabetic rats.
Topics: Animals; Blood Glucose; Body Weight; Cholesterol; Chromans; Diabetes Mellitus, Experimental; Heart; Heart Function Tests; Hypoglycemic Agents; Male; Microscopy, Electron; Myocardial Ischemia; Myocardium; Organ Size; Rats; Rats, Sprague-Dawley; Thiazoles; Thiazolidinediones; Triglycerides; Troglitazone | 1996 |
Effect of troglitazone (CS-045) and bezafibrate on glucose tolerance, liver glycogen synthase activity, and beta-oxidation in fructose-fed rats.
Topics: Animals; Bezafibrate; Blood Glucose; Body Weight; Chromans; Diet; Drug Tolerance; Fatty Acids, Nonesterified; Fructose; Glucose; Glycogen Synthase; Hypoglycemic Agents; Liver; Male; Mitochondria, Liver; Oxidation-Reduction; Potassium Cyanide; Rats; Rats, Wistar; Thiazoles; Thiazolidinediones; Triglycerides; Troglitazone | 1995 |
Effect of oral Sulfenamide TS administration on prenatal development in rats.
Topics: Abnormalities, Drug-Induced; Administration, Oral; Animals; Benzothiazoles; Body Weight; Dose-Response Relationship, Drug; Embryonic and Fetal Development; Female; Fetal Death; Hydrocephalus; Male; Organ Size; Placenta; Pregnancy; Pregnancy, Animal; Rats; Spleen; Thiazoles | 1996 |
Prevention of hyperglycemia in the Zucker diabetic fatty rat by treatment with metformin or troglitazone.
Topics: Age Factors; Animals; Body Weight; Chromans; Diabetes Mellitus, Type 2; Fatty Acids, Nonesterified; Glucose; Hyperglycemia; Insulin; Islets of Langerhans; Male; Metformin; Rats; Rats, Zucker; Thiazoles; Thiazolidinediones; Triglycerides; Troglitazone | 1996 |
Oral L-2-oxo-4-thiazolidine reduces bacterial translocation after radiation in the Fischer rat.
Topics: Administration, Oral; Animals; Bacteria; Bacterial Translocation; Body Weight; Buthionine Sulfoximine; Cells, Cultured; Eating; Glutathione; Jejunum; Liver; Lymph Nodes; Mesentery; Pyrrolidonecarboxylic Acid; Radiation-Protective Agents; Rats; Rats, Inbred F344; Thiazoles; Thiazolidines | 1996 |
Comparative toxicology of two enantiomers of the peripherally acting non-narcotic antitussive drug moguisteine.
Topics: Administration, Oral; Animals; Antitussive Agents; Body Weight; Dogs; Female; Injections, Intraperitoneal; Male; Mice; Mice, Inbred Strains; Mutagenicity Tests; Mutagens; Organ Size; Rats; Rats, Sprague-Dawley; Stereoisomerism; Thiazoles; Thiazolidines | 1996 |
Effects of a novel potent aldose reductase inhibitor, GP-1447, on aldose reductase activity in vitro and on diabetic neuropathy and cataract formation in rats.
Topics: Aldehyde Reductase; Animals; Blood Glucose; Body Weight; Cataract; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Enzyme Inhibitors; Humans; Male; Phenylacetates; Rats; Rats, Sprague-Dawley; Sorbitol; Thiazoles | 1997 |
Subacute toxicity of ebrotidine in rats and dogs.
Topics: Animals; Benzenesulfonates; Blood Chemical Analysis; Body Weight; Dogs; Eating; Female; Histamine H2 Antagonists; Male; Organ Size; Rats; Rats, Sprague-Dawley; Thiazoles; Urinalysis | 1997 |
Chronic toxicity of ebrotidine in rats and dogs.
Topics: Animals; Benzenesulfonates; Blood Chemical Analysis; Body Weight; Dogs; Eating; Female; Histamine H2 Antagonists; Male; Organ Size; Rats; Rats, Sprague-Dawley; Thiazoles | 1997 |
Carcinogenicity studies on ebrotidine.
Topics: Animals; Benzenesulfonates; Body Weight; Carcinogenicity Tests; Female; Histamine H2 Antagonists; Male; Mice; Neoplasms; Rats; Rats, Sprague-Dawley; Specific Pathogen-Free Organisms; Survival Rate; Thiazoles | 1997 |
Pioglitazone: in vitro effects on rat hepatoma cells and in vivo liver hypertrophy in KKAy mice.
Topics: Animals; Blood Glucose; Body Weight; Carcinoma, Hepatocellular; Cell Division; Diabetes Mellitus, Type 2; DNA; Dose-Response Relationship, Drug; Drug Synergism; Glyburide; Hypertrophy; Hypoglycemic Agents; Insulin; Liver; Male; Mice; Mice, Inbred C57BL; Organ Size; Pioglitazone; Rats; Thiazoles; Thiazolidinediones; Tumor Cells, Cultured | 1997 |
KB-R7785, a novel matrix metalloproteinase inhibitor, exerts its antidiabetic effect by inhibiting tumor necrosis factor-alpha production.
Topics: Animals; Blood Glucose; Body Weight; Glycine; Hydroxamic Acids; Hypoglycemic Agents; Insulin; Insulin Resistance; Male; Metalloendopeptidases; Mice; Mice, Inbred BALB C; Pioglitazone; Protease Inhibitors; Thiazoles; Thiazolidinediones; Tumor Necrosis Factor-alpha | 1997 |
Pioglitazone induces in vivo adipocyte differentiation in the obese Zucker fa/fa rat.
Topics: Adipocytes; Animals; Body Weight; Cell Differentiation; Fatty Acid Synthases; Female; Gene Expression Regulation; Gene Expression Regulation, Enzymologic; Glucose; Glucose Transporter Type 4; Insulin Resistance; Leptin; Lipid Metabolism; Lipid Mobilization; Monosaccharide Transport Proteins; Muscle Proteins; Obesity; Phosphoenolpyruvate Carboxykinase (GTP); Pioglitazone; Proteins; Rats; Rats, Mutant Strains; Thiazoles; Thiazolidinediones | 1997 |
Troglitazone action is independent of adipose tissue.
Topics: Adipose Tissue; Animals; Blood Glucose; Body Weight; Cholesterol; Chromans; Diabetes Mellitus, Type 2; Eating; Fatty Acids; Glycogen; Hypoglycemic Agents; Insulin; Insulin Resistance; Insulin Secretion; Leptin; Lipoproteins, LDL; Lipoproteins, VLDL; Mice; Mice, Transgenic; Organ Size; Proteins; Receptors, Cytoplasmic and Nuclear; Thiazoles; Thiazolidinediones; Transcription Factors; Triglycerides; Troglitazone | 1997 |
Effect of troglitazone on blood insulin levels after pancreas transplantation with systemic venous drainage in rats.
Topics: Animals; Blood Glucose; Body Weight; Chromans; Diabetes Mellitus, Type 1; Drainage; Glucose Tolerance Test; Hypoglycemic Agents; Injections; Insulin; Male; Pancreas; Pancreas Transplantation; Rats; Rats, Inbred Lew; Streptozocin; Thiazoles; Thiazolidinediones; Time Factors; Troglitazone; Veins; Weight Loss | 1997 |
Increased feeding in fatty Zucker rats by the thiazolidinedione BRL 49653 (rosiglitazone) and the possible involvement of leptin and hypothalamic neuropeptide Y.
Topics: Animals; Appetite Stimulants; Body Weight; Eating; Hyperphagia; Hypoglycemic Agents; Hypothalamus; Leptin; Male; Neuropeptide Y; Proteins; Rats; Rats, Wistar; Rats, Zucker; Rosiglitazone; Thiazoles; Thiazolidinediones | 1997 |
The therapeutic effect of C1-inhibitor on gut-derived bacterial translocation after thermal injury.
Topics: Animals; Bacterial Translocation; Body Weight; Burns; Complement C1 Inactivator Proteins; Complement Membrane Attack Complex; Complement System Proteins; Digestive System; Edema; Feces; Glycoproteins; Hemodynamics; Kidney; Liver; Lung; Lymph Nodes; Male; Skin; Swine; Tetrazolium Salts; Thiazoles | 1998 |
Troglitazone increases the number of small adipocytes without the change of white adipose tissue mass in obese Zucker rats.
Topics: Adipocytes; Adipose Tissue; Animals; Apoptosis; Blood Glucose; Blotting, Northern; Body Weight; Chromans; DNA; DNA, Complementary; Hyperglycemia; Hyperinsulinism; Hypoglycemic Agents; Insulin; Insulin Resistance; Leptin; Male; Mesentery; Polymerase Chain Reaction; Proteins; Rats; Rats, Zucker; Receptors, Cytoplasmic and Nuclear; Retroperitoneal Space; RNA; RNA, Messenger; Thiazoles; Thiazolidinediones; Transcription Factors; Triglycerides; Troglitazone; Tumor Necrosis Factor-alpha | 1998 |
A rat model of chemical-induced polycystic kidney disease with multistage tumors.
Topics: Animals; Body Weight; Carcinogens; Disease Models, Animal; Kidney; Kidney Neoplasms; Kidney Tubules; Male; Nitrosamines; Polycystic Kidney Diseases; Rats; Rats, Sprague-Dawley; Thiazoles | 1998 |
Amelioration of neurovascular deficits in diabetic rats by a novel aldose reductase inhibitor, GP-1447: minor contribution of nitric oxide.
Topics: Aldehyde Reductase; Animals; Blood Glucose; Body Weight; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Erythrocyte Deformability; Male; Motor Neurons; Neural Conduction; Nitric Oxide; Nitric Oxide Synthase; Nitroarginine; Phenylacetates; Rats; Rats, Sprague-Dawley; Sciatic Nerve; Sorbitol; Thiazoles | 1998 |
Peroxisome proliferator-activated receptor-gamma agonist, rosiglitazone, protects against nephropathy and pancreatic islet abnormalities in Zucker fatty rats.
Topics: Acetylglucosaminidase; Albuminuria; Animals; Blood Pressure; Body Weight; Histocytochemistry; Hypoglycemic Agents; Immunohistochemistry; Islets of Langerhans; Kidney; Kidney Diseases; Male; Obesity; Pancreas; Pancreatic Diseases; Proteinuria; Rats; Rats, Zucker; Rosiglitazone; Systole; Thiazoles; Thiazolidinediones | 1998 |
The development of overt diabetes in young Zucker Diabetic Fatty (ZDF) rats and the effects of chronic MCC-555 treatment.
Topics: Age Factors; Animals; Body Weight; Diabetes Mellitus, Type 2; Drinking; Glucose; Glucose Intolerance; Hypoglycemic Agents; Male; Rats; Rats, Zucker; Thiazoles; Thiazolidinediones; Time Factors | 1998 |
Inhibitory effect of troglitazone on diabetic neuropathy in streptozotocin-induced diabetic rats.
Topics: Animals; Antioxidants; Blood Glucose; Body Weight; Chromans; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Lipid Peroxidation; Lipid Peroxides; Male; Motor Neurons; Neural Conduction; Rats; Rats, Wistar; Thiazoles; Thiazolidinediones; Tibial Nerve; Troglitazone | 1998 |
A novel insulin sensitizer acts as a coligand for peroxisome proliferator-activated receptor-alpha (PPAR-alpha) and PPAR-gamma: effect of PPAR-alpha activation on abnormal lipid metabolism in liver of Zucker fatty rats.
Topics: Acyl-CoA Oxidase; Adipose Tissue; Animals; Blood Glucose; Body Weight; Carrier Proteins; Fatty Acid-Binding Protein 7; Fatty Acid-Binding Proteins; Fatty Acids; Gene Expression; Hypoglycemic Agents; Insulin; Ligands; Lipid Metabolism; Liver; Male; Myelin P2 Protein; Neoplasm Proteins; Nerve Tissue Proteins; Obesity; Organ Size; Oxidoreductases; Radioligand Assay; Rats; Rats, Wistar; Rats, Zucker; Receptors, Cytoplasmic and Nuclear; RNA, Messenger; Rosiglitazone; Thiazoles; Thiazolidinediones; Thiazolidines; Transcription Factors; Transcriptional Activation; Triglycerides | 1998 |
Improved metabolic status and insulin sensitivity in obese fatty (fa/fa) Zucker rats and Zucker Diabetic Fatty (ZDF) rats treated with the thiazolidinedione, MCC-555.
Topics: Animals; Basal Metabolism; Blood Glucose; Body Weight; Diabetes Mellitus, Experimental; Fatty Acids; Hypoglycemic Agents; Insulin; Insulin Resistance; Liver Glycogen; Male; Obesity; Rats; Rats, Zucker; Thiazoles; Thiazolidinediones; Treatment Outcome; Triglycerides | 1998 |
Twenty-four-month oral carcinogenicity study of ebrotidine in rats.
Topics: Animals; Benzenesulfonates; Body Weight; Carcinogens; Dose-Response Relationship, Drug; Feeding Behavior; Female; Gastric Mucosa; Histamine H2 Antagonists; Male; Neoplasms, Experimental; Precancerous Conditions; Rats; Rats, Sprague-Dawley; Risk; Sex Factors; Survival Rate; Thiazoles; Time Factors; Tissue Distribution | 1998 |
Effects of troglitazone on substrate storage and utilization in insulin-resistant rats.
Topics: Animals; Body Weight; Chromans; Eating; Glucose; Glycogen; In Vitro Techniques; Insulin; Insulin Resistance; Insulin Secretion; Islets of Langerhans; Lipoprotein Lipase; Muscle, Skeletal; Palmitates; Pyruvate Dehydrogenase Complex; Rats; Rats, Zucker; Thiazoles; Thiazolidinediones; Triglycerides; Troglitazone | 1999 |
Triglyceride-lowering effect of a novel insulin-sensitizing agent, JTT-501.
Topics: Animals; Blood Glucose; Body Weight; Dietary Fats; Hypoglycemic Agents; Hypolipidemic Agents; Insulin; Insulin Resistance; Isoxazoles; Male; Pioglitazone; Rats; Rats, Sprague-Dawley; Thiazoles; Thiazolidinediones; Triglycerides | 1999 |
Toxicological response of rats to a novel monoamine oxidase type-A inhibitor, (5R)-3-[2-((1S)-3-cyano-1-hydroxypropyl)benzothiazol-6-yl]-5- methoxymethyl-2-oxazolidinone (E2011), orally administered for 13 weeks.
Topics: Administration, Oral; Animals; Benzothiazoles; Body Weight; Eating; Female; Glutathione S-Transferase pi; Glutathione Transferase; Harderian Gland; Hematologic Tests; Isoenzymes; Liver; Liver Neoplasms, Experimental; Male; Monoamine Oxidase Inhibitors; Organ Size; Oxazoles; Oxazolidinones; Precancerous Conditions; Rats; Rats, Sprague-Dawley; Salivation; Thiazoles | 1999 |
Troglitazone prevents mitochondrial alterations, beta cell destruction, and diabetes in obese prediabetic rats.
Topics: Animals; Blood Glucose; Body Weight; Chromans; Diabetes Mellitus; Eating; Hypoglycemic Agents; Islets of Langerhans; Lipids; Mitochondria; Obesity; Rats; Thiazoles; Thiazolidinediones; Triglycerides; Troglitazone | 1999 |
PPAR gamma mediates high-fat diet-induced adipocyte hypertrophy and insulin resistance.
Topics: Adipocytes; Animals; Blood Glucose; Body Weight; Cell Differentiation; Cell Size; Diet; Eating; Energy Metabolism; Fats; Fetal Viability; Hypoglycemic Agents; Insulin Resistance; Leptin; Mice; Mice, Knockout; Myocardium; Pioglitazone; Placenta; Receptors, Cytoplasmic and Nuclear; Thiazoles; Thiazolidinediones; Transcription Factors | 1999 |
Chronic and acute effects of thiazolidinediones BM13.1258 and BM15.2054 on rat skeletal muscle glucose metabolism.
Topics: Animals; Biological Transport; Body Weight; Cell Line; Deoxyglucose; Glucose; In Vitro Techniques; Insulin; Ligands; Male; Muscle, Skeletal; Obesity; Oxazoles; Rats; Rats, Sprague-Dawley; Rats, Zucker; Receptors, Cytoplasmic and Nuclear; Recombinant Fusion Proteins; Thiazoles; Thiazolidinediones; Transcription Factors; Weight Gain | 1999 |
Therapeutic index for rosiglitazone in dietary obese rats: separation of efficacy and haemodilution.
Topics: Animals; Body Weight; Diet; Disease Models, Animal; Dose-Response Relationship, Drug; Eating; Hemodilution; Hemodynamics; Hypoglycemic Agents; Insulin; Leptin; Male; Obesity; Rats; Rats, Wistar; Rosiglitazone; Thiazoles; Thiazolidinediones | 1999 |
Effects of troglitazone on collagen accumulation and distensibility of aortic wall in prestage of non-insulin-dependent diabetes mellitus of Otsuka Long-Evans Tokushima Fatty rats.
Topics: Animals; Aorta, Thoracic; Body Weight; Chromans; Collagen; Diabetes Mellitus, Type 2; Glucose Tolerance Test; Hemodynamics; Hydroxyproline; Hypoglycemic Agents; Male; Muscle, Smooth, Vascular; Observer Variation; Rats; Rats, Inbred OLETF; Thiazoles; Thiazolidinediones; Troglitazone | 2000 |
Troglitazone improves insulin-stimulated glucose utilization associated with an increased muscle glycogen content in obese Zucker rats.
Topics: 3-Hydroxyacyl CoA Dehydrogenases; Animals; Blood Glucose; Body Weight; Chromans; Eating; Glucose Clamp Technique; Glucose Transporter Type 4; Glycogen; Hypoglycemic Agents; Insulin; Male; Metabolic Clearance Rate; Monosaccharide Transport Proteins; Muscle Proteins; Muscle, Skeletal; Obesity; Pyruvate Dehydrogenase Complex; Rats; Rats, Zucker; Thiazoles; Thiazolidinediones; Troglitazone | 1999 |
Lipotoxic heart disease in obese rats: implications for human obesity.
Topics: Age Factors; Animals; Apoptosis; Blood Glucose; Body Weight; Chromans; DNA Fragmentation; Echocardiography; Heart Diseases; Humans; Insulin; Lipid Metabolism; Male; Microscopy, Electron; Myocardium; Obesity; Organ Size; Rats; Rats, Zucker; RNA, Messenger; Thiazoles; Thiazolidinediones; Troglitazone | 2000 |
Fenofibrate and rosiglitazone lower serum triglycerides with opposing effects on body weight.
Topics: Acyl-CoA Oxidase; Animals; Apolipoprotein A-I; Apolipoprotein C-III; Apolipoproteins C; Body Weight; Carrier Proteins; Fatty Acid-Binding Protein 7; Fatty Acid-Binding Proteins; Fenofibrate; Hypolipidemic Agents; Male; Mice; Myelin P2 Protein; Neoplasm Proteins; Nerve Tissue Proteins; Oxidoreductases; Rats; Rats, Zucker; Receptors, Cytoplasmic and Nuclear; Rosiglitazone; Thiazoles; Thiazolidinediones; Thiazolidines; Time Factors; Transcription Factors; Triglycerides | 2000 |
Pioglitazone attenuates basal and postprandial insulin concentrations and blood pressure in the spontaneously hypertensive rat.
Topics: Animals; Area Under Curve; Blood Glucose; Blood Pressure; Body Weight; Diabetes Mellitus, Type 2; Glucose; Hyperglycemia; Hyperinsulinism; Hypertension; Hypoglycemic Agents; Insulin; Male; Pioglitazone; Postprandial Period; Rats; Rats, Inbred SHR; Thiazoles; Thiazolidinediones | 2000 |
Effects of peroxisome proliferator-activated receptor-alpha and -gamma agonist, JTT-501, on diabetic complications in Zucker diabetic fatty rats.
Topics: Absorptiometry, Photon; Animals; Body Weight; Bone Density; Bone Diseases, Metabolic; Cataract; Chromans; Diabetes Complications; Diabetes Mellitus; Diabetic Nephropathies; Diabetic Neuropathies; Eating; Hypoglycemic Agents; Isoxazoles; Male; Neural Conduction; Obesity; Pancreas; Rats; Rats, Zucker; Receptors, Cytoplasmic and Nuclear; Thiazoles; Thiazolidinediones; Time Factors; Transcription Factors; Troglitazone | 2000 |
Effect of the specific cyclooxygenase-2 inhibitor meloxicam on tumour growth and cachexia in a murine model.
Topics: Adenocarcinoma; Animals; Body Weight; Cachexia; Colonic Neoplasms; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dose-Response Relationship, Drug; Isoenzymes; Male; Meloxicam; Mice; Mice, Inbred Strains; Neoplasm Transplantation; Prostaglandin-Endoperoxide Synthases; Thiazines; Thiazoles; Time Factors | 2000 |
A new thiazolidinedione, NC-2100, which is a weak PPAR-gamma activator, exhibits potent antidiabetic effects and induces uncoupling protein 1 in white adipose tissue of KKAy obese mice.
Topics: Adipose Tissue; Animals; Body Weight; Carrier Proteins; Diabetes Mellitus; Hypoglycemic Agents; Ion Channels; Male; Membrane Proteins; Mice; Mice, Mutant Strains; Mitochondrial Proteins; Obesity; Organ Size; Quinolines; Receptors, Cytoplasmic and Nuclear; Thiazoles; Transcription Factors; Uncoupling Protein 1 | 2000 |
Selective cyclooxygenase-2 inhibition prevents alveolar bone loss in experimental periodontitis in rats.
Topics: Alveolar Bone Loss; Alveolar Process; Animals; Anti-Inflammatory Agents, Non-Steroidal; Body Weight; Cell Count; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Disease Models, Animal; Indomethacin; Injections, Subcutaneous; Isoenzymes; Leukocyte Count; Leukocytes, Mononuclear; Leukocytosis; Male; Meloxicam; Molar; Neutrophils; Osteoclasts; Periodontitis; Peroxidases; Prostaglandin-Endoperoxide Synthases; Rats; Rats, Wistar; Stomach; Thiazines; Thiazoles; Tooth Cervix | 2000 |
Enhancing effects of 2-amino-4,5-diphenylthiazole-induced polycystic kidneys on renal carcinogenesis in rats treated with dimethylnitrosamine.
Topics: Animals; Body Weight; Cytochrome P-450 CYP2E1; Dimethylnitrosamine; Immunohistochemistry; Kidney Neoplasms; Male; Organ Size; Polycystic Kidney Diseases; Proliferating Cell Nuclear Antigen; Rats; Rats, Wistar; Thiazoles | 2000 |
Retinoid X receptor agonists have anti-obesity effects and improve insulin sensitivity in Zucker fa/fa rats.
Topics: Analysis of Variance; Animals; Blood Glucose; Body Weight; Eating; Hypoglycemic Agents; Insulin; Insulin Resistance; Male; Nicotinic Acids; Obesity; Rats; Rats, Zucker; Receptors, Retinoic Acid; Retinoid X Receptors; Rosiglitazone; Tetrahydronaphthalenes; Thiazoles; Thiazolidinediones; Transcription Factors | 2000 |
Troglitazone prevents and reverses dyslipidemia, insulin secretory defects, and histologic abnormalities in a rat model of naturally occurring obese diabetes.
Topics: Adipose Tissue; Aging; Animals; Blood Glucose; Body Weight; Cholesterol; Chromans; Diabetes Mellitus; Diabetes Mellitus, Type 2; Eating; Fasting; Fatty Acids, Nonesterified; Glucose Tolerance Test; Hyperlipidemias; Hypoglycemic Agents; Insulin; Insulin Secretion; Male; Obesity; Organ Size; Pancreas; Rats; Rats, Inbred Strains; Thiazoles; Thiazolidinediones; Triglycerides; Troglitazone | 2000 |
Beneficial insulin-sensitizing and vascular effects of S15261 in the insulin-resistant JCR:LA-cp rat.
Topics: Animals; Blood Glucose; Body Weight; Chromans; Eating; Fluorenes; Gene Expression; Glucose Tolerance Test; Glucose-6-Phosphatase; Hypoglycemic Agents; In Vitro Techniques; Insulin; Insulin Resistance; Lactic Acid; Lipids; Liver; Male; Mesenteric Arteries; Metformin; Muscle Relaxation; Muscle, Smooth, Vascular; Phosphoenolpyruvate Carboxylase; Rats; RNA, Messenger; Thiazoles; Thiazolidinediones; Troglitazone; Vascular Resistance | 2000 |
Troglitazone (CS-045) normalizes hypertriglyceridemia and restores the altered patterns of glucose-stimulated insulin secretion in dyslipidemic rats.
Topics: Animals; Body Weight; Chromans; Dietary Sucrose; Fatty Acids, Nonesterified; Glucose; Hypertriglyceridemia; Hypoglycemic Agents; Insulin; Insulin Secretion; Liver; Male; Rats; Rats, Wistar; Thiazoles; Thiazolidinediones; Triglycerides; Troglitazone | 2000 |
Renal protective effect of troglitazone in Wistar fatty rats.
Topics: Animals; Blood Pressure; Body Weight; Chromans; Female; Hypoglycemic Agents; Insulin Resistance; Kidney; Proteinuria; Rats; Rats, Wistar; Thiazoles; Thiazolidinediones; Troglitazone | 2000 |
Aging and the neuroendocrine regulation of reproduction and body weight.
Topics: Aging; Animals; Arcuate Nucleus of Hypothalamus; Body Composition; Body Weight; Chromans; Eating; Gene Expression Regulation, Developmental; Gonadotropin-Releasing Hormone; Gonadotropins, Pituitary; Humans; Hypoglycemic Agents; Insulin; Leptin; Male; Models, Animal; Neuropeptide Y; Neurosecretory Systems; Pituitary Gland; Rats; Rats, Inbred BN; Reproduction; RNA, Messenger; Testis; Thiazoles; Thiazolidinediones; Troglitazone; Weight Gain | 2000 |
Troglitazone halts diabetic glomerulosclerosis by blockade of mesangial expansion.
Topics: Animals; Basement Membrane; Body Weight; Chondroitin Sulfate Proteoglycans; Chromans; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Disease Models, Animal; Fibrosis; Glomerular Mesangium; Hyperglycemia; Hyperinsulinism; Hypertriglyceridemia; Hypoglycemic Agents; Islets of Langerhans; Rats; Rats, Zucker; Thiazoles; Thiazolidinediones; Troglitazone | 2000 |
UCP3 gene expression does not correlate with muscle oxidation rates in troglitazone-treated Zucker fatty rats.
Topics: Animals; Antioxidants; Body Weight; Carbon Dioxide; Carrier Proteins; Chromans; Diabetes Mellitus, Type 2; Disease Models, Animal; Energy Metabolism; Fatty Acids; Gene Expression Regulation; Glucose; Insulin Resistance; Ion Channels; Mitochondrial Proteins; Muscle, Skeletal; Rats; Rats, Zucker; RNA, Messenger; Thiazoles; Thiazolidinediones; Troglitazone; Uncoupling Protein 3 | 2000 |
Alteration in expression profiles of a series of diabetes-related genes in db/db mice following treatment with thiazolidinediones.
Topics: Adipocytes; Animals; Blood Glucose; Body Weight; Chromans; Diabetes Mellitus, Experimental; Female; Gene Expression; Gene Expression Profiling; Hypoglycemic Agents; Liver; Mice; Muscles; Pioglitazone; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Thiazoles; Thiazolidinediones; Triglycerides; Troglitazone | 2000 |
Dietary fat-induced increase in blood pressure and insulin resistance in rats.
Topics: Adipose Tissue; Animals; Blood Glucose; Blood Pressure; Body Weight; Chromans; Dietary Carbohydrates; Dietary Fats; Dietary Fats, Unsaturated; Fatty Acids, Nonesterified; Hypertension; Hypoglycemic Agents; Insulin; Insulin Resistance; Male; Obesity; Rats; Rats, Wistar; Sucrose; Thiazoles; Thiazolidinediones; Triglycerides; Troglitazone | 2000 |
The effects of rexinoids and rosiglitazone on body weight and uncoupling protein isoform expression in the Zucker fa/fa rat.
Topics: Adipose Tissue, Brown; Animals; Body Weight; Carrier Proteins; Eating; Ion Channels; Membrane Proteins; Membrane Transport Proteins; Mitochondrial Proteins; Nicotinic Acids; Obesity; Proteins; Rats; Rats, Zucker; Receptors, Retinoic Acid; Retinoid X Receptors; RNA, Messenger; Rosiglitazone; Tetrahydronaphthalenes; Thiazoles; Thiazolidinediones; Transcription Factors; Uncoupling Protein 1; Uncoupling Protein 2; Uncoupling Protein 3; Weight Gain | 2000 |
Cytochrome P450 2E1 (CYP2E1)-dependent production of a 37-kDa acetaldehyde-protein adduct in the rat liver.
Topics: Acetaldehyde; Alcohol Dehydrogenase; Aldehyde Dehydrogenase; Animals; Anticarcinogenic Agents; Body Weight; Cytochrome P-450 CYP2E1; Ethanol; Immunoblotting; Immunohistochemistry; Liver; Male; Molecular Weight; Rats; Rats, Wistar; Thiazoles | 2000 |
Regulation of cardiac and skeletal muscle malonyl-CoA decarboxylase by fatty acids.
Topics: Animals; Aorta; Blood Pressure; Body Weight; Carboxy-Lyases; Chromans; Constriction; Diabetes Mellitus, Experimental; Dietary Fats; Fasting; Fatty Acids; Fatty Acids, Nonesterified; Food; Gene Expression Regulation, Enzymologic; Heart; Male; Muscle, Skeletal; Myocardium; Organ Size; Pyrimidines; Rats; Rats, Sprague-Dawley; Receptors, Cytoplasmic and Nuclear; RNA, Messenger; Thiazoles; Thiazolidinediones; Transcription Factors; Troglitazone | 2001 |
Troglitazone stimulates acetyl-CoA carboxylase activity through a post-translational mechanism.
Topics: Acetyl-CoA Carboxylase; Animals; Body Weight; Chromans; Eating; Hypoglycemic Agents; Indicators and Reagents; Liver; Male; Nuclease Protection Assays; Phosphates; Protein Processing, Post-Translational; Rats; Rats, Inbred F344; RNA, Messenger; Stimulation, Chemical; Subcellular Fractions; Thiazoles; Thiazolidinediones; Troglitazone | 2000 |
Dehydroepiandrosterone suppresses elevated hepatic glucose-6-phosphatase mRNA level in C57BL/KsJ-db/db mice: comparison with troglitazone.
Topics: Animals; Blood Glucose; Blotting, Northern; Body Weight; Chromans; Dehydroepiandrosterone; Diabetes Mellitus; Glucose-6-Phosphatase; Hypoglycemic Agents; Insulin; Insulin Resistance; Liver; Male; Mice; Mice, Inbred C57BL; Organ Size; RNA, Messenger; Thiazoles; Thiazolidinediones; Troglitazone | 2000 |
Troglitazone inhibits formation of early atherosclerotic lesions in diabetic and nondiabetic low density lipoprotein receptor-deficient mice.
Topics: Animals; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Aorta; Arteriosclerosis; Blood Glucose; Body Weight; Cell Movement; Cells, Cultured; Chemokine CCL2; Chromans; Diabetes Mellitus, Type 2; Dietary Carbohydrates; Dietary Fats; Endothelium, Vascular; Flavonoids; Fructose; Humans; Insulin; Lipids; Macrophages; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Monocytes; Receptors, LDL; Rosiglitazone; Thiazoles; Thiazolidinediones; Troglitazone; Tumor Cells, Cultured; Vasodilator Agents | 2001 |
Troglitazone inhibits atherosclerosis in apolipoprotein E-knockout mice: pleiotropic effects on CD36 expression and HDL.
Topics: Animals; Aorta; Apolipoproteins E; Arteriosclerosis; Blood Glucose; Blotting, Northern; Body Weight; CD36 Antigens; Cells, Cultured; Chromans; Fatty Acids, Nonesterified; Female; Gene Expression Regulation; Hypoglycemic Agents; Insulin; Lipids; Lipoprotein Lipase; Lipoproteins; Lipoproteins, HDL; Macrophages, Peritoneal; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Receptors, Cytoplasmic and Nuclear; RNA, Messenger; Thiazoles; Thiazolidinediones; Time Factors; Transcription Factors; Troglitazone | 2001 |
Troglitazone corrects metabolic changes but not vascular dysfunction in dietary-obese rats.
Topics: Acetylcholine; Animals; Blood Glucose; Body Weight; Chromans; Diet; Dose-Response Relationship, Drug; Endothelium, Vascular; Energy Metabolism; Fatty Acids, Nonesterified; Female; Hypoglycemic Agents; In Vitro Techniques; Insulin; Leptin; Mesenteric Arteries; Nitroprusside; Norepinephrine; Obesity; Potassium Chloride; Rats; Rats, Wistar; Thiazoles; Thiazolidinediones; Triglycerides; Troglitazone; Vasoconstriction; Vasoconstrictor Agents; Vasodilation; Vasodilator Agents | 2001 |
Effect of obesity and troglitazone on expression of two glutathione peroxidases: cellular and extracellular types in serum, kidney and adipose tissue.
Topics: Adipose Tissue; Animals; Blood Glucose; Blotting, Western; Body Weight; Chromans; Enzyme-Linked Immunosorbent Assay; Gene Expression Regulation, Enzymologic; Glutathione Peroxidase; Kidney; Male; Obesity; Organ Size; Rats; Rats, Inbred OLETF; Rats, Inbred Strains; Reverse Transcriptase Polymerase Chain Reaction; Thiazoles; Thiazolidinediones; Troglitazone; Tumor Necrosis Factor-alpha | 2001 |
Beta-cell mass dynamics in Zucker diabetic fatty rats. Rosiglitazone prevents the rise in net cell death.
Topics: Aging; Animals; Blood Glucose; Body Weight; Cell Death; Diabetes Mellitus; Diabetes Mellitus, Type 2; Fatty Acids, Nonesterified; Hypoglycemic Agents; Insulin; Islets of Langerhans; Male; Obesity; Organ Size; Pancreas; Rats; Rats, Zucker; Rosiglitazone; Thiazoles; Thiazolidinediones | 2001 |
Thiazolidinediones increase plasma-adipose tissue FFA exchange capacity and enhance insulin-mediated control of systemic FFA availability.
Topics: Adipose Tissue; Animals; Blood Glucose; Body Weight; Fasting; Fatty Acids, Nonesterified; Glucose Clamp Technique; Humans; Hyperinsulinism; Hypertriglyceridemia; Hypoglycemic Agents; Infusions, Intravenous; Insulin; Kinetics; Lipid Mobilization; Lipoproteins, VLDL; Liver; Male; Metabolic Clearance Rate; Muscle, Skeletal; Obesity; Oxidation-Reduction; Polyethylene Glycols; Postprandial Period; Rats; Rats, Zucker; Rosiglitazone; Thiazoles; Thiazolidinediones; Time Factors; Triglycerides | 2001 |
Insulin-sensitizing action of rosiglitazone is enhanced by preventing hyperphagia.
Topics: Animals; Body Weight; Carrier Proteins; Eating; Food Deprivation; Hyperphagia; Hypoglycemic Agents; Hypothalamus; Insulin Resistance; Ion Channels; Leptin; Male; Mitochondrial Proteins; Neuropeptide Y; Obesity; Rats; Rats, Wistar; RNA, Messenger; Rosiglitazone; Thiazoles; Thiazolidinediones; Uncoupling Protein 3 | 2001 |
Effects of troglitazone and voluntary running on insulin resistance induced high fat diet in the rat.
Topics: Animals; Blood Glucose; Body Weight; Chromans; Dietary Fats; Female; Glucose; Glucose Clamp Technique; Glycogen; Hypoglycemic Agents; Insulin; Insulin Resistance; Muscle, Skeletal; Rats; Rats, Wistar; Running; Thiazoles; Thiazolidinediones; Troglitazone | 2001 |
A thiazolidinedione improves in vivo insulin action on skeletal muscle glycogen synthase in insulin-resistant monkeys.
Topics: Adipose Tissue; Animals; Blood Glucose; Body Weight; Glucose Clamp Technique; Glucose-6-Phosphate; Glycogen Synthase; Hypoglycemic Agents; Infusions, Intravenous; Insulin; Insulin Resistance; Macaca mulatta; Male; Muscle, Skeletal; Obesity; Thiazoles | 2000 |
Characterization of an inhibitory effect of pioglitazone on balloon-injured vascular smooth muscle cell growth.
Topics: Animals; Body Weight; Cell Division; Cells, Cultured; DNA Replication; Male; Mitogen-Activated Protein Kinases; Muscle, Smooth, Vascular; Nuclear Proteins; Phosphorylation; Pioglitazone; Rats; Rats, Sprague-Dawley; Thiazoles; Thiazolidinediones | 2001 |
A unique PPARgamma ligand with potent insulin-sensitizing yet weak adipogenic activity.
Topics: Adipocytes; Amino Acids; Animals; Binding Sites; Blood Glucose; Body Weight; Cell Differentiation; Cell Line; Dose-Response Relationship, Drug; Fluorenes; Gene Expression Regulation; Genes, Reporter; Hypoglycemic Agents; Insulin Resistance; Leucine; Ligands; Male; Mice; Mice, Inbred Strains; Molecular Structure; Protein Binding; Protein Conformation; Receptors, Cytoplasmic and Nuclear; Recombinant Fusion Proteins; Rosiglitazone; Spectrometry, Mass, Electrospray Ionization; Thiazoles; Thiazolidinediones; Transcription Factors; Transcriptional Activation; Tyrosine | 2001 |
Insulin-sensitizing effect of rosiglitazone (BRL-49653) by regulation of glucose transporters in muscle and fat of Zucker rats.
Topics: 3T3 Cells; Adipocytes; Adipose Tissue; Administration, Oral; Animals; Blood Glucose; Body Weight; Glucose; Glucose Clamp Technique; Glucose Transporter Type 1; Glucose Transporter Type 4; Hypoglycemic Agents; Insulin; Insulin Resistance; Male; Mice; Monosaccharide Transport Proteins; Muscle Proteins; Muscle, Skeletal; Obesity; Rats; Rats, Zucker; Rosiglitazone; Thiazoles; Thiazolidinediones; Thinness | 2001 |
Increased lymphatic lipid transport in genetically diabetic obese rats.
Topics: Animals; Bile Acids and Salts; Body Weight; Carrier Proteins; Chromans; Diabetes Mellitus; Diabetes Mellitus, Type 2; Energy Intake; Fistula; Hypoglycemic Agents; Lymphatic System; Male; Obesity; Phosphatidylcholines; Physical Conditioning, Animal; Rats; Rats, Inbred OLETF; Thiazoles; Thiazolidinediones; Triglycerides; Troglitazone | 2002 |
Thiazolidinediones influence plasma steroids of male obese Zucker rats.
Topics: Animals; Blood Glucose; Body Weight; Chromans; Glucose; Hormones; Insulin; Male; Muscle, Skeletal; Obesity; Rats; Rats, Zucker; Rosiglitazone; Thiazoles; Thiazolidinediones; Troglitazone | 2002 |
Peroxisome proliferator-activated receptor gamma plays a critical role in inhibition of cardiac hypertrophy in vitro and in vivo.
Topics: Actins; Angiotensin II; Animals; Atrial Natriuretic Factor; Body Weight; Cardiomegaly; Cell Size; Cells, Cultured; Chromans; Disease Models, Animal; Gene Expression; Heart; Heterozygote; Hypoglycemic Agents; Ligands; Mice; Mice, Knockout; Myocardium; Organ Size; Pioglitazone; Rats; Rats, Wistar; Receptors, Cytoplasmic and Nuclear; Rosiglitazone; Thiazoles; Thiazolidinediones; Transcription Factors; Troglitazone | 2002 |
Troglitazone stimulates pancreatic growth in normal rats.
Topics: Aging; Alanine Transaminase; Amylases; Animals; Aspartate Aminotransferases; Blood Glucose; Body Weight; Cholecystokinin; Chromans; Diet; DNA; Eating; Hypoglycemic Agents; Insulin; Insulin Resistance; Liver; Male; Organ Size; Pancreas; Proteins; Rats; Rats, Long-Evans; Receptors, Cytoplasmic and Nuclear; Thiazoles; Thiazolidinediones; Transcription Factors; Troglitazone | 2002 |
Thiazolidinedione derivatives ameliorate albuminuria in streptozotocin-induced diabetic spontaneous hypertensive rat.
Topics: Albuminuria; Animals; Basement Membrane; Blood Glucose; Blood Pressure; Body Weight; Chromans; Creatinine; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Hemodynamics; Hypoglycemic Agents; Kidney Glomerulus; Male; Rats; Rats, Inbred SHR; Reference Values; Thiazoles; Thiazolidinediones; Troglitazone | 2002 |
Long-term treatment with the dipeptidyl peptidase IV inhibitor P32/98 causes sustained improvements in glucose tolerance, insulin sensitivity, hyperinsulinemia, and beta-cell glucose responsiveness in VDF (fa/fa) Zucker rats.
Topics: Acetyl-CoA Carboxylase; Adipose Tissue; Animals; Blood Glucose; Body Weight; Dipeptidyl Peptidase 4; Drinking Behavior; Glucose; Glucose Tolerance Test; Glycogen Synthase; Hyperinsulinism; Insulin; Islets of Langerhans; Male; Muscle, Skeletal; Pentanoic Acids; Protease Inhibitors; Rats; Rats, Zucker; Reference Values; Thiazoles; Thiazolidines; Time Factors | 2002 |
Thiazolidinedione treatment normalizes insulin resistance and ischemic injury in the zucker Fatty rat heart.
Topics: Animals; Blood Glucose; Blood Pressure; Body Weight; Heart; Heart Rate; Hypoglycemic Agents; Insulin Resistance; Myocardial Ischemia; Myocardial Reperfusion; Obesity; Organ Size; Perfusion; Rats; Rats, Zucker; Reference Values; Rosiglitazone; Thiazoles; Thiazolidinediones; Time Factors | 2002 |
A peroxisome proliferator-activated receptor gamma agonist influenced daily profile of energy expenditure in genetically obese diabetic rats.
Topics: Animals; Blood Glucose; Body Weight; Diabetes Mellitus; Diet; Energy Metabolism; Hypoglycemic Agents; Leptin; Lipids; Obesity; Organ Size; Pancreas; Pioglitazone; Rats; Rats, Inbred OLETF; Receptors, Cytoplasmic and Nuclear; Thiazoles; Thiazolidinediones; Transcription Factors; Tumor Necrosis Factor-alpha | 2002 |
Effects of combined pioglitazone and metformin on diabetes and obesity in Wistar fatty rats.
Topics: Adipose Tissue; Animals; Body Weight; Diabetes Mellitus; Drug Therapy, Combination; Eating; Glycogen; Hypoglycemic Agents; Ketone Bodies; Liver; Male; Metformin; Muscle, Skeletal; Obesity; Organ Size; Pioglitazone; Rats; Rats, Wistar; Thiazoles; Thiazolidinediones | 2002 |
Structure, endothelial function, cell growth, and inflammation in blood vessels of angiotensin II-infused rats: role of peroxisome proliferator-activated receptor-gamma.
Topics: Aldosterone; Angiotensin II; Animals; Blood Pressure; Blood Vessels; Body Weight; Cell Cycle Proteins; Cell Division; Collagen; DNA; Drug Administration Schedule; Endothelium, Vascular; In Vitro Techniques; Inflammation; Injections, Subcutaneous; Lipids; Male; NF-kappa B; Pioglitazone; Platelet Endothelial Cell Adhesion Molecule-1; Rats; Rats, Sprague-Dawley; Receptors, Angiotensin; Receptors, Cytoplasmic and Nuclear; Renin; Rosiglitazone; Thiazoles; Thiazolidinediones; Transcription Factors; Vascular Cell Adhesion Molecule-1; Vasoconstrictor Agents; Vasodilator Agents | 2002 |
Effect of pioglitazone on abdominal fat distribution and insulin sensitivity in type 2 diabetic patients.
Topics: Abdomen; Adipose Tissue; Adult; Aged; Blood Glucose; Body Weight; Diabetes Mellitus, Type 2; Female; Glucose; Glucose Clamp Technique; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Male; Middle Aged; Pioglitazone; Regression Analysis; Thiazoles; Thiazolidinediones | 2002 |
Lipid response to pioglitazone in diabetic patients: clinical observations from a retrospective chart review.
Topics: Anticholesteremic Agents; Blood Glucose; Body Weight; California; Cholesterol, HDL; Cholesterol, LDL; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Ethnicity; Female; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Lipids; Male; Middle Aged; Pioglitazone; Retrospective Studies; Thiazoles; Thiazolidinediones; Triglycerides | 2002 |
Combination of insulin and thiazolidinedione therapy in massively obese patients with Type 2 diabetes.
Topics: Adult; Aged; Body Mass Index; Body Weight; Diabetes Complications; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Edema; Female; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Male; Middle Aged; Obesity; Rosiglitazone; Thiazoles; Thiazolidinediones | 2002 |
Favorable effects of the antioxidants sodium and magnesium thiazolidine carboxylate on the vitality and life span of Drosophila and mice.
Topics: Aging; Animals; Antioxidants; Body Weight; Drosophila melanogaster; Eating; Female; Longevity; Magnesium; Male; Mice; Sexual Behavior, Animal; Sodium; Thiazoles | 1979 |
[Effects of oxythiamine and pyrithiamine on rat liver. --Biochemical and morphological changes in the thiamine deficient rat (author's transl)].
Topics: Animals; Body Weight; Diet; Lipid Metabolism; Liver; Male; Microscopy, Electron; Organ Size; Oxythiamine; Pyridinium Compounds; Pyrithiamine; Rats; Thiamine; Thiamine Deficiency; Thiazoles | 1979 |
[Toxicological study on piprozoline (author's transl)].
Topics: Animals; Body Weight; Cholagogues and Choleretics; Dogs; Female; Fertility; Fetal Resorption; Male; Piperidines; Pregnancy; Rabbits; Rats; Teratogens; Thiazoles | 1977 |
Effect of thiamine deficiency, pyrithiamine and oxythiamine on pyruvate metabolism in rat liver and brain in vivo.
Topics: Animals; Aspartic Acid; Body Weight; Brain; Decarboxylation; Glutamates; Liver; Male; Oxythiamine; Pyridinium Compounds; Pyrithiamine; Pyruvates; Rats; Thiamine Deficiency; Thiazoles | 1977 |
Effects of ozolinone, a diuretic active metabolite of etozoline, on renal function. II. Localization of tubular site of diuretic action by micropuncture in the rat.
Topics: Animals; Blood Pressure; Body Weight; Diuretics; Half-Life; Kidney; Kidney Tubules; Male; Nephrons; Potassium; Rats; Regional Blood Flow; Sodium; Thiazoles | 1978 |
A profile of the gastrointestinal toxicity of aspirin, indomethacin, oxaprozin, phenylbutazone, and fentiazac in arthritic and Lewis normal rats.
Topics: Acetates; Animals; Anti-Inflammatory Agents; Arthritis; Arthritis, Experimental; Aspirin; Body Weight; Gastrointestinal Diseases; Indomethacin; Intestine, Small; Male; Oxazoles; Phenylbutazone; Propionates; Rats; Stomach; Thiazoles; Time Factors | 1977 |
Effect of 1-(m-chlorophenyl)-3-N,N-dimethyl-carbamoyl-5-methoxypyrazole (PZ-177) on drug-metabolizing enzyme on rat liver.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Benzothiazoles; Body Weight; Enzyme Induction; Kinetics; Liver; Male; Organ Size; Phenobarbital; Phenylbutazone; Piperazines; Pyrazoles; Rats; Thiazoles; Time Factors | 1976 |
Effect of avitaminosis A and hypervitaminosis A on urinary bladder carcinogenicity of N-(4-(5-Nitro-2-furyl)-2-thiazolyl)formamide.
Topics: Animals; Body Weight; FANFT; Female; Metaplasia; Neoplasms, Experimental; Rats; Thiazoles; Urinary Bladder; Urinary Bladder Diseases; Urinary Bladder Neoplasms; Vitamin A; Vitamin A Deficiency | 1976 |
Ciglitazone prevents and reverses dexamethasone-induced hyperglycemia in female viable yellow mice.
Topics: Administration, Oral; Animals; Blood Glucose; Body Weight; Corticosterone; Dexamethasone; Dose-Response Relationship, Drug; Female; Hyperglycemia; Hypoglycemic Agents; Insulin; Male; Mice; Thiazoles; Thiazolidinediones | 1992 |
Elevation of lung glutathione by oral supplementation of L-2-oxothiazolidine-4-carboxylate protects against oxygen toxicity in protein-energy malnourished rats.
Topics: Administration, Oral; Animals; Body Weight; Glutathione; Lung; Magnetic Resonance Spectroscopy; Organ Size; Oxygen; Protein-Energy Malnutrition; Pyrrolidonecarboxylic Acid; Rats; Rats, Inbred Strains; Thiazoles; Thiazolidines | 1992 |
Comparative biochemical and morphometric changes associated with induction of the hepatic mixed function oxidase system in the rat.
Topics: 7-Alkoxycoumarin O-Dealkylase; Animals; Anti-Inflammatory Agents, Non-Steroidal; Body Weight; Cytochrome P-450 CYP4A; Cytochrome P-450 Enzyme System; Dose-Response Relationship, Drug; Enzyme Induction; Hypertrophy; Imidazoles; Leukotriene B4; Liver; Male; Microscopy, Electron; Mixed Function Oxygenases; Organ Size; Organelles; Phenobarbital; Rats; Rats, Inbred Strains; Thiazoles | 1991 |
Thiazolidine-4-carboxylate and 2-phenylthiazolidine-4-carboxylate are active as cysteine precursors but have no effect on growth of a methionine-dependent tumor in rats.
Topics: Amino Acids; Animals; Antineoplastic Agents; Body Weight; Cysteine; Glutathione; Male; Methionine; Rats; Rats, Inbred Strains; Rhabdomyosarcoma; Thiazoles; Thiazolidines | 1992 |
Effects of pioglitazone on hepatic and peripheral insulin resistance in Wistar fatty rats.
Topics: Animals; Blood Glucose; Body Weight; Hyperglycemia; Hypoglycemic Agents; Insulin; Insulin Resistance; Liver; Male; Pioglitazone; Rats; Rats, Inbred Strains; Thiazoles; Thiazolidinediones; Triglycerides | 1990 |
Marked nitrosation by stimulation with lipopolysaccharide in ascorbic acid-deficient rats.
Topics: Adrenal Glands; Animals; Ascorbic Acid; Ascorbic Acid Deficiency; Body Weight; Bone Diseases, Metabolic; Escherichia coli; Female; Kidney; Lipopolysaccharides; Liver; Nitrates; Nitroso Compounds; Rats; Rats, Mutant Strains; Spleen; Thiazoles; Thiazolidines | 1990 |
Effects of L-2-oxothiazolidine-4-carboxylate, a cysteine pro-drug, on teratogenicity of 5-fluorouracil in mice.
Topics: Animals; Body Weight; Cystine; Drug Synergism; Female; Fluorouracil; Glutathione; Limb Deformities, Congenital; Liver; Maternal-Fetal Exchange; Mice; Mice, Inbred ICR; Pregnancy; Pyrrolidonecarboxylic Acid; Thiazoles; Thiazolidines | 1990 |
[Toxicity of 2-mercaptobenzothiazole in mice].
Topics: Administration, Oral; Animals; Benzothiazoles; Body Weight; Eating; Female; Hematologic Tests; Lethal Dose 50; Liver; Lung; Male; Mice; Thiazoles | 1989 |
Famotidine: summary of preclinical safety assessment.
Topics: Administration, Oral; Animals; Body Weight; Dogs; Dose-Response Relationship, Drug; Drug Evaluation; Famotidine; Female; Histamine H2 Antagonists; Injections, Intravenous; Lethal Dose 50; Mice; Microscopy, Electron; Mutagenicity Tests; Pregnancy; Rabbits; Rats; Reproduction; Stomach; Thiazoles | 1985 |
Diphenylthiazole-induced changes in renal ultrastructure and enzymology: toxicologic mechanisms in polycystic kidney disease?
Topics: Animals; Body Weight; Glucuronidase; Glucuronosyltransferase; Glycosaminoglycans; Hydrogen Peroxide; Kidney; Male; Polycystic Kidney Diseases; Rats; Rats, Inbred Strains; Sulfates; Thiazoles; Uridine Diphosphate Glucuronic Acid | 1987 |
Effects of aldose reductase inhibitor on retinal microangiopathy in streptozotocin-diabetic rats.
Topics: Aldehyde Reductase; Animals; Basement Membrane; Blood Glucose; Body Weight; Capillaries; Diabetes Mellitus, Experimental; Diabetic Angiopathies; Male; Microscopy, Electron; Rats; Rats, Inbred Strains; Retinal Vessels; Rhodanine; Streptozocin; Sugar Alcohol Dehydrogenases; Thiazoles; Thiazolidines | 1985 |
The acute toxicity and mutagenic potential of 3-methyl-2-benzothiazolinone hydrazone.
Topics: Animals; Benzothiazoles; Body Weight; Eye Diseases; Female; Hydrazones; In Vitro Techniques; Irritants; Male; Mutagenicity Tests; Mutagens; Rabbits; Rats; Rats, Inbred Strains; Salmonella typhimurium; Skin Diseases; Thiazoles | 1988 |
Effect of dietary protein deficiency and L-2-oxothiazolidine-4-carboxylate on the diurnal rhythm of hepatic glutathione in the rat.
Topics: Analysis of Variance; Animals; Body Weight; Circadian Rhythm; Cysteine; Diet; Glutathione; Liver; Male; Protein Deficiency; Pyrrolidonecarboxylic Acid; Rats; Rats, Inbred Strains; Thiazoles; Thiazolidines; Time Factors | 1988 |
Effects of ciglitazone on energy balance, thermogenesis and brown fat activity in the rat.
Topics: Adipose Tissue, Brown; Animals; Body Temperature Regulation; Body Weight; Eating; Energy Metabolism; Male; Oxygen Consumption; Propranolol; Purine Nucleotides; Rats; Rats, Inbred Strains; Thiazoles; Thiazolidinediones | 1987 |
Inhibition by aspirin of N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide initiation and sodium saccharin promotion of urinary bladder carcinogenesis in male F344 rats.
Topics: Animals; Aspirin; Body Weight; Cocarcinogenesis; FANFT; Hydrogen-Ion Concentration; Male; Rats; Rats, Inbred F344; Saccharin; Thiazoles; Urinary Bladder Neoplasms | 1986 |
Platelet activating factor-induced ischemic bowel necrosis: the effect of PAF antagonists.
Topics: Animals; Body Weight; Hematocrit; Intestine, Small; Ischemia; Lipopolysaccharides; Male; Necrosis; Platelet Activating Factor; Rats; Rats, Inbred Strains; Splanchnic Circulation; Thiazoles | 1986 |
An animal model of iron overload and its application to study hepatic ferritin iron mobilization by chelators.
Topics: Administration, Oral; Animals; Body Weight; Chelating Agents; Deferoxamine; Dihydropyridines; Ferritins; Ferrous Compounds; Injections, Intraperitoneal; Liver; Male; Metallocenes; Organ Size; Organometallic Compounds; Pyridines; Rats; Rats, Inbred Strains; Thiazoles | 1986 |
The influence of simultaneous exposure to carbon disulfide and hydrogen sulfide on the peripheral nerve toxicity and metabolism of carbon disulfide in rats.
Topics: Animals; Body Weight; Carbon Disulfide; Hydrogen Sulfide; Male; Neural Conduction; Peripheral Nerves; Rats; Rats, Inbred Strains; Thiazoles; Thiazolidines | 1986 |
Production of urinary tract tumors by co-administration of uracil and N-[4-(5-nitro-2-furyl)-2-thiazolyl]-formamide in F344 rats.
Topics: Animals; Body Weight; Carcinoma; Cocarcinogenesis; FANFT; Female; Hyperplasia; Kidney Pelvis; Rats; Rats, Inbred F344; Thiazoles; Uracil; Ureter; Urinary Bladder; Urinary Bladder Calculi; Urinary Bladder Neoplasms | 1987 |
Pre-clinical toxicology of nitazoxanide--a new antiparasitic compound.
Topics: Animals; Anticestodal Agents; Blood Chemical Analysis; Body Weight; Cats; Dogs; Eye; Female; Irritants; Lethal Dose 50; Male; Mice; Mutagenicity Tests; Nitro Compounds; Organ Size; Rats; Rats, Inbred Strains; Salmonella typhimurium; Species Specificity; Stomach Ulcer; Thiazoles | 1985 |
Toxicological and teratological studies of 4((5-chloro-2-oxo-3-benzothiazolinyl)acetyl)-1-piperazine ethanol hydrochloride (Tiaramide hydrochloride), an anti-inflammatory drug.
Topics: Abnormalities, Drug-Induced; Animals; Anti-Inflammatory Agents; Behavior, Animal; Blood Cells; Blood Chemical Analysis; Body Weight; Dogs; Ethanol; Female; Fetus; Haplorhini; Lethal Dose 50; Macaca; Male; Mice; Organ Size; Piperazines; Pregnancy; Rabbits; Rats; Seizures; Thiazoles; Time Factors | 1973 |
The effects of thiamine deprivation, and oxythiamine- and pyrithiamine-treatment on cardiac function and metabolism in the rat.
Topics: Adenosine Diphosphate; Adenosine Monophosphate; Adenosine Triphosphate; Animals; Antimetabolites; Body Weight; Carbon Dioxide; Cardiomegaly; Electrocardiography; Heart; Heart Rate; Hydrogen-Ion Concentration; Lactates; Male; Myocardium; Organ Size; Phosphocreatine; Pyridinium Compounds; Pyrimidines; Pyruvates; Rats; Thiamine; Thiamine Deficiency; Thiazoles | 1974 |
Carcinogenicity of formic acid 2-[4-(5-nitro-2-furyl)-2-thiazolyl]-hydrazide in Swiss mice.
Topics: Adenocarcinoma; Adenocarcinoma, Bronchiolo-Alveolar; Animals; Body Weight; Carcinogens; Carcinoma, Squamous Cell; Diet; Female; Formates; Hydrazines; Leukemia, Experimental; Liver Neoplasms; Lung Neoplasms; Mammary Neoplasms, Experimental; Mice; Neoplasm Metastasis; Neoplasms, Experimental; Nitrofurans; Skin Neoplasms; Stomach Neoplasms; Thiazoles; Uterine Neoplasms | 1970 |
Some observations on the toxicology of morphine-N-oxide.
Topics: Acridines; Animals; Body Weight; Female; Fetus; Growth; Morphinans; Morphine; Nalorphine; Oxides; Pregnancy; Rats; Spleen; Stomach; Thiazoles | 1969 |
Effect of thiazol-4-ylmethoxyamine, a new inhibition of histamine biosynthesis on brain histamine, monoamine levels and behavior.
Topics: Amines; Animals; Behavior, Animal; Body Weight; Brain; Dopamine; Drinking Behavior; Electroencephalography; Ethers; Exploratory Behavior; Feeding Behavior; Histamine; Histamine H1 Antagonists; Male; Motor Activity; Rats; Thiazoles; Time Factors | 1971 |
[Action of phenylimidothiazole (tetramisole) on the graft versus host reaction. Role of macrophages].
Topics: Animals; Body Weight; Graft vs Host Reaction; Histocompatibility; Hybridization, Genetic; Macrophages; Mice; Organ Size; Spleen; Splenomegaly; Thiazoles; Time Factors; Transplantation, Homologous | 1972 |
[Studies on the influence of electrolytes upon immunization processes. I. Immunological reactivity as a function of the rhodanide level in guinea pigs sensitized with horse serum].
Topics: Animals; Antibodies; Antibody Formation; Binding Sites, Antibody; Body Weight; Cell Membrane Permeability; Cell Migration Inhibition; DNA; Guinea Pigs; Hemagglutination Tests; Horses; Immune Sera; Rhodanine; RNA; Thiazoles | 1974 |
Effects of thiamin deficiency and thiamin antagonists on serum and liver cholesterol levels and on cholesterol biosynthesis in rats.
Topics: Animal Nutritional Physiological Phenomena; Animals; Body Weight; Carbon Radioisotopes; Cholesterol; Fatty Acids; Liver; Male; Organ Size; Pyridinium Compounds; Pyrimidines; Pyruvates; Rats; Sterols; Thiamine; Thiamine Deficiency; Thiazoles; Triglycerides | 1974 |
Basic ethers of 2-anilinobenzothiazoles and 2-anilinobenzoxazoles as potential antidepressants.
Topics: Abnormalities, Drug-Induced; Aniline Compounds; Animals; Antidepressive Agents; Behavior, Animal; Benzoxazoles; Body Weight; Cats; Dogs; Ethers; Female; Haplorhini; Mice; Motor Activity; Pregnancy; Rabbits; Rats; Reserpine; Stimulation, Chemical; Structure-Activity Relationship; Thiazoles | 1972 |
The use of trienbolone acetate implants in heifer beef production at pasture.
Topics: Anabolic Agents; Androstanes; Anilides; Animals; Anthelmintics; Body Weight; Cattle; Female; Growth; Ketones; Thiazoles | 1972 |
Prolonged effect of previous helminth infection in cattle.
Topics: Animals; Anthelmintics; Body Weight; Cattle; Cattle Diseases; Nematode Infections; Thiazoles | 1972 |
Cross tolerance to histamine by the chronic administration of histamine analogues.
Topics: Aerosols; Animals; Asthma; Blood Pressure; Body Weight; Cats; Desensitization, Immunologic; Dogs; Drug Tolerance; Ethylamines; Female; Gastric Juice; Gastric Mucosa; Guinea Pigs; Histamine; In Vitro Techniques; Intestines; Muscle Contraction; Muscle, Smooth; Pyrazoles; Pyridines; Reaction Time; Stimulation, Chemical; Thiazoles | 1972 |
The use of molasses blocks medicated with phenothiazine to control nematodes in sheep in Western Australia.
Topics: Animals; Anthelmintics; Body Weight; Feces; Molasses; Nematoda; Nematode Infections; Parasite Egg Count; Phenothiazines; Sheep; Sheep Diseases; Thiazoles; Wool | 1973 |
Epidemiological studies on gastro-intestinal nematode parasites of sheep. The control of infection in lambs on clean pasture.
Topics: Abomasum; Animals; Animals, Newborn; Anthelmintics; Body Weight; Environment; Female; Gastrointestinal Diseases; Intestine, Large; Intestine, Small; Nematode Infections; Parasite Egg Count; Sheep; Sheep Diseases; Thiazoles | 1973 |
Effects of thiamin antagonists on drug hydroxylation and properties of cytochrome P-450 in the rat.
Topics: Aniline Compounds; Animals; Antimetabolites; Binding, Competitive; Body Weight; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Hexobarbital; Hydroxylation; In Vitro Techniques; Kinetics; Liver; Male; Microsomes, Liver; Mixed Function Oxygenases; Organ Size; Proteins; Pyrimidines; Rats; Thiamine; Thiazoles | 1973 |
Age changes of the sodium rhodanide compartment in piglets.
Topics: Age Factors; Animals; Body Fluids; Body Weight; Extracellular Space; Food; Swine; Thiazoles; Water | 1970 |
Residues of beclotiamine, a new coccidiostat, in chicken tissues and egg yolks, and its toxicity to chickens.
Topics: Alanine Transaminase; Alkaline Phosphatase; Animals; Antiprotozoal Agents; Aspartate Aminotransferases; Body Weight; Chickens; Coccidiosis; Feeding Behavior; Female; Food Additives; Liver; Muscles; Ovum; Poultry Diseases; Thiamine; Thiazoles | 1971 |
Field experiment on levamisole against certain helminths in pigs, with emphasis on test of activity against lungworms.
Topics: Animal Feed; Animals; Anthelmintics; Ascaris; Body Weight; Helminthiasis; Helminthiasis, Animal; Imidazoles; Lung; Metastrongyloidea; Nematode Infections; Strongyloides; Swine; Swine Diseases; Thiazoles; Trichuroidea | 1971 |
Bovine parasitic gastro-enteritis: growth responses following routine anthelmintic treatment of sub-clinical infections in grazing animals.
Topics: Animals; Anthelmintics; Body Weight; Cattle; Cattle Diseases; Diethylcarbamazine; Feces; Female; Gastroenteritis; Larva; Male; Nematode Infections; Parasite Egg Count; Pyrimidines; Thiazoles | 1971 |
The control of parasitism in fat lamb production by routine dosing with tetramisole, thiabendazole and a morantel-diethylcarbamazine combination.
Topics: Animals; Anthelmintics; Body Weight; Diethylcarbamazine; Meat; Nematode Infections; Parasite Egg Count; Pyrimidines; Sheep; Sheep Diseases; Thiabendazole; Thiazoles | 1971 |
Change in delta 4-steroid hydrogenase activity in rat liver after tumor implantation.
Topics: Animals; Body Weight; Carbon Isotopes; Corticosterone; Cortisone; Enzyme Repression; Fasting; Hydrocortisone; In Vitro Techniques; Liver; Male; Mixed Function Oxygenases; Neoplasm Transplantation; Rats; Sarcoma, Experimental; Thiazoles; Time Factors | 1969 |
Dosage schemes and dosage response of niridazole in schistosomiasis.
Topics: Adolescent; Adult; Age Factors; Aged; Anthelmintics; Body Weight; Child; Child, Preschool; Drug Tolerance; Female; Humans; Imidazoles; Infant; Male; Middle Aged; Schistosoma; Schistosomiasis; Thiazoles; Time Factors | 1969 |
The effects of oxythiamine injection into the brain of rats and a comparison with pyrithiamine similarly injected.
Topics: Animals; Body Weight; Brain; Brain Chemistry; Depression, Chemical; Feeding and Eating Disorders; Female; Humans; Phosphates; Picolines; Rats; Stimulation, Chemical; Thiamine; Thiazoles | 1970 |
Effect of treating beef weaners with tetramisole and methyridine on New Zealand hill country.
Topics: Age Factors; Animals; Anthelmintics; Body Weight; Cattle; Cattle Diseases; Helminthiasis; Helminthiasis, Animal; New Zealand; Pyridines; Thiazoles | 1970 |
Biochemical factors involved in the anorexia of thiamin deficiency in rats.
Topics: Aldehydes; Animals; Body Weight; Carbon Dioxide; Carbon Isotopes; Feeding and Eating Disorders; Heptoses; Humans; Intestinal Mucosa; Intestine, Small; Male; Oxidoreductases; Picolines; Pyruvates; Radiochemistry; Rats; Thiamine; Thiamine Deficiency; Thiamine Pyrophosphate; Thiazoles; Time Factors; Transferases | 1971 |
A study of dl-tetramisole in lambs: anthelmintic efficacy and toxicity.
Topics: Abomasum; Animals; Anthelmintics; Body Weight; Feces; Gastrointestinal Diseases; Sheep; Sheep Diseases; Thiazoles; Trichostrongyloidiasis | 1970 |
Evaluation of certain factors related to subclinical parasitism in cattle in Argentina.
Topics: Animals; Anthelmintics; Body Weight; Cattle; Cattle Diseases; Feces; Intestinal Diseases, Parasitic; Isoniazid; Nematoda; Pyridines; Thiabendazole; Thiazoles; Trichostrongyloidiasis | 1970 |
Comparative carcinogenicity in the rat of 2-hydrazinothiazoles with nitrofuryl, nitrophenyl, or aminophenyl substituents in the 4-position.
Topics: Adenocarcinoma; Adenofibroma; Animals; Body Weight; Carcinogens; Chemical Phenomena; Chemistry; Diet; Female; Hydrazines; Lung Neoplasms; Lymphoma, Non-Hodgkin; Mammary Neoplasms, Experimental; Neoplasm Metastasis; Neoplasms, Experimental; Nitrobenzenes; Nitrofurans; Rats; Salivary Gland Neoplasms; Splenic Neoplasms; Thiazoles | 1970 |
Toxicity of the levo form of tetramisole in Angora goats.
Topics: Administration, Oral; Animals; Body Weight; Drug Tolerance; Goats; Imidazoles; Neurologic Manifestations; Poisoning; Seizures; Species Specificity; Thiazoles | 1971 |
[On the use of evaporated homogenized milk as food for premature babies, with special reference to the role of the 2nd carbohydrate].
Topics: Animals; Body Weight; Dietary Carbohydrates; Feces; Humans; Infant Nutritional Physiological Phenomena; Infant, Newborn; Infant, Premature; Milk; Milk, Human; Nitrogen; Oryza; Thiazoles; Thiocyanates | 1967 |
N-Gamma-dimethylaminopropyl-1,2-benzisothiazolone (Bu-310) an anti-inflammatory agent.
Topics: Analgesics; Anesthesia; Animals; Anti-Inflammatory Agents; Anticonvulsants; Antitussive Agents; Body Temperature; Body Weight; Cardiovascular System; Dextrans; Dogs; Edema; Granuloma; Hydrocortisone; Hypophysectomy; Rats; Respiratory System; Thiazoles | 1968 |